<SEC-DOCUMENT>0001558370-25-001016.txt : 20250214
<SEC-HEADER>0001558370-25-001016.hdr.sgml : 20250214
<ACCEPTANCE-DATETIME>20250214163512
ACCESSION NUMBER:		0001558370-25-001016
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250214
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250214
DATE AS OF CHANGE:		20250214

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GLYCOMIMETICS INC
		CENTRAL INDEX KEY:			0001253689
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36177
		FILM NUMBER:		25629890

	BUSINESS ADDRESS:	
		STREET 1:		9708 MEDICAL CENTER DRIVE
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		240-243-1201

	MAIL ADDRESS:	
		STREET 1:		9708 MEDICAL CENTER DRIVE
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>glyc-20250214x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 10.9.0.3 -->
<!-- Based on: iXBRL 1.1 -->
<!-- Created on: 2/14/2025 9:05:58 PM -->
<!-- iXBRL Library version: 1.0.9062.16423 -->
<!-- iXBRL Service Job ID: a4ec0d0c-f234-4ee1-a8a4-8fd40d2bf6a8 -->
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:glyc="http://www.glycomimetics.com/20250214" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html"/><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" name="dei:EntityCentralIndexKey" id="Tc_VFZFOnyiGUW7BkFyDsRoyQ_2_1">0001253689</ix:nonNumeric><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" name="dei:AmendmentFlag" id="Tc_G70hKF1Zr0mf8M4xS-2ptA_3_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="glyc-20250214.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001253689</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-14</xbrli:startDate><xbrli:endDate>2025-02-14</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:9.41%;padding-right:9.41%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:11.5pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;border-top:9pt double #000000;margin:0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><a id="_4b68d034_7df4_4e3b_a977_8d6913c59aa1"></a><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;letter-spacing:-0.1pt;line-height:1.19;text-align:center;margin:0pt;">UNITED STATES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:14pt;font-weight:bold;letter-spacing:-0.1pt;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.1pt;">Washington, DC 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.1pt;">FORM </b><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" name="dei:DocumentType" id="Narr_hkHrv1rqhkqZiIHUhxoJmw"><b style="font-weight:bold;letter-spacing:-0.1pt;">8-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.1pt;">CURRENT REPORT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.1pt;">Pursuant to Section 13 or 15(d) of</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;letter-spacing:-0.1pt;">The Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:9pt;font-weight:bold;letter-spacing:-0.1pt;">Date of Report (Date of earliest event reported):</b><b style="font-size:9pt;font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="Narr_Achih0528kWTRxt5H6pNGQ"><b style="font-size:9pt;font-weight:bold;">February 14, 2025</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" name="dei:EntityRegistrantName" id="Narr_tH5F6Xi56USkDEwsYqDqYA"><b style="font-weight:bold;letter-spacing:-0.1pt;">GlycoMimetics, Inc.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><span style="letter-spacing:-0.1pt;">(Exact name of registrant as specified in its charter)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><a id="_e1f4de58_61bd_4709_b865_8049cd6378dd"></a><a id="Tc_g-djdD3MX0upMeWH_odgyQ_2_0"></a><a id="Tc_5gXmatokvkmN0_UBcxqBMg_2_2"></a><a id="Tc_oPDByRN9VUONTZ16NwWJ1w_2_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:29.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:3.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:31.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:32.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:29.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_TE3aAhMD9Uy8KXayjPqxLQ_1_0"><b style="font-size:9pt;font-weight:bold;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:3.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;letter-spacing:-0.1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" name="dei:EntityFileNumber" id="Tc_VlaW4NVFgUKYklpi8ujmqg_1_2"><b style="font-size:9pt;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">001-36177</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;letter-spacing:-0.1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" name="dei:EntityTaxIdentificationNumber" id="Tc_HtaYfpdrxkurU8KX1CstVA_1_4"><b style="font-size:9pt;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">06-1686563</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:29.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><span style="letter-spacing:-0.1pt;">(State or other jurisdiction of</span> <span style="letter-spacing:-0.1pt;">incorporation)</span></p></td><td style="vertical-align:bottom;width:3.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;letter-spacing:-0.1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:31.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><span style="letter-spacing:-0.1pt;">(Commission File Number)</span></p></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;letter-spacing:-0.1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:32.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><span style="letter-spacing:-0.1pt;">(IRS Employer</span><br/><span style="letter-spacing:-0.1pt;">Identification No.)</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" name="dei:EntityAddressAddressLine1" id="Narr_6WsCYmA5LkyAAKZe3MhWAQ"><b style="font-size:9pt;font-weight:bold;">P.O. Box 65</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" name="dei:EntityAddressCityOrTown" id="Narr_1Qn0II5Ct0OAHSBpuk8HVA"><b style="font-size:9pt;font-weight:bold;">Monrovia</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="Narr_ipRb7N7CdUGULi7CzxncVQ"><b style="font-size:9pt;font-weight:bold;">Maryland</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" name="dei:EntityAddressPostalZipCode" id="Narr_WWMxc3G7f0i-T70P6iFFAA"><b style="font-size:9pt;font-weight:bold;">21770</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><span style="letter-spacing:-0.1pt;">(Address of principal executive offices, including zip code)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:9pt;font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" name="dei:CityAreaCode" id="Narr_L8n1veQWX0Cbn4_HlqfBuA"><b style="font-size:9pt;font-weight:bold;">240</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" name="dei:LocalPhoneNumber" id="Narr_HAYE4dzPykyGMXQdhhQqQg"><b style="font-size:9pt;font-weight:bold;">243-1201</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><span style="letter-spacing:-0.1pt;">(Registrant&#8217;s telephone number, including area code)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;letter-spacing:-0.1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">N/A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><span style="letter-spacing:-0.1pt;">(Former name or former address, if changed since last report)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.25pt;text-indent:-14.25pt;margin:5pt 0pt 5pt 0pt;"><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_T-O69Ap4hEqqVb61LJTExw"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9745;</span></ix:nonNumeric><span style="font-size:9pt;"> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.25pt;text-indent:-14.25pt;margin:5pt 0pt 5pt 0pt;"><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_1yY4ExtT5E6WWY_Cw4HVHw"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-family:'Segoe UI Symbol';font-size:9pt;"> </span><span style="font-size:9pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.25pt;text-indent:-14.25pt;margin:5pt 0pt 5pt 0pt;"><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_c77Rbco8QUypY9vQj0BBZQ"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-family:'Segoe UI Symbol';font-size:9pt;"> </span><span style="font-size:9pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:-0.1pt;padding-left:14.25pt;text-indent:-14.25pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_77h5LUwZBUuMmKRlH0OtBA"><span style="font-family:'Segoe UI Symbol';font-size:9pt;letter-spacing:0pt;">&#9744;</span></ix:nonNumeric><span style="font-size:9pt;letter-spacing:0pt;"> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:-0.1pt;padding-left:14.25pt;text-indent:-14.25pt;margin:0pt;"><span style="font-size:9pt;letter-spacing:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><a id="_815aaab8_f3ad_460f_b7c2_43bd0f552b4c"></a><div style="margin-left:0pt;"><a id="Tc_0CahA-wuBEy-9_wU-IeQ9A_1_0"></a><a id="Tc_iI8PO1meeUWORuu7_LzbGw_1_1"></a><a id="Tc_TwTI0LpQt06K-wCVQYTMdg_1_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;width:97.58%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:22.29%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:44.35%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:33.34%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:5pt 0pt 5pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Title of each class</b></p></td><td style="vertical-align:top;width:22.29%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:5pt 0pt 5pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Trading Symbol(s)</b></p></td><td style="vertical-align:top;width:44.35%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:5pt 0pt 5pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Name of each exchange on which registered</b></p></td></tr><tr><td style="vertical-align:top;width:33.34%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:5pt 0pt 5pt 0pt;"><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" name="dei:Security12bTitle" id="Tc_8KQidQyaJEOwbeIKp1xoyw_2_0"><span style="font-size:9pt;">Common Stock, $0.001 par value</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:22.29%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:5pt 0pt 5pt 0pt;"><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" name="dei:TradingSymbol" id="Tc_PVJzyohEWUqcxzc4qnD-6g_2_1"><span style="font-size:9pt;">GLYC</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:44.35%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:5pt 0pt 5pt 0pt;"><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Tc_D8_yu_gLG0-hXm6vPt0dOg_2_2"><span style="font-size:9pt;">The Nasdaq Stock Market</span></ix:nonNumeric></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:-0.1pt;padding-left:14.25pt;text-indent:-14.25pt;margin:0pt;"><span style="font-size:9pt;letter-spacing:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;">Emerging growth company </span><ix:nonNumeric contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_wBsVxEXIGEWPN4Qm2WN_8Q"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><div style="margin-left:0pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:97.58%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"> <span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:22.3%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:44.35%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:22.3%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:44.35%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;border-bottom:9pt double #000000;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Courier New';line-height:0pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:81.18%;border:0;margin:30pt 9.41% 30pt 9.41%;"></div><div style="max-width:100%;padding-left:10.29%;padding-right:10.29%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_55a00a60_74c6_4d0b_a2e2_ebc756fd789e"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item &#160;1.01</b></span><b style="font-weight:bold;">Entry into a Material Definitive Agreement.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:12pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Amendment to Merger Agreement</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:12pt 0pt 6pt 0pt;">On February 14, 2025, GlycoMimetics, Inc., a Delaware corporation (&#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">GlycoMimetics</span>&#8221;), Gemini Merger Sub Corp., a Delaware corporation and a wholly-owned subsidiary of GlycoMimetics (&#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">First Merger Sub</span>&#8221;), Gemini Merger Sub II, LLC, a Delaware limited liability company and wholly-owned subsidiary of GlycoMimetics (&#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Second Merger Sub</span>&#8221; and, together with First Merger Sub, &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Merger Subs</span>&#8221;), and Crescent Biopharma, Inc., a Delaware corporation (&#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Crescent</span>&#8221;), entered into an amendment (the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Amendment</span>&#8221;) to that certain Agreement and Plan of Merger and Reorganization (the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Merger Agreement</span>,&#8221; and the mergers contemplated thereby, the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Merger</span><span style="white-space:pre-wrap;">&#8221;), dated October 28, 2024, by and among GlycoMimetics,  Merger Subs and Crescent. The Amendment adjusts, among other things, (i) the structure of financing described in the Merger Agreement (as described below) and (ii) the filings contemplated to be made with the U.S. Securities and Exchange Commission in connection with the transactions contemplated by the Merger Agreement. Relative to the terms of the Merger Agreement, the Amendment does not result in a change to the expected Exchange Ratio or ownership of the combined company by GlycoMimetics securityholders as of immediately prior to the Merger. Based on GlycoMimetics&#8217; capitalization as of September 30, 2024 and Crescent&#8217;s capitalization as of October 28, 2024 (the date the Merger Agreement was executed), each share of Crescent capital stock is estimated to be entitled to receive approximately 14.9149 shares of GlycoMimetics common stock. Immediately after the Merger, GlycoMimetics securityholders as of immediately prior to the Merger are expected to own approximately 3.10% of the outstanding shares of capital stock of the combined company (on a fully-diluted basis, and subject to dilution from any equity issued by Crescent after the date of the Merger Agreement and before the closing), and former holders of Crescent securities (including those issued in the financing described below) are expected to own approximately 96.90% of the outstanding shares of capital stock of the combined company (on a fully-diluted basis), subject to certain assumptions, including, but not limited to, GlycoMimetics&#8217; net cash as of closing being equal to $1.8 million. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:12pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Amended and Restated Securities Purchase Agreement </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:12pt 0pt 6pt 0pt;">On February 14, 2025, immediately following the execution of the Amendment, Crescent, GlycoMimetics and certain parties entered into an Amended and Restated Securities Purchase Agreement (the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">A&amp;R Purchase Agreement</span>&#8221;), amending and restating in its entirety that certain Securities Purchase Agreement, dated October 28, 2024, by and among GlycoMimetics and the investors party thereto (the &#8220;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Purchasers</span>&#8221;). The A&amp;R Purchase Agreement provides, among other things, for the purchase of $200.0 million of securities of Crescent immediately prior to the Closing of the Merger in lieu of the purchase of $200.0 million of securities of GlycoMimetics immediately following the closing of the Merger. The price and other economic terms of the financing remain materially unchanged, including that Crescent and GlycoMimetics will enter into a Registration Rights Agreement with the Purchasers at closing, which will provide that, following the Merger, the combined company will register the resale of the securities issued (or issuable) pursuant to the A&amp;R Purchase Agreement. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:12pt 0pt 6pt 0pt;">The foregoing descriptions of the Amendment and the A&amp;R Purchase Agreement are summaries only and are qualified in their entirety by reference to the full text of the forms of the Amendment and the A&amp;R Purchase Agreement, copies of which are filed as Exhibits 10.1 and 10.2, respectively, to this Current Report on Form 8-K and incorporated herein by reference.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:12pt 0pt 6pt 0pt;"><b style="font-weight:bold;">No Offer or Solicitation </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:12pt 0pt 0pt 0pt;">This Current Report on Form&#160;8-K&#160;and the exhibits filed or furnished herewith are not intended to and do not constitute (i)&#160;a solicitation of a proxy, consent or approval with respect to any securities or in respect of the proposed transaction or (ii)&#160;an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities pursuant to the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act or an exemption therefrom. Subject to certain exceptions to be approved by the relevant regulators or certain facts to be ascertained, the public offer will not be made directly or indirectly, in or into any jurisdiction where to do so would constitute a violation of the laws of such jurisdiction, or by use of the mails or by any means or instrumentality (including without limitation, facsimile transmission, telephone and the internet) of interstate </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.41%;border:0;margin:30pt 10.29% 30pt 10.29%;"></div><div style="max-width:100%;padding-left:10.29%;padding-right:10.29%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 6pt 0pt;">or foreign commerce, or any facility of a national securities exchange, of any such jurisdiction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:12pt 0pt 6pt 0pt;">NEITHER THE SEC NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THE SECURITIES OR DETERMINED IF THIS CURRENT REPORT ON FORM&#160;8-K&#160;AND THE EXHIBITS FILED OR FURNISHED HEREWITH ARE TRUTHFUL OR COMPLETE.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:12pt 0pt 6pt 0pt;"><b style="font-weight:bold;background:#ffffff;">Important Additional Information About the Proposed Transaction Will be Filed with the SEC</b></p><a id="_9kMIH5YVt4666AKkxi"></a><a id="_9kMIH5YVt4666EMixi"></a><a id="_9kMHG5YVt4666BCPI7zqbQxu27r2"></a><a id="_9kMHG5YVt4666ENXI7zqbQxu27r2"></a><a id="_9kMIH5YVt4666BCPI7zqbQxu27r2"></a><a id="_9kMIH5YVt4666ENXI7zqbQxu27r2"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:12pt 0pt 6pt 0pt;"><span style="background:#ffffff;">This Current Report on Form&#160;8-K&#160;and the exhibits filed or furnished herewith are not substitutes for the Registration Statement or for any other document that GlycoMimetics may file with the SEC in connection with the proposed transaction. In connection with the proposed transaction between GlycoMimetics and Crescent, GlycoMimetics intends to file relevant materials with the SEC, including a Registration Statement on Form S-4. </span><span style="text-transform:uppercase;background:#ffffff;">GlycoMimetics</span><span style="background:#ffffff;"> URGES INVESTORS AND STOCKHOLDERS TO READ THE REGISTRATION STATEMENT AND ANY OTHER RELEVANT DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION </span><span style="text-transform:uppercase;background:#ffffff;">ABOUT GlycoMimetics, CRESCENT, THE PROPOSED TRANSACTION AND RELATED MATTERS</span><span style="background:#ffffff;">. Investors and stockholders will be able to obtain free copies of the Registration Statement and other documents filed by GlycoMimetics with the SEC (when they become available) through the website maintained by the SEC at&#160;</span><i style="font-style:italic;background:#ffffff;">www.</i><i style="font-style:italic;background:#ffffff;">sec</i><i style="font-style:italic;background:#ffffff;">.gov</i><span style="background:#ffffff;">. In addition, investors and stockholders should note that GlycoMimetics communicates with investors and the public using its website (</span><i style="font-style:italic;background:#ffffff;">www.</i><i style="font-style:italic;background:#ffffff;">glycomimetics</i><i style="font-style:italic;background:#ffffff;">.com</i><span style="background:#ffffff;">) and the investor relations website (</span><i style="font-style:italic;background:#ffffff;">www.</i><i style="font-style:italic;background:#ffffff;">glycomimetics</i><i style="font-style:italic;background:#ffffff;">.com/investor-relations</i><span style="background:#ffffff;">) where anyone will be able to obtain free copies of the Registration Statement and other documents filed by GlycoMimetics with the SEC and stockholders are urged to read the Registration Statement and the other relevant materials when they become available before making any voting or investment decision with respect to the proposed transaction.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:12pt 0pt 6pt 0pt;"><b style="font-weight:bold;">Participants in the Solicitation </b></p><a id="_9kR3WTr26647GPCw4skcQv69FD8aWFEPRl"></a><a id="_9kR3WTr2664BINCw4skcQv69FD8aWFEPRl"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:12pt 0pt 6pt 0pt;"><span style="background:#ffffff;">GlycoMimetics</span>, Crescent and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from stockholders in connection with the proposed transaction. Information about GlycoMimetics&#8217; directors and executive officers including a description of their interests in GlycoMimetics is included in GlycoMimetics&#8217; most recent Annual Report on Form&#160;10-K, as filed with the SEC on February 13, 2025. Additional information regarding these persons and their interests in the proposed transaction will be included in the <span style="background:#ffffff;">Registration </span>Statement relating to the proposed transaction when it is filed with the SEC. These documents can be obtained free of charge from the sources indicated above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">Item 9.01</b></span><b style="font-weight:bold;">Financial Statements and Exhibits.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (d)&#160;Exhibits</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:10.27%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:88.13%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:10.27%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;min-height:8.0pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exhibit</b></p></td><td style="vertical-align:top;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:8.0pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:88.13%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;min-height:8.0pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;min-height:8.0pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:top;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;min-height:8.0pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:88.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;min-height:8.0pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Exhibit&#160;Description</b></p></td></tr><tr style="height:3.55pt;"><td style="vertical-align:top;width:10.27%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;">10.1*</p></td><td style="vertical-align:top;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.13%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="glyc-20250214xex10d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Amendment to the Agreement and Plan of Merger and Reorganization</span></a></p></td></tr><tr style="height:3.55pt;"><td style="vertical-align:top;width:10.27%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.13%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p></td></tr><tr style="height:3.55pt;"><td style="vertical-align:top;width:10.27%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;">10.2*</p></td><td style="vertical-align:top;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.13%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="glyc-20250214xex10d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Amended and Restated Securities Purchase Agreement</span></a></p></td></tr><tr><td style="vertical-align:top;width:10.27%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;"><span style="margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.13%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:10.27%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-align:center;text-indent:-7.2pt;margin:0pt;">104</p></td><td style="vertical-align:top;width:1.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:88.13%;margin:0pt;padding:0pt 0.69pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Cover Page Interactive Data File (formatted as Inline XBRL)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">*</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Exhibits and/or schedules have been omitted pursuant to Item 601(a)(5) of Regulation&#160;S-K.&#160;The registrant hereby undertakes to furnish supplementally copies of any of the omitted exhibits and schedules upon request by the SEC;&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</span>,&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</span>, that the registrant may request confidential treatment pursuant to Rule&#160;24b-2&#160;under the Exchange Act for any exhibits or schedules so furnished.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.41%;border:0;margin:30pt 10.29% 30pt 10.29%;"></div><div style="max-width:100%;padding-left:10.29%;padding-right:10.29%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:0.05pt;margin:0pt;"><span style="font-size:0.05pt;visibility:hidden;">&#8203;</span></p><a id="_b6864f86_f37e_46ca_b009_a457bc4d33e8"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;letter-spacing:-0.1pt;line-height:1.19;text-align:center;margin:0pt;">SIGNATURES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:-0.1pt;text-align:justify;text-indent:37.05pt;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="letter-spacing:-0.1pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0.7pt;padding-right:0.7pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:29.85%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:1pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></div></div></td><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:29.85%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">GLYCOMIMETICS, INC.</p></td></tr><tr><td style="vertical-align:top;width:29.85%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.1pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:29.85%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="letter-spacing:-0.1pt;">By:&#160;&#160;</span></p></td><td style="vertical-align:top;width:50%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="letter-spacing:-0.1pt;">/s/ </span>Brian M. Hahn</p></td></tr><tr><td style="vertical-align:top;width:29.85%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;"><span style="letter-spacing:-0.1pt;white-space:pre-wrap;">Date:  February 14, 2025</span></p></td><td style="vertical-align:top;width:20.14%;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="letter-spacing:-0.1pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;border-top:1px solid #000000;margin:0pt;padding:0pt 0.69pt 0pt 0.69pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Brian M. Hahn<br/>Senior Vice President and Chief Financial Officer </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.29%;margin-right:10.29%;margin-top:30pt;page-break-after:avoid;width:79.41%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>glyc-20250214xex10d1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.128.0--><!--Created on: 2/14/2025 09:05:54 PM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-transform:uppercase;">Amendment No. 1 to the</b><b style="font-weight:bold;text-transform:uppercase;"><br></b><b style="font-weight:bold;text-transform:uppercase;">Agreement and Plan of Merger AND REORGANIZATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;text-indent:36pt;margin:0pt;">This <b style="font-weight:bold;text-transform:uppercase;">Amendment No. 1 to Agreement and Plan of Merger and reorganization</b> (this &#8220;<font style="font-style:italic;font-weight:bold;">Amendment</font>&#8221;) is made as of February 14, 2025, with respect to that certain Agreement and Plan of Merger and Reorganization (the &#8220;<font style="font-style:italic;font-weight:bold;">Merger Agreement</font>&#8221;), dated as of October 28, 2024 (the &#8220;<font style="font-style:italic;font-weight:bold;">Agreement Date</font>&#8221;), by and among GlycoMimetics, Inc., a Delaware corporation (&#8220;<font style="font-style:italic;font-weight:bold;">Parent</font>&#8221;), Gemini Merger Sub Corp., a Delaware corporation and wholly owned subsidiary of Parent (&#8220;<font style="font-style:italic;font-weight:bold;">First Merger Sub</font>&#8221;), Gemini Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of Parent (&#8220;<font style="font-style:italic;font-weight:bold;">Second Merger Sub</font>&#8221; and, together with First Merger Sub, &#8220;<font style="font-style:italic;font-weight:bold;">Merger Subs</font>&#8221;), and Crescent Biopharma, Inc. (the &#8220;<font style="font-style:italic;font-weight:bold;">Company</font>&#8221;), a Delaware corporation. All capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to them in the Merger Agreement. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:18pt 0pt 12pt 0pt;"><b style="font-weight:bold;">W I T N E S S E T H:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;text-transform:uppercase;">Whereas</b>, pursuant to Section 11.2 of the Merger Agreement, the Merger Agreement may be amended by any instrument in writing signed on behalf of the Company, Parent and Merger Subs, with the approval of the respective boards of directors of the Company, Parent and Merger Subs; </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;text-transform:uppercase;">Whereas</b>, the Parent Board has (i) determined that the Contemplated Transactions (including as adjusted pursuant to this Amendment) are fair to, advisable and in the best interests of Parent and its stockholders, (ii) approved and declared advisable the Merger Agreement (including as amended hereby) and the Contemplated Transactions, including the issuance of shares of Parent Capital Stock to the stockholders of the Company pursuant to the terms of the Merger Agreement (including as amended hereby) and (iii) determined to recommend, upon the terms and subject to the conditions set forth in the Merger Agreement (including as amended hereby), that the stockholders of Parent vote to approve the Merger Agreement (including as amended hereby) and thereby approve the Parent Stockholder Matters, including the Contemplated Transactions, and against any competing proposals; </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;text-transform:uppercase;">Whereas</b>, the First Merger Sub Board has (i) determined that the Contemplated Transactions (including as adjusted pursuant to this Amendment) are fair to, advisable, and in the best interests of First Merger Sub and its sole stockholder, (ii) approved and declared advisable the Merger Agreement (including as amended hereby) and the Contemplated Transactions and (iii) determined to recommend, upon the terms and subject to the conditions set forth in the Merger Agreement (including as amended hereby), that the stockholder of First Merger Sub votes to adopt the Merger Agreement (including as amended hereby) and thereby approve the Contemplated Transactions; </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;text-transform:uppercase;">Whereas</b>, the sole member of the Second Merger Sub has (i) determined that the Contemplated Transactions (including as adjusted pursuant to this Amendment) are fair to, advisable, and in the best interests of Second Merger Sub and its sole member, (ii) approved and declared advisable the Merger Agreement (including as amended hereby) and the Contemplated Transactions and (iii) determined to recommend, upon the terms and subject to the conditions set forth in the Merger Agreement (including as amended hereby), that the sole member of Second Merger Sub votes to adopt the Merger Agreement (including as amended hereby) and thereby approve the Contemplated Transactions; and </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;text-transform:uppercase;">Whereas</b>, the Company Board has (i) determined that the Contemplated Transactions (including as adjusted pursuant to this Amendment) are fair to, advisable and in the best interests of the Company and its stockholders, and (ii) approved and declared advisable the Merger Agreement (including as amended hereby) and the Contemplated Transactions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="font-size:11pt;">1</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:7pt;">4919-9031-6822v.8</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;text-indent:36pt;margin:0pt;"><b style="font-weight:bold;text-transform:uppercase;">Now, Therefore</b>, in consideration of the foregoing recitals, the mutual covenants and agreements set forth herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, intending to be legally bound, the Company, Parent and Merger Subs hereby agree as follows:</p><div style="margin-top:12pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:center;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;text-transform:uppercase;vertical-align:text-top;white-space:nowrap;width:72pt;padding:0pt;">Article 1</td><td style="padding:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:bold;text-transform:uppercase;">Amendments to the Merger Agreement</b></td></tr></table><div style="margin-top:12pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:0pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;white-space:nowrap;">1.1.</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Pre-Closing Financing</u><font style="font-size:11pt;">. &#160;</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.1.1</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">Recital L of the Merger Agreement shall be, and hereby is, amended and replaced in its entirety with the following: </font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 90pt;"><font style="display:inline-block;text-align:left;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">L.</font></font><font style="display:inline-block;width:36pt;"></font>Certain investors have executed a Securities Purchase Agreement in the form attached hereto as <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit C</u> among Parent, the Company and the Persons named therein (including as may be amended, restated and/or superseded from time to time, the &#8220;<b style="font-weight:bold;">Subscription Agreement</b>&#8221;), pursuant to which such Persons will have agreed to purchase in the amounts set forth therein (including by contribution of Company Notes) (i) shares of Company Common Stock and (ii) pre-funded Company Warrants, in each case, immediately prior to the First Effective Time (the &#8220;<b style="font-weight:bold;">Company Pre-Closing Financing</b>&#8221;).</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.1.2</td><td style="padding:0pt;"><u style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit C</u><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;"> of the Merger Agreement shall be, and hereby is, amended and replaced in its entirety with the form of Subscription Agreement set forth on </font><u style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annex A</u><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;"> hereto. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.1.3</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">The definition of &#8220;Company Outstanding Shares&#8221; shall be, and hereby is, amended and replaced in its entirety with the following: </font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 90pt;">&#8220;<b style="font-weight:bold;">Company Outstanding Shares</b>&#8221; means, without duplication, the total number of shares of Company Capital Stock outstanding immediately prior to the First Effective Time (including any shares of Company Common Stock or Company Preferred Stock that are issued in, or issuable upon the exercise or conversion of securities issued in, the Company Pre-Closing Financing, any Interim Financing or any Company Acquisition), expressed on a fully diluted and as-converted-to-Company Common Stock basis assuming, without limitation or duplication, the exercise of all Company Options, Company Warrants or other rights or commitments to receive shares of Company Common Stock or Company Preferred Stock (or securities convertible or exercisable into shares of Company Common Stock or Company Preferred Stock, including the Company Notes), whether conditional or unconditional or vested or unvested, that are outstanding as of immediately prior to the First Effective Time; <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u>, that Company Outstanding Shares shall exclude (i) any Company Options, Company Warrants and any other equity awards issued under the Company Stock Plans (including any shares of Company Common Stock issuable upon the exercise of such Company Options, Company Warrants or other equity awards) issued to directors, employees, consultants or other service providers following the Agreement Date but prior to the Closing (collectively, the &#8220;<b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Service Provider Grants</b>&#8221;) and (ii) any shares of Company Common Stock underlying Company Notes that are to be contributed as consideration in the Company Pre-Closing Financing pursuant to the Subscription Agreement (to avoid double counting).</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.1.4</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">The definition of &#8220;Company Valuation&#8221; shall be, and hereby is, amended and replaced in its entirety with the following: </font></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;">2</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:7pt;">4919-9031-6822v.8</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 90pt;">&#8220;<b style="font-weight:bold;">Company Valuation</b>&#8221; means (i) <font style="font-size:12pt;"><a name="_cp_change_409"></a></font>$50,000,000, <i style="font-style:italic;">plus</i> (ii) <font style="font-size:12pt;"><a name="_cp_change_413"></a></font>the <font style="font-size:12pt;"><a name="_cp_change_410"></a></font>amount of proceeds actually received by the Company from the Company Pre-Closing Financing (including the Company Notes and any interest thereon contributed as consideration in the Company Pre-Closing Financing), <i style="font-style:italic;">plus</i> (iii) the Fair Market Value of each Company Acquisition, <i style="font-style:italic;">plus</i> (iv) the Fair Market Value of any Interim Financing. </p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.1.5</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">The definition of &#8220;Parent Valuation Floor&#8221; shall be, and hereby is, amended and replaced in its entirety with the following: </font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 90pt;">&#8220;<b style="font-weight:bold;">Parent Valuation Floor</b>&#8221; means an amount equal to (i) 0.03, multiplied by (ii) the sum of (A) the Company Valuation (as of immediately prior to the Closing), and (B) $8,000,000. </p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.1.6</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">The Parties hereby acknowledge and agree that (i) references to shares of Company Common Stock in Section 2.5(a)(ii) of the Merger Agreement shall include any shares issued pursuant to the Company Pre-Closing Financing and (ii) references to Company Warrants in Section 6.5(b) of the Merger Agreement shall include any pre-funded Company Warrants issued pursuant to the Company Pre-Closing Financing. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.1.7</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">Section 5.1(a)(i) and Section 5.1(b)(i) of the Merger Agreement shall be, and hereby are, amended by deleting any reference to the Subscription Agreement in such provisions. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.1.8</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">References to &#8220;this Agreement&#8221; in Section 5.2(a)(i) and Section 5.2(b)(i) of the Merger Agreement shall be, and hereby are, deemed to include &#8220;or the Subscription Agreement.&#8221; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.1.9</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">References to &#8220;Parent&#8221; in Section 8.6 of the Merger Agreement shall be deemed deleted and replaced with a reference to &#8220;the Company.&#8221; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.1.10</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">All references to the Parent Financing in the Merger Agreement shall be (to the extent not otherwise deleted pursuant to Section 1.1 of this Amendment) deemed deleted and replaced with a reference to the Company Pre-Closing Financing. </font></td></tr></table><div style="margin-top:12pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:0pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;white-space:nowrap;">1.2.</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Registration Statement on Form S-4</u><font style="font-size:11pt;">. &#160;</font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.2.1</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">Section 6.1 of the Merger Agreement shall be, and hereby is, amended and replaced in its entirety with the following:</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 90pt;"><font style="display:inline-block;text-align:left;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">6.1.</font></font><font style="display:inline-block;width:36pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Registration Statement, Proxy Statement</u>. </p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;margin-bottom:12pt;margin-left:90pt;text-align:justify;text-indent:0pt;"><font style="display:inline-block;font-size:11pt;font-weight:normal;min-width:18pt;white-space:nowrap;">(a)</font><a name="_Ref23140810"></a><font style="font-size:11pt;font-weight:normal;">As promptly as practicable after the date of this </font><a name="_9kMH7AK7aXv5BEBGIN9xwktuwC"></a><font style="font-size:11pt;font-weight:normal;">Agreement</font><font style="font-size:11pt;font-weight:normal;">, Parent, in cooperation with the Company, shall prepare and file with the SEC a registration statement on Form S-4 (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Form S-4</b><font style="font-size:11pt;font-weight:normal;">&#8221;), in which a proxy statement relating to the Parent Stockholder Meeting to be held in connection with the Merger (together with any amendments thereof or supplements thereto, the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Proxy Statement</b><font style="font-size:11pt;font-weight:normal;">&#8221;) shall be included as a part (the Proxy Statement and the Form S-4, collectively, the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Registration Statement</b><font style="font-size:11pt;font-weight:normal;">&#8221;), in connection with the registration under the Securities Act of the shares of Parent Common Stock (including any Parent Common Stock issuable upon (I) conversion of the Parent Convertible Preferred Stock or (II) exercise of any Assumed Warrant) to be issued by virtue of the Contemplated Transactions, other than any shares of Parent Capital Stock which are not permitted to be registered on Form S-4 pursuant to applicable Law. Parent shall use commercially reasonable efforts to </font><a name="DocXTextRef521"></a><font style="font-size:11pt;font-weight:normal;">(i)</font><font style="font-size:11pt;font-weight:normal;"> cause the </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;">3</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:7pt;">4919-9031-6822v.8</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;margin-bottom:12pt;margin-left:90pt;text-align:justify;text-indent:0pt;"><font style="font-size:11pt;font-weight:normal;">Registration Statement to comply with applicable rules and regulations promulgated by the SEC, (ii) cause the Registration Statement to become effective as promptly as practicable, and (iii) respond promptly to any comments or requests of the SEC or its staff related to the Registration Statement. Parent shall use commercially reasonable efforts to take all actions required under any applicable federal, state, securities and other Laws in connection with the issuance of shares of Parent Capital Stock pursuant to the Contemplated Transactions (including any Parent Common Stock issuable upon (I) conversion of the Parent Convertible Preferred Stock or (II) exercise of any Assumed Warrant). Each of the Parties shall reasonably cooperate with the other Party and furnish all information concerning itself and its Affiliates, as applicable, to the other Parties that is required by law to be included in the Registration Statement as the other Parties may reasonably request in connection with such actions and the preparation of the Registration Statement and Proxy Statement.</font><font style="font-size:11pt;font-weight:normal;"> </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;margin-bottom:12pt;margin-left:90pt;text-align:justify;text-indent:0pt;"><font style="display:inline-block;font-size:11pt;font-weight:normal;min-width:18pt;white-space:nowrap;">(b)</font><a name="_Ref132145986"></a><font style="font-size:11pt;font-weight:normal;">Parent covenants and agrees that the Registration Statement (and the letter to stockholders, notice of meeting and form of proxy included therewith) will </font><a name="DocXTextRef522"></a><font style="font-size:11pt;font-weight:normal;">(i)</font><font style="font-size:11pt;font-weight:normal;"> comply as to form in all material respects with the requirements of applicable U.S. federal securities laws and the DGCL and DLLCA, and (ii)&#160;will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. The Company covenants and agrees that the information supplied by or on behalf of the Company to Parent for inclusion in the Registration Statement will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make such information, in light of the circumstances under which they were made, not misleading. Notwithstanding the foregoing, neither Party makes any covenant, representation or warranty with respect to statements made in the Registration Statement (and the letter to stockholders, notice of meeting and form of proxy included therewith), if any, based on information provided by the other Party or any of its Representatives regarding such other Party or its Affiliates for inclusion therein.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;margin-bottom:12pt;margin-left:90pt;text-align:justify;text-indent:0pt;"><font style="display:inline-block;font-size:11pt;font-weight:normal;min-width:18pt;white-space:nowrap;">(c)</font><a name="_Ref132145987"></a><font style="font-size:11pt;font-weight:normal;">Parent shall use commercially reasonable efforts to cause the Proxy Statement to be mailed to Parent&#8217;s stockholders as promptly as practicable after the Registration Statement is declared effective under the Securities Act. If at any time before the First Effective Time, </font><a name="DocXTextRef526"></a><font style="font-size:11pt;font-weight:normal;">(i)</font><font style="font-size:11pt;font-weight:normal;">&#160;Parent, Merger Subs or the Company </font><a name="DocXTextRef527"></a><font style="font-size:11pt;font-weight:normal;">(A)</font><font style="font-size:11pt;font-weight:normal;"> become aware of any event or information that, pursuant to the Securities Act or the Exchange Act, should be disclosed in an amendment or supplement to the Registration Statement or Proxy Statement, </font><a name="DocXTextRef528"></a><font style="font-size:11pt;font-weight:normal;">(B)</font><font style="font-size:11pt;font-weight:normal;"> receives notice of any SEC request for an amendment or supplement to the Registration Statement or for additional information related thereto, or </font><a name="DocXTextRef529"></a><font style="font-size:11pt;font-weight:normal;">(C)</font><font style="font-size:11pt;font-weight:normal;"> receives SEC comments on the Registration Statement, or (ii) the information provided in the Registration Statement has become &#8220;stale&#8221; and new information should be disclosed in an amendment or supplement to the Registration Statement, as the case may be, then such Party, as the case may be, shall promptly inform the other Parties thereof and shall cooperate with such other Parties in Parent filing such amendment or supplement with the SEC (and, if appropriate, in mailing such amendment or supplement to the Parent stockholders) or otherwise addressing such SEC request or comments and each Party and shall use their commercially reasonable efforts to cause any such amendment to become effective, if required. Parent shall promptly notify the Company if it becomes aware </font><a name="DocXTextRef523"></a><font style="font-size:11pt;font-weight:normal;">(1)</font><font style="font-size:11pt;font-weight:normal;"> that the Registration Statement has become effective, </font><a name="DocXTextRef524"></a><font style="font-size:11pt;font-weight:normal;">(2)</font><font style="font-size:11pt;font-weight:normal;"> of the issuance of any stop order or suspension of the qualification or registration of the Parent Capital </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;">4</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:7pt;">4919-9031-6822v.8</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;margin-bottom:12pt;margin-left:90pt;text-align:justify;text-indent:0pt;"><font style="font-size:11pt;font-weight:normal;">Stock issuable in connection with the Contemplated Transactions (including any Parent Common Stock issuable upon (I) conversion of the Parent Convertible Preferred Stock and (II) exercise of any Assumed Warrant) for offering or sale in any jurisdiction, or </font><a name="DocXTextRef525"></a><font style="font-size:11pt;font-weight:normal;">(3)</font><font style="font-size:11pt;font-weight:normal;"> any order of the SEC related to the Registration Statement, and shall promptly provide to the Company copies of all written correspondence between it or any of its Representatives, on the one hand, and the SEC or staff of the SEC, on the other hand, with respect to the Registration Statement and all orders of the SEC relating to the Registration Statement.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;margin-bottom:12pt;margin-left:90pt;text-align:justify;text-indent:0pt;"><font style="display:inline-block;font-size:11pt;font-weight:normal;min-width:18pt;white-space:nowrap;">(d)</font><a name="_Ref132145988"></a><a name="_Ref160813762"></a><font style="font-size:11pt;font-weight:normal;">The Company shall reasonably cooperate with Parent and provide, and cause its Representatives to provide, Parent and its Representatives, with all true, correct and complete information regarding the Company that is required by Law to be included in the Registration Statement or reasonably requested by Parent to be included in the Registration Statement (collectively, the </font><a name="_Hlk130767711"></a><font style="font-size:11pt;font-weight:normal;">&#8220;</font><b style="font-size:11pt;font-weight:bold;">Company Required S-4 Information</b><font style="font-size:11pt;font-weight:normal;">&#8221;</font><font style="font-size:11pt;font-weight:normal;">). Without limiting the foregoing, the Company will use commercially reasonable efforts to cause to be delivered to Parent a consent letter of the Company&#8217;s independent accounting firm, dated no later than the date on which the Registration Statement is filed with the SEC (and reasonably satisfactory in form and substance to Parent), that is customary in scope and substance for consent letters delivered by independent public accountants in connection with registration statements similar to the Registration Statement. The Company and its legal counsel shall be given reasonable opportunity to review and comment on the Registration Statement, including all amendments and supplements thereto, prior to the filing thereof with the SEC, and on the response to any comments of the SEC on the Registration Statement, prior to the filing thereof with the SEC.</font><font style="font-size:11pt;font-weight:normal;"> Parent may file the Registration Statement, or any amendment or supplement thereto, without the prior consent of the Company, </font><u style="font-size:11pt;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u><font style="font-size:11pt;font-weight:normal;"> that Parent has included the Company Required S-4 Information in the Registration Statement in substantially the same form as it was provided to Parent by the Company pursuant to this </font><u style="font-size:11pt;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">6.1</u><font style="font-size:11pt;font-weight:normal;">; </font><u style="font-size:11pt;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u><font style="font-size:11pt;font-weight:normal;">, </font><u style="font-size:11pt;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">further</u><font style="font-size:11pt;font-weight:normal;">, that if the prior consent of the Company is not obtained then, notwithstanding anything else herein, the Company makes no covenant or representation regarding the portion of such information supplied by or on behalf of the Company to Parent for inclusion in such Registration Statement that the Company reasonably identifies prior to such filing of the Registration Statement.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;margin-bottom:12pt;margin-left:90pt;text-align:justify;text-indent:0pt;"><font style="display:inline-block;font-size:11pt;font-weight:normal;min-width:18pt;white-space:nowrap;">(e)</font><a name="_Ref132145989"></a><font style="font-size:11pt;font-weight:normal;">As promptly as reasonably practicable following February 14, 2025, the Company will use commercially reasonable efforts to furnish to Parent audited financial statements for the year ended December 31, 2024 (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Company Financial Statements</b><font style="font-size:11pt;font-weight:normal;">&#8221;) required to be included in the Proxy Statement. &#160;As promptly as reasonably practicable following any request therefore, the Company will use commercially reasonable efforts to furnish to Parent any unaudited interim financial statements for each interim period completed prior to Closing that would be required to be included in the Registration Statement or any periodic report due prior to the Closing if the Company were subject to the periodic reporting requirements under the Securities Act or the Exchange Act. </font></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.2.2</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">The parties acknowledge and agree that, as a result of this Amendment, the further approval of the Merger Agreement (including as amended hereby) by the stockholders of the Company is required. &#160;As a result, Section 6.2(a) of the Merger Agreement shall be, and hereby is, amended and replaced in its entirety with the following: </font></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;">5</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:7pt;">4919-9031-6822v.8</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 90pt;">Promptly after the Registration Statement has been declared effective under the Securities Act, and in any event no later than two (2) Business Days thereafter, the Company shall obtain the approval by written consent from Company stockholders sufficient for the Required Company Stockholder Vote in lieu of a meeting pursuant to Section 228 of the DGCL, for purposes of (i) adopting and approving this Agreement and the Contemplated Transactions, (ii) acknowledging that the approval given thereby is irrevocable and that such stockholder is aware of its rights to demand appraisal for its shares pursuant to Section 262 of the DGCL, and that such stockholder has received and read a copy of Section 262 of the DGCL and (iii) acknowledging that by its approval of the Merger it is not entitled to appraisal rights with respect to its shares in connection with the Merger and thereby waives any rights to receive payment of the fair value of its capital stock under the DGCL (the &#8220;<b style="font-weight:bold;">Company Stockholder Written Consents</b>&#8221;). Under no circumstances shall the Company assert that any other approval or consent is necessary by its stockholders to approve this Agreement and the Contemplated Transactions.</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.2.3</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">The second sentence of Section 6.3(a) shall be, and hereby is, amended and replaced in its entirety with the following: </font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 90pt;">The Parent Stockholder Meeting shall be held as promptly as practicable after the date that the Registration Statement is declared effective under the Securities Act, and in any event, no later than 45 days after the effective date of the Registration Statement.</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.2.4</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">A new Section 7.8 is hereby inserted into the Merger Agreement as follows: </font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 90pt;"><font style="display:inline-block;text-align:left;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">7.8.</font></font><font style="display:inline-block;width:36pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Effectiveness of Registration Statement</u>. &#160;The Registration Statement shall have become effective in accordance with the provisions of the Securities Act, and shall not be subject to any stop order or Legal Proceeding seeking a stop order with respect to the Registration Statement that has not been withdrawn. </p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.2.5</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">A new proviso is hereby inserted at the end of Section 10.1(b) the Merger Agreement as follows: &#8220;; provided further, however, that, in the event that the SEC has not declared effective under the Securities Act the Registration Statement by the date which is sixty (60) days prior to the End Date, then either the Company or Parent shall be entitled to extend the End Date for an additional sixty (60) days.&#8221; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.2.6</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">Section 10.1(d) of the Merger Agreement shall be, and hereby is, amended and replaced in its entirety with the following:</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 90pt;"><font style="display:inline-block;text-align:left;width:18pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(d) </font></font><font style="display:inline-block;width:36pt;"></font>by Parent if the Required Company Stockholder Vote shall not have been obtained within two (2) Business Days of the Registration Statement becoming effective in accordance with the provisions of the Securities Act; provided, however, that once the Required Company Stockholder Vote has been obtained (whether timely or not), Parent may not terminate this Agreement pursuant to this Section &#8206;10.1(d);</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">1.2.7</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">All references to the Proxy Statement in the Merger Agreement shall be (to the extent not otherwise deleted pursuant to Section 1.2 of this Amendment) deemed deleted and replaced with a reference to the Registration Statement. </font></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;">6</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:7pt;">4919-9031-6822v.8</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:center;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman Bold';font-size:11pt;font-weight:bold;text-transform:uppercase;vertical-align:text-top;white-space:nowrap;width:72pt;padding:0pt;">Article 2</td><td style="padding:0pt;"><b style="font-family:'Times New Roman Bold';font-size:11pt;font-style:normal;font-weight:bold;text-transform:uppercase;">Additional Support Agreements</b></td></tr></table><div style="margin-top:12pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:0pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;white-space:nowrap;">2.1.</font><font style="font-size:11pt;">Subject to applicable law, the Company hereby agrees to obtain additional Support Agreements from the investors in an Interim Financing such that the Company Common Stock subject to Support Agreements continues to exceed a majority of the Company Outstanding Shares (measured as of immediately following the closing of such Interim Financing). &#160;</font></div><div style="margin-top:12pt;"></div><div style="margin-top:12pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:center;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman Bold';font-size:11pt;font-weight:bold;text-transform:uppercase;vertical-align:text-top;white-space:nowrap;width:72pt;padding:0pt;">Article 3</td><td style="padding:0pt;"><b style="font-family:'Times New Roman Bold';font-size:11pt;font-style:normal;font-weight:bold;text-transform:uppercase;">Miscellaneous</b></td></tr></table><div style="margin-top:12pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:0pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;white-space:nowrap;">3.1.</font><font style="font-size:11pt;">Except as specifically modified herein, the Merger Agreement remains in full force and effect, and the Parties hereto reserve all of their respective rights and remedies with respect to all other matters and claims, whether known or unknown, arising under the Merger Agreement. &#160;The Merger Agreement (including as amended hereby) and the other schedules, exhibits, certificates, instruments and agreements referred to in the Merger Agreement constitute the entire agreement and supersede all prior agreements and understandings, both written and oral, among or between any of the Parties with respect to the subject matter hereof and thereof; provided, however, that the Confidentiality Agreement shall not be superseded and shall remain in full force and effect in accordance with its terms.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:0pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;white-space:nowrap;">3.2.</font><font style="font-size:11pt;">This Amendment may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument, with the same effect as if the signatures thereto were in the same instrument. &#160;The exchange of a fully executed Amendment (in counterparts or otherwise) by all Parties by electronic transmission in PDF format shall be sufficient to bind the Parties to the terms and conditions of this Amendment.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:0pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;white-space:nowrap;">3.3.</font><font style="font-size:11pt;">Article 11 of the Merger Agreement is hereby incorporated by reference into this Amendment, </font><i style="font-size:11pt;font-style:italic;">mutatis mutandis</i><font style="font-size:11pt;">.</font></div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;padding-left:18pt;text-align:center;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;">[<i style="font-style:italic;">Signature Pages Follow</i>]</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="display:none;line-height:0pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;">7</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:7pt;">4919-9031-6822v.8</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:18pt;margin:0pt;"><b style="font-family:'Times New Roman Bold';font-weight:bold;text-transform:uppercase;">In Witness Whereof</b><b style="font-weight:bold;">,</b> the Parties have caused this Amendment to be executed as of the date first above written.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 12pt 216pt;"><b style="font-weight:bold;text-transform:uppercase;">GlycoMimetics </b><b style="font-family:'Times New Roman Bold';font-weight:bold;text-transform:uppercase;">Inc</b><b style="font-variant:small-caps;font-weight:bold;">.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 12pt 216pt;"><font style="font-variant:small-caps;font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 216pt;">By:<font style="display:inline-block;width:18.66pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:216pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 216pt;">Name:<font style="display:inline-block;width:4.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:216pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 216pt;">Title:<font style="display:inline-block;width:10.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:216pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 30pt 216pt;"><font style="font-variant:small-caps;font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 30pt 216pt;"><b style="font-weight:bold;text-transform:uppercase;">Gemini</b><b style="font-variant:small-caps;font-weight:bold;"> MERGER SUB CORP.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 216pt;">By:<font style="display:inline-block;width:18.66pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:216pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 216pt;">Name:<font style="display:inline-block;width:4.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:216pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 216pt;">Title:<font style="display:inline-block;width:10.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:216pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 30pt 216pt;"><font style="font-variant:small-caps;font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 30pt 216pt;"><b style="font-weight:bold;text-transform:uppercase;">Gemini</b><b style="font-variant:small-caps;font-weight:bold;"> MERGER SUB II, LLC</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 216pt;">By:<font style="display:inline-block;width:18.66pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:216pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 216pt;">Name:<font style="display:inline-block;width:4.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:216pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 216pt;">Title:<font style="display:inline-block;width:10.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:216pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-variant:small-caps;font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:0pt;">[<i style="font-style:italic;">Signature Page to Amendment No. 1</i>]</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:7pt;">4919-9031-6822v.8</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-indent:18pt;margin:0pt;"><b style="font-family:'Times New Roman Bold';font-weight:bold;text-transform:uppercase;">In Witness Whereof</b><b style="font-weight:bold;">,</b> the Parties have caused this Amendment to be executed as of the date first above written.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 216pt;"><b style="font-weight:bold;text-transform:uppercase;">Crescent </b><b style="font-family:'Times New Roman Bold';font-weight:bold;text-transform:uppercase;">Biopharma, Inc.</b><b style="font-variant:small-caps;font-weight:bold;"><br><br><br></b>By:<font style="display:inline-block;width:18.66pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:216pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 216pt;">Name:<font style="display:inline-block;width:4.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:216pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 216pt;">Title:<font style="display:inline-block;width:10.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:216pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="display:none;line-height:0pt;padding-left:18pt;text-align:center;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:0pt;">[<i style="font-style:italic;">Signature Page to Amendment No. 1</i>]</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:7pt;">4919-9031-6822v.8</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;padding-left:18pt;text-align:right;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-transform:uppercase;">Annex A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;padding-left:18pt;text-align:center;text-indent:-18pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Form of Amended and Restated Subscription Agreement</b></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:center;margin:0pt;">A-1</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="font-size:7pt;">4919-9031-6822v.8</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>glyc-20250214xex10d2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.128.0--><!--Created on: 2/14/2025 09:05:56 PM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-size:11pt;font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;"><a name="_Hlk168222603"></a></font><b style="font-weight:bold;text-transform:uppercase;">Amended and Restated</b><b style="font-weight:bold;text-transform:uppercase;"><br></b><b style="font-weight:bold;text-transform:uppercase;">SECURITIES PURCHASE AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">This <b style="font-weight:bold;text-transform:uppercase;">Amended and Restated SEC</b><b style="font-weight:bold;">URITIES PURCHASE AGREEMENT</b> (this &#8220;<b style="font-weight:bold;">Agreement</b>&#8221;) is dated as of February 14, 2025, by and among Crescent Biopharma, Inc., a Delaware corporation (&#8220;<b style="font-weight:bold;">Crescent</b>&#8221;), GlycoMimetics, Inc., a Delaware corporation (&#8220;<b style="font-weight:bold;">Parent</b>&#8221;), and each of the Persons listed on <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</u> attached to this Agreement (each, an &#8220;<font style="font-size:12pt;"><a name="_9kR3WTr19A457QK4wuA76"></a></font><b style="font-weight:bold;">Investor</b>&#8221; and together, the &#8220;<b style="font-weight:bold;">Investors</b>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WHEREAS</b>, Crescent, Parent and the Investors are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the U.S. Securities Act of 1933, as amended (the &#8220;<b style="font-weight:bold;">Securities Act</b>&#8221;);</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WHEREAS</b>, Parent and the Investors are party to a Securities Purchase Agreement, dated as of October 28, 2024 (the &#8220;<b style="font-weight:bold;">Original Agreement</b>&#8221;); </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WHEREAS</b>, Parent and each Investor, in accordance with Section 8.15 of the Original Agreement, desire to amend and restate the Original Agreement as hereinafter set forth in order to provide for the purchase of securities of Crescent in lieu of the purchase of securities of Parent; </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WHEREAS</b>, Crescent desires to sell to the Investors, and each Investor desires to purchase from Crescent, severally and not jointly, upon the terms and subject to the conditions stated in this Agreement, (A) shares (the &#8220;<b style="font-weight:bold;">Initial Shares</b>&#8221;) of Crescent&#8217;s common stock, par value $0.0001 per share (the &#8220;<b style="font-weight:bold;">Common Stock</b>&#8221;), including Common Stock being issued pursuant to any cancellation or conversion of Convertible Securities (as defined below) at a per share purchase price equal to the Share Price, and/or (B) the pre-funded warrants to purchase shares of Common Stock (the &#8220;<b style="font-weight:bold;">Pre-Funded Warrants</b>&#8221;) substantially in the form attached hereto as <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit B</u> at a per warrant price equal to the Pre-Funded Warrant Price (as defined below); </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WHEREAS</b>, contemporaneously with the sale of the Initial Shares and/or the Pre-Funded Warrants, Crescent, Parent and the Investors will execute and deliver a Registration Rights Agreement, in the form attached hereto as <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit C</u>, pursuant to which the Company will agree to provide certain registration rights in respect of the Shares (as defined below) under the Securities Act and applicable state securities laws; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">WHEREAS</b>, <font style="font-size:12pt;"><a name="_Hlk190088225"></a></font>Crescent is party to that certain Agreement and Plan of Merger and Reorganization by and among the Crescent, Parent, Gemini Merger Sub Corp., a Delaware corporation and wholly-owned subsidiary of Parent (&#8220;<b style="font-weight:bold;">First Merger Sub</b>&#8221;) and Gemini Merger Sub II, LLC, a Delaware limited liability company and wholly-owned subsidiary of Parent (&#8220;<b style="font-weight:bold;">Second Merger Sub</b>&#8221;), dated October 28, 2024 (as amended from time to time, including on or around the date hereof, the &#8220;<b style="font-weight:bold;">Merger Agreement</b>&#8221;), pursuant to which (i) First Merger Sub will merge with and into Crescent, with Crescent surviving and becoming a wholly-owned subsidiary of Parent, (ii) Crescent will merge with and into Second Merger Sub, with Second Merger Sub being the surviving entity and a wholly-owned subsidiary of Parent ((i) and (ii) together, the &#8220;<b style="font-weight:bold;">Merger</b>&#8221;), and (iii) Parent will change its name to Crescent Biopharma, Inc. (&#8220;<b style="font-weight:bold;">TopCo</b>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">NOW THEREFORE</b>, in consideration of the mutual agreements, representations, warranties and covenants herein contained, Parent, Crescent and each Investor, severally and not jointly, agree as follows:</p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-decoration-line:none;text-indent:0pt;vertical-align:baseline;white-space:nowrap;">1.</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076109"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Definitions</u><font style="font-size:11pt;">. As used in this Agreement, the following terms shall have the following respective meanings:</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">2024 SEC Reports</b>&#8221; means (a) <font style="font-size:12pt;"><a name="_9kR3WTr266459KCw4skcQv69FD8aWFEPRl"></a></font>Parent&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and (b) any <font style="font-size:12pt;"><a name="_9kR3WTr266469ZZqo8wv3BsTy9CIKGCeaJITVv"></a></font>Quarterly Reports on Form 10-Q or any <font style="font-size:12pt;"><a name="_9kR3WTr26645ERL75tq6lRw7AGIEAcYHGYu"></a></font>Current Reports on Form 8-K filed or furnished (as applicable) by Parent after January 1, 2024 and prior to the Business Day immediately preceding the date hereof, together in each case with any documents incorporated by reference therein or exhibits thereto.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Additional Securities</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;8.15</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Affiliate</b>&#8221; means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls, is controlled by or is under common control with such Person.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Aggregate Purchase Amount</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2.2</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Agreement</b>&#8221; has the meaning set forth in the recitals hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Amended and Restated Bylaws</b>&#8221; means the bylaws of the Company, as currently in effect and as in effect on the Closing Date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Amended and Restated Certificate of Incorporation</b>&#8221; means the <font style="font-size:12pt;"><a name="_9kR3WTr26645BO5r7zmnlew1xzUXy0GIGJ69IEK"></a></font>Certificate of Incorporation of the Company, as currently in effect and as in effect on the Closing Date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Beneficial Ownership Limitation</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2.1</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Benefit Plan</b>&#8221; or &#8220;<b style="font-weight:bold;">Benefit Plans</b>&#8221; means employee benefit plans as defined in Section 3(3) of ERISA and all other employee benefit practices or arrangements, including, without limitation, any such practices or arrangements providing severance pay, sick leave, vacation pay, salary continuation for disability, retirement benefits, deferred compensation, bonus pay, incentive pay, stock options or other stock-based compensation, hospitalization insurance, medical insurance, life insurance, scholarships or tuition reimbursements, maintained by the Company or to which the Company or any of its Subsidiaries is obligated to contribute for employees or former employees of the Company and its Subsidiaries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Board of Directors</b>&#8221; means the board of directors of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Business Day</b>&#8221; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Closing</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2.2</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Closing Date</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2.2</u> hereof.<sup style="font-size:8.25pt;vertical-align:top;"> </sup></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Code</b>&#8221; means the U.S. Internal Revenue Code of 1986, as amended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Commitment Amount</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2.1</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Common Stock</b>&#8221; has the meaning set forth in the recitals hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;"><a name="_Hlk190088243"></a></font>&#8220;<b style="font-weight:bold;">Company</b>&#8221; means Crescent for all periods prior to the Effective Time and TopCo for all periods following the Effective Time.</p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">2</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Company Presentation</b>&#8221; means that certain Investor Presentation, dated October 2024, as provided to the Investors prior to the date hereof and filed by Parent on Form 8-K on October 29, 2024. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Confidential Data</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3.30</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Contribution</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2.2</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Convertible Security</b>&#8221; means a convertible note issued by the Company or any of its Subsidiaries. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Disclosure Document</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;5.3</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Disclosure Time</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;5.3</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Drug Regulatory Agency</b>&#8221; means the U.S. Food and Drug Administration (&#8220;<b style="font-weight:bold;">FDA</b>&#8221;) or other foreign, state, local or comparable governmental authority responsible for regulation of the research, development, testing, manufacturing, processing, storage, labeling, sale, marketing, advertising, distribution and importation or exportation of drug or biological products and drug or biological product candidates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Environmental Laws</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3.15</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">ERISA</b>&#8221; means the U.S. Employee Retirement Income Security Act of 1974, as amended.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Exchange Act</b>&#8221; means the U.S. Securities Exchange Act of 1934, as amended, and all of the rules and regulations promulgated thereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Financial Statements</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3.8</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">GAAP</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3.8</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">GDPR</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3.31</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Governmental Authorizations</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3.11</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Health Care Laws</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3.21</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">HIPAA</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3.30</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Indemnified Persons</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;5.10(a)</u>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Initial Shares</b>&#8221; has the meaning set forth in the recitals hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Intellectual Property</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3.12</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<font style="font-size:12pt;"><a name="_9kMHG5YVt3BC679SM6ywC98"></a></font><b style="font-weight:bold;">Investor</b>&#8221; and &#8220;<b style="font-weight:bold;">Investors</b>&#8221; have the meanings set forth in the recitals hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Investor Majority</b>&#8221; means, (i) prior to the Closing, the Investors committed to purchase at least a majority of the Securities, which majority shall include any Investor who, together with any affiliated funds or commonly managed funds, has committed to purchase at least $18.0 million of the Securities, and (ii) following the Closing, the Investors who hold (as of such time) at least a majority of the Securities (including any Pre-Funded Warrant Shares).</p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">3</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">IT Systems</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3.30</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Material Adverse Effect</b>&#8221; means any change, event, circumstance, development, condition, occurrence or effect that, individually or in the aggregate, (a) was, is, or would reasonably be expected to be, materially adverse to the business, financial condition, properties, assets, liabilities, stockholders&#8217; equity or results of operations of the Company and its Subsidiaries, taken as a whole, or (b) materially delays or materially impairs the ability of the Company to timely comply, or prevents the Company from complying, with its obligations under this Agreement, the other Transaction Agreements, or with respect to the Closing, or would reasonably be expected to do so; provided, however, that none of the following will be deemed in themselves, either alone or in combination, to constitute, and that none of the following will be taken into account in determining whether there has been or will be, a Material Adverse Effect under subclause (a) of this definition:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(i)</font></font>any change generally affecting the economy, financial markets or political, economic or regulatory conditions in the United States or any other geographic region in which the Company or its Subsidiaries conducts business, provided that the Company or its Subsidiaries are not disproportionately affected thereby;</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(ii)</font></font>general financial, credit or capital market conditions, including interest rates or exchange rates, or any changes therein, provided that the Company or its Subsidiaries are not disproportionately affected thereby;</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(iii)</font></font>any change that generally affects industries in which the Company and its Subsidiaries conduct business, provided that the Company and its Subsidiaries are not disproportionately affected thereby;</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(iv)</font></font>earthquakes, hurricanes, tsunamis, tornadoes, floods, mudslides, fires or other natural disasters, weather conditions, global pandemics, including the COVID-19 pandemic and related strains, epidemic or similar health emergency, and other force majeure events in the United States or any other location, provided that the Company and its Subsidiaries are not disproportionately affected thereby;</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(v)</font></font>national or international political or social conditions (or changes in such conditions), whether or not pursuant to the declaration of a national emergency or war, or the occurrence of any military or terrorist attack, provided that the Company and its Subsidiaries are not disproportionately affected thereby;</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(vi)</font></font>material changes in laws after the date of this Agreement; and</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">(vii)</font></font>in and of itself, any material failure by the Company or its Subsidiaries to meet any published or internally prepared estimates of drug development timelines (it being understood that the facts and circumstances giving rise to such failure may be deemed to constitute, and may be taken into account in determining whether there has been, a Material Adverse Effect to the extent that such facts and circumstances are not otherwise described in clauses (i)-(v) of this definition).</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Nasdaq</b>&#8221; means the Nasdaq Stock Market LLC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt;">&#8220;<b style="font-weight:bold;">National Exchange</b>&#8221; means (i) on and prior to the Closing Date, the Nasdaq Global Market, and (ii) following the Closing Date, any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question, together with any successor thereto: the <font style="font-size:12pt;"><a name="_9kR3WTr266468VAGxgFqw1ngs"></a></font>NYSE </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">4</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;">American, The New York Stock Exchange, the Nasdaq Global Market, the Nasdaq Global Select Market and the <font style="font-size:12pt;"><a name="_9kR3WTr26645FdCosbpS7r05yreO0Bz9"></a></font>Nasdaq Capital Market.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Person</b>&#8221; means an individual, partnership, corporation, limited liability company, business trust, joint stock company, trust, unincorporated association, joint venture or any other entity or organization.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Personal Data</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3.30</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Placement Agent</b>&#8221; means each of Jefferies LLC, TD Securities (USA) LLC, Stifel, Nicolaus &amp; Company, Incorporated and LifeSci Capital LLC. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Pre-Funded Warrant Price</b>&#8221; means an amount equal to (i) the Share Price minus (ii) $0.0001.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Pre-Funded Warrant Shares</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2.1</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Pre-Funded Warrants</b>&#8221; has the meaning set forth in the recitals hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Privacy Laws</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3.31</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Privacy Statements</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3.31</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Process</b>&#8221; or &#8220;<b style="font-weight:bold;">Processing</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3.31</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Registration Rights Agreement</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6.1(j)</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Regulatory Agencies</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3.20</u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </u>hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Rule 144</b>&#8221; means Rule 144 promulgated by the SEC pursuant to the Securities Act, as such rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the SEC having substantially the same effect as such rule.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">SEC</b>&#8221; means the U.S. Securities and Exchange Commission.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Securities</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2.1</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Securities Act</b>&#8221; has the meaning set forth in the recitals hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Share Price</b>&#8221; means an amount equal to (i) the Company Valuation (as defined in the Merger Agreement), (ii) divided by the number of Company Outstanding Shares (as defined in the Merger Agreement but excluding the Securities being issued hereunder) as of immediately prior to the Closing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Shares</b>&#8221; means the Initial Shares and the Pre-Funded Warrant Shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Short Sales</b>&#8221; include, without limitation, (i) all &#8220;short sales&#8221; as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, whether or not against the box, and all types of direct and indirect stock pledges, forward sale contracts, options, puts, calls, short sales, swaps, &#8220;put equivalent positions&#8221; (as defined in Rule 16a-1(h) under the Exchange Act) and similar arrangements (including on a total return basis), and (ii) sales and other transactions through non-U.S. broker dealers or non-U.S. regulated brokers (but shall not be deemed to include the location and/or reservation of borrowable shares of Common Stock), in each case, solely to the extent it has the same economic effect as a &#8220;short sale&#8221; (as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act).</p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">5</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Subsidiaries</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3.1</u> hereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Tax</b>&#8221; or &#8220;<b style="font-weight:bold;">Taxes</b>&#8221; means any and all federal, state, local, foreign and other taxes, levies, fees, imposts, duties and charges of whatever kind (including any interest, penalties or additions to the tax imposed in connection therewith or with respect thereto), whether or not imposed on the Company, including, without limitation, taxes imposed on, or measured by, income, franchise, profits or gross receipts, and also ad valorem, value added, sales, use, service, real or personal property, capital stock, license, payroll, withholding, employment, social security, workers&#8217; compensation, unemployment compensation, utility, severance, production, excise, stamp, occupation, premium, windfall profits, transfer and gains taxes and customs duties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Tax Returns</b>&#8221; means returns, reports, information statements and other documentation (including any additional or supporting material) filed or maintained, or required to be filed or maintained, in connection with the calculation, determination, assessment or collection of any Tax and shall include any amended returns required as a result of examination adjustments made by the Internal Revenue Service or other Tax authority.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Transaction Agreements</b>&#8221; means this Agreement, the Pre-Funded Warrants, the Registration Rights Agreement and any other documents or agreements explicitly contemplated hereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Transfer Agent</b>&#8221; means, with respect to the Common Stock, Equiniti (formerly known as the American Stock Transfer &amp; Trust Company), or such other financial institution that provides transfer agent services as the Company may engage from time to time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Transfer Taxes</b>&#8221; means all real property transfer, sales, use, value added, stamp, documentary, recording, registration, conveyance, stock transfer, intangible property transfer, personal property transfer, gross receipts, registration, duty, securities transactions or similar fees or Taxes (together with any interest, penalty, or addition thereto) incurred in connection with the transactions contemplated by this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">Wire</b>&#8221; has the meaning set forth in <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2.2</u> hereof.<sup style="font-size:8.25pt;vertical-align:top;"> </sup></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-decoration-line:none;text-indent:0pt;vertical-align:baseline;white-space:nowrap;">2.</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc113811260"></a><a name="_Toc166076110"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Purchase and Sale of Securities</u><font style="font-size:11pt;">.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">2.1</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref113003030"></a><a name="_Toc166076111"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Purchase and Sale</u><font style="font-size:11pt;">. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Investors, severally and not jointly, agree to purchase, the number of Initial Shares equal to (rounded down to the nearest whole Initial Share) (i) the aggregate commitment amount set forth under the heading &#8220;Commitment Amount&#8221; and opposite such Investor&#8217;s name on the </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</u><font style="font-size:11pt;"> (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Commitment Amount</b><font style="font-size:11pt;">&#8221;) divided by (ii) the Share Price; </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u><font style="font-size:11pt;">, </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</u><font style="font-size:11pt;">, for any Investor that has provided notice to the Company at least ten (10) Business Days prior to the Closing that such Investor would beneficially own (when aggregated with all Securities then beneficially owned by the Investor and its affiliates (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder)) in excess of the Beneficial Ownership Limitation, or as such Investor may otherwise choose, in lieu of purchasing Initial Shares such Investor may elect to purchase Pre-Funded Warrants to purchase a number of shares of Common Stock issuable upon exercise of the Pre-Funded Warrants (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Pre-Funded Warrant Shares</b><font style="font-size:11pt;">&#8221;) equal to (rounded down to the nearest whole Pre-Funded Warrant Share) (i) the Commitment Amount (or any remainder thereof) divided by (ii) the Pre-Funded Warrant Price in lieu of Initial Shares in such manner to result in the same Aggregate Purchase Amount being paid by such Investor in the aggregate (including upon exercise of such Pre-Funded Warrants). The &#8220;</font><b style="font-size:11pt;font-weight:bold;">Beneficial Ownership Limitation</b><font style="font-size:11pt;">&#8221; shall initially be set at the discretion of each Investor to a percentage designated by such Investor on its signature page hereto between 0% and 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of the </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">6</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;background:#ffffff;margin:0pt 0pt 12pt 0pt;"><font style="font-style:normal;font-weight:normal;">Initial Shares and Pre-Funded Warrants on the Closing Date (collectively, the &#8220;</font><b style="font-style:normal;font-weight:bold;">Securities</b><font style="font-style:normal;font-weight:normal;">&#8221;); </font><u style="font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u><font style="font-style:normal;font-weight:normal;"> that such percentage shall be set at 9.99% for any Investor that does not make such designation on its signature page hereto. Notwithstanding the foregoing, by written notice to the Company, any Investor may reset the Beneficial Ownership Limitation percentage to a higher or lower percentage, not to exceed 9.99%; </font><u style="font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u><font style="font-style:normal;font-weight:normal;"> that any increase prior to the Closing will not be effective until the sixty-first (61st) day after such written notice is delivered to the Company. Upon such a change by an Investor of the Beneficial Ownership Limitation, the Beneficial Ownership Limitation may not be further amended by such Investor without first providing the minimum notice required by this </font><u style="font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2.1</u><font style="font-style:normal;font-weight:normal;">. &#160;Notwithstanding anything to the contrary set forth in this Agreement, for any Investor that has provided notice to the Company that this sentence shall apply to it, (i) the Investor shall not be required to purchase Pre-Funded Warrants and (ii) the Company shall not issue or sell, and the Investor shall not purchase or acquire, any Initial Shares which, when aggregated with all shares of Common Stock then beneficially owned by the Investor and its affiliates (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder), would result in the beneficial ownership by the Investor of more than 9.99% of the outstanding shares of Common Stock immediately after giving effect to the Closing and the consummation of the transactions contemplated hereby, and the number of Initial Shares and the Aggregate Purchase Amount for such Investor shall be reduced accordingly.</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">2.2</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref112961366"></a><a name="_Toc166076112"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Closing</u><font style="font-size:11pt;">. Subject to the satisfaction or waiver of the conditions set forth in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6</u><font style="font-size:11pt;">, the closing of the purchase and sale of the Securities (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Closing</b><font style="font-size:11pt;">&#8221; and the date on which the Closing occurs, the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Closing Date</b><font style="font-size:11pt;">&#8221;) shall occur remotely via the exchange of documents and signatures immediately prior to the First Effective Time (as defined in the Merger Agreement), or at such other time as agreed to by the Company and the Investor Majority. Not less than three (3) Business Days prior to the anticipated Closing Date, the Company shall provide written notice to the Investors (the &#8220;</font><b style="font-size:11pt;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Closing Notice</b><font style="font-size:11pt;">&#8221;) of the anticipated Closing Date and the wire instructions for delivery of the Aggregate Purchase Amount. At the Closing, the Securities shall be issued and registered in the name of such Investor, or in such nominee name(s) as designated by such Investor, representing the number of Securities to be purchased by such Investor at such Closing as set forth in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</u><font style="font-size:11pt;">, in each case against payment to the Company of the purchase price therefor (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Aggregate Purchase Amount</b><font style="font-size:11pt;">&#8221;) in full, either by (x) wire transfer to the Company of immediately available funds (a &#8220;</font><b style="font-size:11pt;font-weight:bold;">Wire</b><font style="font-size:11pt;">&#8221;), at or prior to the Closing, in accordance with wire instructions provided by the Company to the Investors in the Closing Notice; (y) the cancellation of Convertible Securities or other debt of the Company or its Subsidiaries (</font><a name="_Hlk180506928"></a><font style="font-size:11pt;">including any outstanding principal, interest or any other amounts due thereon</font><font style="font-size:11pt;">) set forth under the heading &#8220;Convertible Securities Amount&#8221; and opposite such Investor&#8217;s name in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</u><font style="font-size:11pt;"> (any such cancellation, a &#8220;</font><b style="font-size:11pt;font-weight:bold;">Contribution</b><font style="font-size:11pt;">&#8221;); or (z) a combination of such methods. On the Closing Date, the Company will (A) cause the Transfer Agent to issue the Initial Shares in book-entry form, free and clear of all restrictive and other legends (except as expressly provided in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;4.10</u><font style="font-size:11pt;"> hereof) and the Company shall provide evidence of such issuance from the Company&#8217;s Transfer Agent as soon as reasonably practical following the Closing Date to each Investor and (B) deliver to such Investor (or such Investor&#8217;s designated custodian per its delivery instructions), or in such nominee name(s) as designated by such Investor, a Pre-Funded Warrant exercisable for a number of shares of Common Stock as set forth in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</u><font style="font-size:11pt;"> with respect to such Investor. If the Closing has not occurred within two (2) Business Days after the expected Closing Date, unless otherwise agreed by the Company and such Investor, the Company shall promptly (but no later than one (1) Business Day thereafter) return the previously wired Aggregate Purchase Amount to each respective Investor by wire transfer of United States dollars in immediately available funds to the account specified by each Investor, and any book entries for the Securities shall be deemed cancelled; </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u><font style="font-size:11pt;"> that, unless this Agreement has been terminated pursuant to </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;7</u><font style="font-size:11pt;">, such return of funds shall not terminate this Agreement or relieve such Investor of its obligation to purchase, or the Company of its obligation to issue and sell, the Securities at the Closing. Notwithstanding the foregoing and anything in this Agreement to the contrary, (i) the Company may amend </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</u><font style="font-size:11pt;"> up to three (3) Business Days prior to the Closing, without the consent of the other parties hereto, to reflect the number of Securities purchased, the Aggregate Purchase Amount to be paid </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">7</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-style:normal;font-weight:normal;">and the Convertible Securities Amount to be Contributed, in each case, by each applicable Investor, and shall provide such updated </font><u style="font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</u><font style="font-style:normal;font-weight:normal;"> to an Investor upon request, and (ii), as may be agreed to among the Company and one or more Investors, if an Investor is (a) an investment company registered under the Investment Company Act of 1940, as amended, (b) advised by an investment adviser subject to regulation under the Investment Advisers Act of 1940, as amended, or (c) otherwise subject to internal policies and/or procedures relating to the timing of funding and issuance of securities, such Investor shall not be required to wire its Aggregate Purchase Amount until it confirms receipt of evidence of the issuance of such Investor&#8217;s Initial Shares from the Transfer Agent in form and substance reasonably acceptable to the Investor (and the Company shall use reasonable best efforts to cause the Transfer Agent to deliver such evidence) and, if applicable, copies of such Investor&#8217;s Pre-Funded Warrants. </font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">2.3</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Conversion and Termination of Convertible Securities</u><font style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:none;">. Notwithstanding anything in this Agreement to the contrary, by executing and delivering this Agreement, each Investor holding one or more Convertible Securities prior to the Closing hereby irrevocably agrees that: </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(a)</font><font style="font-size:11pt;">the aggregate amount of all such Convertible Securities (</font><a name="_Hlk180506948"></a><font style="font-size:11pt;">including any outstanding principal, interest or any other amounts</font><font style="font-size:11pt;">) held by such Investor is set forth under the heading &#8220;Convertible Securities Amount&#8221; and opposite such Investor&#8217;s name in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</u><font style="font-size:11pt;">;</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(b)</font><font style="font-size:11pt;">such Investor is the sole owner of all right, title and interest in and to the Convertible Securities corresponding to the amounts set forth under the heading &#8220;Convertible Securities Amount&#8221; and opposite such Investor&#8217;s name in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</u><font style="font-size:11pt;">;</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(c)</font><font style="font-size:11pt;">at the Closing, (i) all of such Investor&#8217;s Convertible Securities will automatically and without any action on the part of such Investor convert into that number of Securities as is calculated in accordance with </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2.1</u><font style="font-size:11pt;"> based on such Investor&#8217;s Aggregate Purchase Amount (whether paid via Wire or Contribution), regardless of whether any such Convertible Securities or an affidavit of loss therefor is actually delivered in original or other form to the Company, and (ii) any original Convertible Securities held by (or delivered, electronically or otherwise, to) the Company or any Subsidiary, as applicable, shall be cancelled (and marked cancelled) by the Company or any Subsidiary, as applicable, upon or following the Closing; </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(d)</font><a name="_Ref179556509"></a><font style="font-size:11pt;">with respect to any Contribution by such Investor, (i) such Investor (on behalf of itself and all beneficial owners of such Investor&#8217;s Convertible Securities) and Company (on behalf of itself and its Subsidiaries) hereby agree that any Convertible Securities that are Contributed hereby are and will be deemed for all purposes to have been amended and modified by virtue hereof to the full extent necessary to permit and facilitate their conversion as provided in this Agreement into Securities and (ii) such Investor&#8217;s Securities are issued in full and complete discharge and satisfaction of all obligations of the Company or its Subsidiaries, as applicable, (including any outstanding principal, interest or any other amounts) under such Investor&#8217;s Convertible Securities, and such Convertible Securities will be terminated in full and will be null, void and of no further force or effect automatically immediately upon the Closing, </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u><font style="font-size:11pt;"> that the foregoing will not impair the right of such Investor to receive the applicable number of Securities calculated in accordance with </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2.1</u><font style="font-size:11pt;"> above; and</font><font style="font-size:11pt;"> </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(e)</font><a name="_Ref178245749"></a><font style="font-size:11pt;">the Company and its Subsidiaries, affiliates, and agents shall be entitled to deduct and withhold from the amounts deliverable in satisfaction of such Investor&#8217;s Convertible Securities (including any Securities otherwise issuable with respect thereto) such amounts, if any, as are required to be deducted and withheld under the Code or any other applicable tax law. To the extent that amounts are so deducted and withheld and duly paid over to the appropriate tax authority, such withheld amounts shall be treated for all purposes of this Agreement as having been delivered to the person in respect of whom such deduction and withholding was made. Each person holding Convertible Securities shall, upon request, </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">8</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:0pt;"><font style="font-size:11pt;">use its commercially reasonable efforts to provide the applicable withholding agent with all necessary tax forms, including a duly executed IRS Form W-9 or appropriate version of IRS Form W-8, as applicable. Prior to withholding any amounts pursuant to this </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2.3(e)</u><font style="font-size:11pt;">, the Company (and its Subsidiaries, affiliates, and agents) shall use commercially reasonable efforts to notify such Investor, and the Company and such Investor shall cooperate in good faith to reduce or eliminate any such withholding.</font><font style="font-size:11pt;"> </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-decoration-line:none;text-indent:0pt;vertical-align:baseline;white-space:nowrap;">3.</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref113003310"></a><a name="_Toc166076113"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Representations and Warranties of the Company</u><font style="font-size:11pt;">. The Company and, solely for purposes of Section 3.4 and Section 3.33(b), Parent hereby represent and warrant to each of the Investors and the Placement Agents that the statements contained in this </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3</u><font style="font-size:11pt;"> are true and correct as of the date hereof and as of the Closing Date (except for the representations and warranties that speak as of a specific date, which shall be made as of such date):</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.1</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref113003573"></a><a name="_Toc166076114"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Organization and Power</u><font style="font-size:11pt;">. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware, has the requisite power and authority to own, lease and operate its properties and to carry on its business as now conducted and is qualified to do business in each jurisdiction in which the character of its properties or the nature of its business requires such qualification, except where such failure to be in good standing or to have such power and authority or to so qualify would not reasonably be expected to have a Material Adverse Effect. Each of the Company&#8217;s subsidiaries (collectively, the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Subsidiaries</b><font style="font-size:11pt;">&#8221;) is wholly owned by the Company. Each of the Subsidiaries is duly incorporated and validly existing and in good standing under the laws of the jurisdiction of its incorporation and has the requisite power and authority to carry on their business as now conducted and to own or lease its properties. Each of the Subsidiaries is duly qualified to do business as a foreign corporation and is in good standing in each jurisdiction in which such qualification is required unless the failure to so qualify has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.2</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref113003601"></a><a name="_Toc166076115"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Capitalization</u><font style="font-size:11pt;">. The authorized capital stock of the Crescent consists of 40,000,000 shares of Common Stock and 20,000,000 shares of preferred stock, par value $0.0001 per share. All of the issued and outstanding shares of Common Stock have been duly authorized and validly issued and are fully paid and non-assessable. None of the outstanding shares of capital stock of the Company were issued in violation of any preemptive or other similar rights of any securityholder of the Company which have not been waived, and such shares were issued in compliance in all material respects with applicable state and federal securities law and any rights of third parties. </font><a name="_Hlk180757695"></a><font style="font-size:11pt;">There are no securities or instruments issued by or to which the Company is a party containing anti-dilution or similar provisions that will be triggered by the issuance of the Securities pursuant to this Agreement. </font><font style="font-size:11pt;">There are no securities or instruments issued by or to which the Company is a party containing anti-dilution or similar provisions that will be triggered (which, for the avoidance of doubt, excludes any such anti-dilution or similar provision that will be waived in connection with the transactions contemplated by this Agreement and the Merger Agreement) by the issuance of the Securities pursuant to this Agreement. </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.3</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076116"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Registration Rights</u><font style="font-size:11pt;">. Except as set forth in the Transaction Agreements, the Company is presently not under any obligation, and has not granted any rights, to register under the Securities Act any of the Company&#8217;s presently outstanding securities or any of its securities that may hereafter be issued that have not expired or been satisfied or waived.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.4</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref113003580"></a><a name="_Toc166076117"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Authorization</u><font style="font-size:11pt;">. The Company has all requisite corporate power and authority to enter into the Transaction Agreements and to carry out and perform its obligations under the terms of the Transaction Agreements, including the issuance and sale of the Securities and the issuance of the Pre-Funded Warrant Shares. Except for the Required Company Stockholder Vote (as defined in the Merger Agreement), all corporate action on the part of the Company, its officers, directors and stockholders necessary for the authorization of the Securities and the Pre-Funded Warrant Shares, the authorization, </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">9</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-style:normal;font-weight:normal;">execution, delivery and performance of the Transaction Agreements and the consummation of the transactions contemplated herein, including the issuance and sale of the Securities and the Pre-Funded Warrant Shares and the reservation of the Pre-Funded Warrant Shares, has been taken. This Agreement has been duly executed and delivered by each of the Company and Parent and assuming the due authorization, execution and delivery by each Investor and that this Agreement constitutes the legal, valid and binding agreement of each Investor, this Agreement and each of the Pre-Funded Warrants constitutes a legal, valid and binding obligation of each of the Company and Parent, enforceable against the Company and Parent in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium and similar laws relating to or affecting creditors generally or by general equity principles (regardless of whether such enforceability is considered in a proceeding in equity or at law). Upon its execution by the Company and the other parties thereto and assuming that it constitutes legal, valid and binding agreements of the other parties thereto, the Registration Rights Agreement will constitute a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium and similar laws relating to or affecting creditors generally or by general equity principles (regardless of whether such enforceability is considered in a proceeding in equity or at law).</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.5</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref113003589"></a><a name="_Toc166076118"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Valid Issuance</u><font style="font-size:11pt;">. The Initial Shares being purchased by the Investors hereunder have been duly and validly authorized and, upon issuance pursuant to the terms hereof, against full payment therefor in accordance with the terms of this Agreement, will be duly and validly issued, fully paid and non-assessable and will be issued free and clear of any liens or other restrictions (other than those as provided in the Transaction Agreements or restrictions on transfer under applicable state and federal securities laws) and the holder of the Initial Shares shall be entitled to all rights accorded to a holder of Common Stock. The Pre-Funded Warrant Shares have been duly and validly authorized and reserved for issuance and, upon issuance pursuant to the terms of the Pre-Funded Warrants, against full payment therefor in accordance with the terms of the Pre-Funded Warrants, will be duly and validly issued, fully paid and non-assessable and will be issued free and clear of any liens or other restrictions (other than those as provided in the Transaction Agreements or restrictions on transfer under applicable state and federal securities laws) and the holder of the Pre-Funded Warrant Shares shall be entitled to all rights accorded to a holder of Common Stock. Subject to the accuracy of the representations and warranties made by the Investors in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;4</u><font style="font-size:11pt;"> hereof, the offer and sale of the Securities to the Investors is and will be in compliance with applicable exemptions from (i) the registration and prospectus delivery requirements of the Securities Act and (ii) the registration and qualification requirements of applicable securities laws of the states of the United States. </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.6</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076119"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Conflict</u><font style="font-size:11pt;">. The execution, delivery and performance of the Transaction Agreements by the Company, the issuance and sale of the Securities and the consummation of the other transactions contemplated by the Transaction Agreements will not (i) violate any provision of the Amended and Restated Certificate of Incorporation or Amended and Restated Bylaws, (ii) conflict with or result in a violation of or default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancellation or acceleration of any obligation, a change of control right or to a loss of a benefit under any agreement or instrument, credit facility, franchise, license, judgment, order, statute, law, ordinance, rule or regulations, applicable to the Company or any Subsidiary or their respective properties or assets,&#160;</font><font style="font-size:11pt;background:#ffffff;">or (iii)&#160;result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or any Subsidiary is subject (including federal and state securities laws and regulations) and the rules and regulations of any self-regulatory organization to which the Company or its securities are subject, or by which any property or asset of the Company or any Subsidiary is bound or affected,&#160;</font><font style="font-size:11pt;">except, in the case of clauses (ii) and (iii), as would not, individually or in the aggregate, be reasonably expected to have a Material Adverse Effect.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.7</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076120"></a><a name="_Ref179816888"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Consents</u><font style="font-size:11pt;">. </font><a name="_Hlk176804800"></a><font style="font-size:11pt;">Assuming the accuracy of the representations and warranties of the Investors in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;4</u><font style="font-size:11pt;">, no consent, approval, authorization, filing with or order of or registration with, any </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">10</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-style:normal;font-weight:normal;">court or governmental agency or body is required in connection with the authorization, execution or delivery by the Company of the Transaction Agreements, the issuance and sale of the Securities and the performance by the Company of its other obligations under the Transaction Agreements, except such as (a) have been or will be obtained or made under the Securities Act or the Exchange Act, (b) the filing of any requisite notices and/or application(s) to the National Exchange for the issuance and sale of the Shares and the listing of the Shares for trading or quotation, as the case may be, thereon in the time and manner required thereby, (c) customary post-closing filings with the SEC or pursuant to state securities laws in connection with the offer and sale of the Shares by the Company in the manner contemplated herein, which will be filed on a timely basis, (d) the filing of the registration statement required to be filed by the Registration Rights Agreement, or (e) such that the failure of which to obtain would not have a Material Adverse Effect. All notices, consents, authorizations, orders, filings and registrations which the Company is required to deliver or obtain prior to the Closing pursuant to the preceding sentence have been obtained or made or will be delivered or obtained or effected, and shall remain in full force and effect, on or prior to the Closing.</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.8</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076121"></a><a name="_Ref113003364"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Financial Statements</u><font style="font-size:11pt;">.</font><font style="font-size:11pt;"> &#160;The financial statements of the Company for the period ended December 31, 2024 and related balance sheet data as of December 31, 2024 (collectively, the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Financial Statements</b><font style="font-size:11pt;">&#8221;) comply in all material respects with applicable accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at the time of filing (or to the extent corrected by a subsequent restatement) and fairly present in all material respects the financial position of the Company as of the dates indicated, and the results of its operations and cash flows for the periods therein specified, all in accordance with United States generally accepted accounting principles (&#8220;</font><b style="font-size:11pt;font-weight:bold;">GAAP</b><font style="font-size:11pt;">&#8221;) (except as otherwise noted therein, and in the case of unaudited financial statements, as permitted by Form 10-Q of the SEC, and except that the unaudited financial statements may not contain footnotes and are subject to normal and recurring year-end adjustments) applied on a consistent basis unless otherwise noted therein throughout the periods therein specified. Except as set forth in the Financial Statements filed prior to the date hereof, the Company has not incurred any liabilities, contingent or otherwise, except (i) those incurred in the ordinary course of business, consistent with past practices since the date of such Financial Statements or (ii) liabilities not required under GAAP to be reflected in the Financial Statements, in either case, none of which, individually or in the aggregate, have had or would reasonably be expected to have a Material Adverse Effect. </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.9</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076122"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Absence of Changes</u><font style="font-size:11pt;">. Except for the execution and performance of this Agreement and the discussions, negotiations and transactions related thereto, including the Merger Agreement and transactions preceding or related thereto, since the Company&#8217;s inception: (a) the Company has conducted its business only in the ordinary course of business and there have been no material transactions entered into by the Company; (b) no material change to any material contract or arrangement by which the Company is bound or to which any of its assets or properties is subject has been entered into that has not been disclosed to the Investors and the Placement Agents; and (c) there has not been any other event or condition of any character that has had or would reasonably be expected to have a Material Adverse Effect.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.10</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076123"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Absence of Litigation</u><font style="font-size:11pt;">. There is no action, suit, proceeding, arbitration, claim, investigation, charge, complaint or inquiry pending or, to the Company&#8217;s knowledge, threatened against the Company or any Subsidiary which, individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect, nor are there any orders, writs, injunctions, judgments or decrees outstanding of any court or government agency or instrumentality and binding upon the Company or any Subsidiary that have had or would reasonably be expected to have a Material Adverse Effect. </font><font style="font-size:11pt;background:#ffffff;">Neither the Company nor any Subsidiary, nor to the knowledge of the Company, any director or officer of the Company or any Subsidiary, is, or within the last ten (10) years has been, the subject of any action involving a claim of violation of or liability under federal or state securities laws relating to the Company or such Subsidiary or a claim of breach of fiduciary duty relating to the Company or such Subsidiary.</font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">11</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.11</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref112961692"></a><a name="_Toc166076124"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compliance with Law; Permits</u><font style="font-size:11pt;">. None of the Company or any Subsidiary is in violation of, or has received any notices of violations with respect to, any laws, statutes, ordinances, rules or regulations of any governmental body, court or government agency or instrumentality, except for violations which, individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect. The Company and its Subsidiaries have all required licenses, permits, certificates and other authorizations (collectively, &#8220;</font><b style="font-size:11pt;font-weight:bold;">Governmental Authorizations</b><font style="font-size:11pt;">&#8221;) from such federal, state or local government or governmental agency, department or body that are currently necessary for the operation of the business of the Company and its Subsidiaries as currently conducted, except where the failure to possess currently such Governmental Authorizations has not had and is not reasonably expected to have a Material Adverse Effect. None of the Company or any Subsidiary has received any written (or, to the Company&#8217;s knowledge, oral) notice regarding any revocation or material modification of any such Governmental Authorization, which, individually or in the aggregate, if the subject of an unfavorable decision, ruling or finding, has or would reasonably be expected to result in a Material Adverse Effect.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.12</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076125"></a><a name="_Ref180064219"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Intellectual Property</u><font style="font-size:11pt;">. </font><a name="_Ref112961709"></a><font style="font-size:11pt;">The Company and its Subsidiaries own, or have rights to use, all material inventions, patent applications, patents, trademarks, trade names, service names, service marks, copyrights, trade secrets, know how (including unpatented and/or unpatentable proprietary of confidential information, systems or procedures) and other intellectual property, including but not limited to such intellectual property described in the Company Presentation, that is necessary for, or used in the conduct of their respective businesses (collectively, &#8220;</font><b style="font-size:11pt;font-weight:bold;">Intellectual Property</b><font style="font-size:11pt;">&#8221;), except where any failure to own, possess or acquire such Intellectual Property has not had, and would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Intellectual Property of the Company and its Subsidiaries has not been adjudged by a court of competent jurisdiction to be invalid or unenforceable, in whole or in part. To the Company&#8217;s knowledge: (i) there are no third parties who have rights to any Intellectual Property, including no liens, security interests, or other encumbrances; and (ii) there is no infringement by third parties of any Intellectual Property. No action, suit, or other proceeding is pending, or, to the Company&#8217;s knowledge, is threatened: (A) challenging the Company&#8217;s or its Subsidiaries&#8217; rights in or to any Intellectual Property; (B) challenging the validity, enforceability or scope of any Intellectual Property; or (C) alleging that the Company or any of its Subsidiaries infringes, misappropriates, or otherwise violates any patent, trademark, trade name, service name, copyright, trade secret or other proprietary rights of others, except, in each case, which, individually or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect. The Company and its Subsidiaries have complied in all material respects with the terms of each agreement pursuant to which Intellectual Property has been licensed to the Company or any of its Subsidiaries in all material respects, and to the Company&#8217;s knowledge all such agreements are in full force and effect. To the Company&#8217;s knowledge, there are no material defects in any of the patents or patent applications included in the Intellectual Property. The Company and its Subsidiaries have taken all reasonable steps to protect, maintain and safeguard their Intellectual Property.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.13</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc113810060"></a><a name="_Toc113811277"></a><a name="_Toc113810061"></a><a name="_Toc113811278"></a><a name="_Toc113810062"></a><a name="_Toc113811279"></a><a name="_Toc113810063"></a><a name="_Toc113811280"></a><a name="_Toc113810064"></a><a name="_Toc113811281"></a><a name="_Toc166076126"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Employee Benefits</u><font style="font-size:11pt;">. Except as would not be reasonably likely to result in a Material Adverse Effect, each Benefit Plan has been established and administered in accordance with its terms and in compliance with the applicable provisions of ERISA, the Code, the Patient Protection and Affordable Care Act of 2010, as amended, and other applicable laws, rules and regulations. The Company and its Subsidiaries are in compliance with all applicable federal, state and local laws, rules and regulations regarding employment, except for any failures to comply that are not reasonably likely, individually or in the aggregate, to have a Material Adverse Effect. There is no labor dispute, strike or work stoppage against the Company or its Subsidiaries pending or, to the knowledge of the Company, threatened which may interfere with the business activities of the Company, except where such dispute, strike or work stoppage is not reasonably likely, individually or in the aggregate, to have a Material Adverse Effect.</font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">12</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.14</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076127"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Taxes</u><font style="font-size:11pt;">. The Company and its Subsidiaries have filed all federal, state and foreign income Tax Returns and other Tax Returns required to have been filed under applicable law (or extensions have been duly obtained) and have paid all Taxes required to have been paid by them, except for those which are being contested in good faith and except where failure to file such Tax Returns or pay such Taxes would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. No assessment in connection with United States federal tax returns has been made against the Company. The charges, accruals and reserves on the books of the Company in respect of any income and corporation tax liability for any years not finally determined are adequate to meet any assessments or reassessments for additional income tax for any years not finally determined, except to the extent of any inadequacy that would not result in a Material Adverse Effect. No audits, examinations, or other proceedings with respect to any material amounts of Taxes of the Company and its Subsidiaries are presently in progress or have been asserted or proposed in writing without subsequently being paid, settled or withdrawn. There are no liens on any of the assets of the Company. The Company, at all times since inception, has been and continues to be each classified as a corporation for U.S. federal income tax purposes. Neither the Company nor any of its Subsidiaries has been a United States real property holding corporation within the meaning of Code Section 897(c)(2) during the period specified in Code Section 897(c)(1)(A)(ii).</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.15</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref112961560"></a><a name="_Toc166076128"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Environmental Laws</u><font style="font-size:11pt;">. The Company and its Subsidiaries (i)&#160;are in compliance with any and all applicable foreign, federal, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (&#8220;</font><b style="font-size:11pt;font-weight:bold;">Environmental Laws</b><font style="font-size:11pt;">&#8221;), (ii)&#160;have received all permits and other Governmental Authorizations required under applicable Environmental Laws to conduct its business and (iii)&#160;are in compliance with all terms and conditions of any such permit, license or approval, except where such noncompliance with Environmental Laws, failure to receive required permits, licenses or other approvals or failure to comply with the terms and conditions of such permits, licenses or approvals would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. None of the Company or any Subsidiary has received since January 1, 2024, any written notice or other communication (in writing or otherwise), whether from a governmental authority or other Person, that alleges that the Company or any Subsidiary is not in compliance with any Environmental Law and, to the knowledge of the Company, there are no circumstances that may prevent or interfere with the Company&#8217;s or any Subsidiary&#8217;s compliance with any Environmental Law in the future, except where such failure to comply would not reasonably be expected to have a Material Adverse Effect. To the knowledge of the Company: (i) no current or (during the time a prior property was leased or controlled by the Company) prior property leased or controlled by the Company or any Subsidiary has received since January 1, 2024, any written notice or other communication relating to property owned or leased at any time by the Company, whether from a governmental authority, or other Person, that alleges that such current or prior owner or the Company or any Subsidiary is not in compliance with or violated any Environmental Law relating to such property and (ii) the Company has no material liability under any Environmental Law.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.16</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076129"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Title</u><font style="font-size:11pt;">. Each of the Company and its Subsidiaries has good and marketable title to all personal property owned by it that is material to the business of the Company, free and clear of all liens, encumbrances and defects except such as do not materially affect the value of such property and do not materially and adversely interfere with the use made and proposed to be made of such property by the Company or its Subsidiaries, as the case may be. Any real property and buildings held under lease by the Company or its Subsidiaries is held under valid, subsisting and enforceable leases with such exceptions as are not material and do not materially and adversely interfere with the use made and proposed to be made of such property and buildings by the Company or its Subsidiaries, as the case may be. The Company does not own any real property.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.17</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076130"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Insurance</u><font style="font-size:11pt;">. The Company carries or is entitled to the benefits of insurance in such amounts and covering such risks that is customary for comparably situated companies and is adequate for </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">13</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-style:normal;font-weight:normal;">the conduct of its and its Subsidiaries&#8217; businesses and the value of its and its Subsidiaries&#8217; properties (owned or leased) and assets, and each of such insurance policies is in full force and effect and the Company is in compliance in all material respects with the terms thereof. Other than customary end of policy notifications from insurance carriers, since January 1, 2024, the Company has not received any notice or other communication regarding any actual or possible: (i) cancellation or invalidation of any insurance policy or (ii) refusal or denial of any coverage, reservation of rights or rejection of any material claim under any insurance policy.</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.18</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reserved</u><font style="font-size:11pt;">. </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.19</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reserved</u><font style="font-size:11pt;">. </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.20</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref139905625"></a><a name="_Toc166076133"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Clinical Data and Regulatory Compliance</u><font style="font-size:11pt;">. Except as would not reasonably be expected to result in a Material Adverse Effect: (i) the preclinical tests and clinical trials, and other studies used to support regulatory approval (collectively, &#8220;</font><a name="_9kR3WTr233479069ujlw"></a><b style="font-size:11pt;font-weight:bold;">studies</b><font style="font-size:11pt;">&#8221;) being conducted by the Company, including but not limited to studies that are described in, or the results of which are referred to in, the Company Presentation, were and, if still pending, are being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such studies and with standard medical and scientific research procedures; (ii) each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its Subsidiaries have no knowledge of any other studies the results of which are required to be disclosed in accordance with the Exchange Act and are inconsistent with, or otherwise call into question, the results described or referred to in the Company Presentation; (iii) the Company and its Subsidiaries have made all such filings and obtained all such approvals as may be required by the FDA or from any other U.S. federal, state or local government or foreign government or Drug Regulatory Agency, or </font><a name="_9kR3WTr266478PK18z0DE3z5srjX8DxCkX37B"></a><font style="font-size:11pt;">Institutional Review Board</font><font style="font-size:11pt;">, each having jurisdiction over biopharmaceutical products (collectively, the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Regulatory Agencies</b><font style="font-size:11pt;">&#8221;) for the conduct of its business; (iv) neither the Company nor any of its Subsidiaries has received any notice of, or correspondence from, any Regulatory Agency requiring the termination or suspension of or imposing any clinical hold on any clinical trials, including but not limited to studies that are described or referred to in the Company Presentation; and (v) the Company and its Subsidiaries have each operated and currently are in compliance in all material respects with all applicable rules, regulations and policies of the Regulatory Agencies.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.21</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076134"></a><a name="_Ref180064122"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compliance with Health Care Laws</u><font style="font-size:11pt;">. The Company and its Subsidiaries are in compliance in all material respects with all Health Care Laws to the extent applicable to the Company&#8217;s current business and research use only products. For purposes of this Agreement, &#8220;</font><b style="font-size:11pt;font-weight:bold;">Health Care Laws</b><font style="font-size:11pt;">&#8221; means: (i) the Federal Food, Drug, and Cosmetic Act (21 U.S.C. Section 301 et seq.) and the Public Health Service Act (42 U.S.C. Section 201 et seq.), and the regulations promulgated thereunder; (ii) all applicable federal, state, local and foreign health care fraud and abuse laws, including, without limitation, the </font><a name="_9kR3WTr26645ALC2yQLknnegrim12NO9"></a><font style="font-size:11pt;">Anti-Kickback Statute</font><font style="font-size:11pt;"> (42 U.S.C. Section 1320a-7b(b)); (iii) HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act (42 U.S.C. Section 17921 et seq.); (iv) the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010; (v) the European Union (&#8220;</font><b style="font-size:11pt;font-weight:bold;">EU</b><font style="font-size:11pt;">&#8221;) </font><a name="_9kR3WTr26645CPCpstjcmgh3nrArYuBHy7GCI"></a><font style="font-size:11pt;">Clinical Trials Regulation</font><font style="font-size:11pt;"> (Regulation (EU) No. 536/2014); (vi) the </font><a name="_9kR3WTr26646DRxBMiz5mv406"></a><font style="font-size:11pt;">EU Regulation</font><font style="font-size:11pt;"> regarding community procedures for authorization and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Regulation (EC) No. 726/2004); (vii) licensure, quality, safety and accreditation requirements under applicable federal, state, local or foreign laws or regulatory bodies; (viii) all other local, state, federal, national, supranational and foreign laws, relating to the regulation of the Company or its Subsidiaries, and (ix) the regulations promulgated pursuant to such statutes and any state or non-U.S. counterpart thereof. Neither the Company nor any of its Subsidiaries has received written or, to the Company&#8217;s knowledge, oral notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any court or </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">14</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-style:normal;font-weight:normal;">arbitrator or governmental or regulatory authority or third party alleging that any product operation or activity is in material violation of any Health Care Laws nor, to the Company&#8217;s knowledge, is any such claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action threatened. The Company and its Subsidiaries have filed, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Health Care Laws, and all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were complete and accurate on the date filed in all material respects (or were corrected or supplemented by a subsequent submission). Neither the Company nor any of its Subsidiaries is a party to any corporate integrity agreements, monitoring agreements, consent decrees, settlement orders, or similar agreements with or imposed by any governmental or regulatory authority. Additionally, neither the Company, any of its Subsidiaries nor any of their respective employees, officers, directors, or, to the knowledge of the Company, agents has been excluded, suspended or debarred from participation in any U.S. federal health care program or human clinical research or, to the knowledge of the Company, is subject to a governmental inquiry, investigation, proceeding, or other similar action that could reasonably be expected to result in debarment, suspension, or exclusion.</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.22</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc113810074"></a><a name="_Toc113811291"></a><a name="_Toc113810075"></a><a name="_Toc113811292"></a><a name="_Toc113810076"></a><a name="_Toc113811293"></a><a name="_Toc113810077"></a><a name="_Toc113811294"></a><a name="_Toc113810078"></a><a name="_Toc113811295"></a><a name="_Toc113810079"></a><a name="_Toc113811296"></a><a name="_Toc113810080"></a><a name="_Toc113811297"></a><a name="_Toc166076135"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Accounting Controls and Disclosure Controls and Procedures</u><font style="font-size:11pt;">. The Company maintains a system of internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP, including policies and procedures sufficient to provide reasonable assurance (i) that the Company maintains records that in reasonable detail accurately and fairly reflect the Company&#8217;s transactions and dispositions of assets, (ii) that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, (iii) that receipts and expenditures are made only in accordance with authorizations of management and the Board of Directors and (iv) regarding prevention or timely detection of the unauthorized acquisition, use or disposition of the Company&#8217;s assets that could have a material effect on the Company&#8217;s financial statements. Since the end of the Company&#8217;s most recent audited fiscal year, there has been (a) no material weaknesses in the design or operation of the Company&#8217;s internal control over financial reporting (whether or not remediated) and (b) no change in the Company&#8217;s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting. The Company&#8217;s &#8220;disclosure controls and procedures&#8221; (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) are designed to provide reasonable assurance that all information (both financial and non-financial) required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that all such information is accumulated and communicated to the Company&#8217;s management as appropriate to allow timely decisions regarding required disclosure.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.23</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076136"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Price Stabilization of Common Stock</u><font style="font-size:11pt;">. The Company has not taken, nor will it take, directly or indirectly, any action designed to stabilize or manipulate the price of the Common Stock to facilitate the sale or resale of the Shares.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.24</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076137"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Investment Company Act</u><font style="font-size:11pt;">. The Company is not, and immediately after receipt of payment for the Securities will not be, an &#8220;investment company&#8221; within the meaning of the U.S. Investment Company Act of 1940, as amended.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.25</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076138"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">General Solicitation; No Integration or Aggregation</u><font style="font-size:11pt;">. Neither the Company nor any other person or entity authorized by the Company to act on its behalf has engaged in a general solicitation or general advertising (within the meaning of Regulation D of the Securities Act) of investors with respect to offers or sales of the Securities pursuant to this Agreement. The Company has not, directly or indirectly, sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of, any security (as defined </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">15</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-style:normal;font-weight:normal;">in the Securities Act) which, to its knowledge, is or will be (i) integrated with the Securities sold pursuant to this Agreement for purposes of the Securities Act </font><font style="font-style:normal;font-weight:normal;background:#ffffff;">or (ii)&#160;aggregated with prior offerings by the Company for the purposes of the rules and regulations of Nasdaq</font><font style="font-style:normal;font-weight:normal;">. Assuming the accuracy of the representations and warranties of the Investors set forth in Section 4, neither the Company nor any of its Affiliates, its subsidiaries nor any Person acting on their behalf has, directly or indirectly, made any offers or sales of any Company security or solicited any offers to buy any Company security, under circumstances that would adversely affect reliance by the Company on Section 4(a)(2) of the Securities Act for the exemption from registration for the transactions contemplated hereby.</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.26</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076139"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Brokers and Finders</u><font style="font-size:11pt;">. Other than the Placement Agents, neither the Company nor any other </font><font style="font-size:11pt;">Person</font><font style="font-size:11pt;"> authorized by the Company to act on its behalf has retained, utilized or been represented by any broker or finder in connection with the transactions contemplated by this Agreement.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.27</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076140"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reliance by the Investors</u><font style="font-size:11pt;">. </font><font style="font-size:11pt;">The Company has a reasonable basis for making each of the representations set forth in this </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3</u><font style="font-size:11pt;">. &#160;The Company acknowledges that each of the Investors will rely upon the truth and accuracy of, and the </font><font style="font-size:11pt;">Company&#8217;s</font><font style="font-size:11pt;"> compliance with, the representations, warranties, agreements, acknowledgements and understandings of the Company set forth herein.</font><a name="_No_Disqualification_Events"></a></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.28</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076144"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Additional Agreements</u><font style="font-size:11pt;">. </font><font style="font-size:11pt;">There are no agreements or understandings between the Company, on one hand, and any Investor, on the other hand, with respect to the transactions contemplated by the Transaction Agreements other than as specified in the Transaction Agreements.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.29</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076145"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Anti-Bribery and Anti-Money Laundering Laws</u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">; Sanctions</u><font style="font-size:11pt;">. </font><font style="font-size:11pt;">Each of the Company, its Subsidiaries and, to the knowledge of the Company, any of their respective officers, directors, supervisors, managers, agents, or employees are and have at all times been in compliance with and its participation in the offering will not violate: (A) anti-bribery laws, including but not limited to, any applicable law, rule, or regulation of any locality, including but not limited to any law, rule, or regulation promulgated to implement the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, signed December 17, 1997, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.K. Bribery Act 2010, or any other law, rule or regulation of similar purposes and scope, (B) anti-money laundering laws, including, but not limited to, applicable federal, state, international, foreign or other laws, regulations or government guidance regarding anti-money laundering, including, without limitation, Title 18 US. Code sections 1956 and 1957, the Patriot Act, the Bank Secrecy Act, and international anti-money laundering principles or procedures by an intergovernmental group or organization, such as the </font><a name="_9kR3WTr26646ETCrklokjnOA0739pX3EcbK9xAK"></a><font style="font-size:11pt;">Financial Action Task Force on Money Laundering</font><font style="font-size:11pt;">, of which the United States is a member and with which designation the United States representative to the group or organization continues to concur, all as amended, and any executive order, directive, or regulation pursuant to the authority of any of the foregoing, or any orders or licenses issued thereunder, or (C) except as would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect, any laws with respect to import and export control and economic sanctions, including the U.S. Export Administration Regulations, the U.S. International Traffic in Arms Regulations, and economic sanctions regulations and executive orders administered by the U.S. Department of the Treasury Office of Foreign Asset Control. </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.30</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref112961401"></a><a name="_Toc166076146"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Cybersecurity</u><font style="font-size:11pt;">. The Company and its Subsidiaries&#8217; information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases (collectively, &#8220;</font><b style="font-size:11pt;font-weight:bold;">IT Systems</b><font style="font-size:11pt;">&#8221;) are adequate for, and operate and perform in all material respects as required in connection with the operation of the business of the Company and its Subsidiaries as currently conducted, and are free and clear of all material </font><a name="_9kR3WTr26646AdZ1uhm"></a><font style="font-size:11pt;">Trojan</font><font style="font-size:11pt;"> horses, time bombs, malware and other malicious code. The Company and its Subsidiaries have implemented and maintained commercially reasonable physical, technical and administrative controls designed to maintain and protect the confidentiality, integrity, availability, privacy and security of all sensitive, confidential or regulated data (&#8220;</font><b style="font-size:11pt;font-weight:bold;">Confidential Data</b><font style="font-size:11pt;">&#8221;) used </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">16</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-style:normal;font-weight:normal;">or maintained in connection with their businesses and Personal Data (defined below), and the integrity, availability continuous operation, redundancy and security of all IT Systems. &#8220;</font><b style="font-style:normal;font-weight:bold;">Personal Data</b><font style="font-style:normal;font-weight:normal;">&#8221; means the following data used in connection with the Company&#8217;s and its Subsidiaries&#8217; businesses and in their possession or control: (i) a natural person&#8217;s name, street address, telephone number, e-mail address, photograph, social security number or other tax identification number, driver&#8217;s license number, passport number, credit card number or bank information; (ii) information that identifies or may reasonably be used to identify an individual; (iii) any information that would qualify as &#8220;protected health information&#8221; under the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act (collectively, &#8220;</font><b style="font-style:normal;font-weight:bold;">HIPAA</b><font style="font-style:normal;font-weight:normal;">&#8221;); and (iv) any information that would qualify as &#8220;personal data,&#8221; &#8220;personal information&#8221; (or similar term) under the Privacy Laws. To the Company&#8217;s knowledge, there have been no breaches, outages or unauthorized uses of or accesses to the Company&#8217;s IT Systems, Confidential Data, or Personal Data that would require notification under Privacy Laws (as defined below). </font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.31</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref139904656"></a><a name="_Ref139904787"></a><a name="_Toc166076147"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compliance with Data Privacy Laws</u><font style="font-size:11pt;">. </font><font style="font-size:11pt;">The Company and its Subsidiaries are, and at all prior times were, in material compliance with all applicable state, federal and foreign data privacy and security laws and regulations regarding the collection, use, storage, retention, disclosure, transfer, disposal, or any other processing (collectively &#8220;</font><b style="font-size:11pt;font-weight:bold;">Process</b><font style="font-size:11pt;">&#8221; or &#8220;</font><b style="font-size:11pt;font-weight:bold;">Processing</b><font style="font-size:11pt;">&#8221;) of Personal Data, including without limitation HIPAA, the EU General Data Protection Regulation (&#8220;</font><b style="font-size:11pt;font-weight:bold;">GDPR</b><font style="font-size:11pt;">&#8221;) (Regulation (EU) No. 2016/679), all other local, state, federal, national, supranational and foreign laws relating to the regulation of the Company or its Subsidiaries, and the regulations promulgated pursuant to such statutes and any state or non-U.S. counterpart thereof (collectively, the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Privacy Laws</b><font style="font-size:11pt;">&#8221;). To ensure material compliance with the Privacy Laws, the Company and its Subsidiaries have in place, comply with, and take all appropriate steps necessary to ensure compliance in all material respects with their policies and procedures relating to data privacy and security, and the Processing of Personal Data and Confidential Data (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Privacy Statements</b><font style="font-size:11pt;">&#8221;). The Company and its Subsidiaries have, except as would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect, at all times since inception provided accurate notice of its Privacy Statements then in effect to its customers, employees, third party vendors and representatives. None of such disclosures made or contained in any Privacy Statements have been materially inaccurate, misleading, incomplete, or in material violation of any Privacy Laws.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.32</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076148"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Transactions with Affiliates and Employees</u><font style="font-size:11pt;">. </font><font style="font-size:11pt;">No relationship, direct or indirect, exists between or among the Company, on the one hand, and any director, officer, stockholder, customer or supplier of the Company, on the other hand, that is required to be described in any forms, statements, certifications, reports and documents required to be filed or furnished with the SEC under the Exchange Act or the Securities Act that will not be so described in accordance with the Exchange Act following the Closing.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">3.33</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Additional Representations and Warranties</u><font style="font-size:11pt;">. </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(a)</font><font style="font-size:11pt;">As of the date hereof and as of the Closing Date, the representations and warranties of the Company contained in Section 3 of the Merger Agreement and in any certificate or other writing delivered by the Company pursuant thereto are true and correct as though given in accordance with Section 8.1 of the Merger Agreement. </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(b)</font><font style="font-size:11pt;">As of the date hereof and as of the Closing Date the representations and warranties of Parent contained in Section 4 of the Merger Agreement and in any certificate or other writing delivered by Parent pursuant thereto are true and correct as though given in accordance with Section 9.1 of the Merger Agreement. </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">17</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(c)</font><font style="font-size:11pt;">The information supplied by or on behalf of the Company for inclusion or incorporation by reference in the Registration Statement (as defined in the Merger Agreement), or supplied by or on behalf of the Company for inclusion in any filing pursuant to Rule 165 and Rule 425 under the Securities Act or Rule 14a-12 under the Securities Act (each a &#8220;</font><b style="font-size:11pt;font-weight:bold;">Regulation M-A Filing</b><font style="font-size:11pt;">&#8221;), will not, as of the time the Registration Statement or any such Regulation M-A Filing is filed with the Commission, at any time it is amended or supplemented or at the time the Registration Statement is declared effective by the Commission, as applicable, contain any statement that, at such time and in light of the circumstances under which it shall be made, is false or misleading with respect to any material fact, or omit to state any material fact necessary in order to make the statements made in the Registration Statement not false or misleading. &#160;The information to be supplied by or on behalf of the Company for inclusion in the Registration Statement to be sent to the stockholders of Parent in connection with the meeting of Parent&#8217;s stockholders (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Public Company Meeting</b><font style="font-size:11pt;">&#8221;), shall not, on the date the proxy statement/prospectus included in the Registration Statement is first mailed to stockholders of Parent, at the time of the Public Company Meeting or at the Closing Date, contain any statement that, at such time and in light of the circumstances under which it shall be made, is false or misleading with respect to any material fact, or omit to state any material fact necessary in order to make the statements made in the Registration Statement not false or misleading; or omit to state any material fact necessary to correct any statement in any earlier communication with respect to the solicitation of proxies for the Public Company Meeting that has become false or misleading.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-decoration-line:none;text-indent:0pt;vertical-align:baseline;white-space:nowrap;">4.</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref113003343"></a><a name="_Ref113003387"></a><a name="_Ref113003401"></a><a name="_Ref113003865"></a><a name="_Toc166076151"></a><a name="_Ref179817135"></a><a name="_Ref179878694"></a><a name="_Ref179881251"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Representations and Warranties of Each </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Investor</u><font style="font-size:11pt;">. Each Investor, severally for itself and not jointly with any other Investor, represents and warrants to the Company, Parent and the Placement Agents that the statements contained in this </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;4</u><font style="font-size:11pt;"> are true and correct as of the date hereof and the Closing Date (except for the representations and warranties that speak as of a specific date, which shall be made as of such date):</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">4.1</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref113003715"></a><a name="_Toc166076152"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Organization</u><font style="font-size:11pt;">. Such Investor is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization and has the requisite power and authority to own, lease and operate its properties and to carry on its business as now conducted.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">4.2</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref113003722"></a><a name="_Toc166076153"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Authorization</u><font style="font-size:11pt;">. Such Investor has all requisite corporate or similar power and authority to enter into this Agreement and the other Transaction Agreements to which it will be a party and to carry out and perform its obligations hereunder and thereunder. All corporate, member or partnership action on the part of such Investor or its stockholders, members or partners necessary for the authorization, execution, delivery and performance of this Agreement and the other Transaction Agreements to which it will be a party and the consummation of the other transactions contemplated herein has been taken. The signature of the Investor on this Agreement is genuine and the signatory to this Agreement, if the Investor is an individual, has the legal competence and capacity to execute the same or, if the Investor is not an individual, the signatory has been duly authorized to execute the same on behalf of the Investor. Assuming this Agreement constitutes the legal and binding agreement of the Company and Parent, this Agreement constitutes a legal, valid and binding obligation of such Investor, enforceable against such Investor in accordance with its respective terms, except as such enforceability may be limited or otherwise affected by bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and/or similar laws relating to or affecting the rights of creditors generally or by general equity principles (regardless of whether such enforceability is considered in a proceeding in equity or at law).</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">4.3</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref112961754"></a><a name="_Toc166076154"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Conflict</u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">s</u><font style="font-size:11pt;">. The execution, delivery and performance of the Transaction Agreements by such Investor, the purchase of the Securities in accordance with their terms and the consummation by such Investor of the other transactions contemplated hereby will not conflict with or result in any violation of, breach or default by such Investor (with or without notice or lapse of time, or both) under, conflict with, or give rise to a right of termination, cancellation or acceleration of any obligation, a change of control right or to a loss of a material benefit under (i) any provision of the </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">18</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-style:normal;font-weight:normal;">organizational documents of such Investor, including, without limitation, its incorporation or formation papers, bylaws, indenture of trust or partnership or operating agreement, as may be applicable or (ii) any agreement or instrument, undertaking, credit facility, franchise, license, judgment, order, ruling, statute, law, ordinance, rule or regulations, applicable to such Investor or its respective properties or assets, except, in the case of clause (ii), as would not, individually or in the aggregate, be reasonably expected to materially delay or materially hinder the ability of such Investor to perform its obligations under the Transaction Agreements.</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">4.4</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076155"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Residency</u><font style="font-size:11pt;">. Such Investor&#8217;s residence (if an individual) or offices in which its investment decision with respect to the Securities was made (if an entity) are located at the address immediately below such Investor&#8217;s name on </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</u><font style="font-size:11pt;">, except as otherwise communicated by such Investor to the Company.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">4.5</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076156"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Brokers and Finders</u><font style="font-size:11pt;">. Such Investor has not retained, utilized or been represented by any broker or finder in connection with the transactions contemplated by this Agreement whose fees the Company or Parent would be required to pay.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">4.6</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076157"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Investment Representations and Warranties</u><font style="font-size:11pt;">. Each Investor hereby represents and warrants that, it (i) as of the date hereof is, if an entity, a &#8220;qualified institutional buyer&#8221; (as defined in Rule 144A under the Securities Act) or an &#8220;accredited investor&#8221; as that term is defined in Rule 501(a) under Regulation D promulgated pursuant to the Securities Act; or (ii) if an individual, is an &#8220;accredited investor&#8221; as that term is defined in Rule 501(a) of Regulation D of the Securities Act and has such knowledge and experience in financial and business matters as to be able to protect its own interests in connection with an investment in the Securities. Each Investor further represents and warrants that (x) it is capable of evaluating the merits and risk of such investment, and (y) that it has not been organized for the purpose of acquiring the Securities and is an &#8220;institutional account&#8221; as defined by FINRA Rule 4512(c). Such Investor understands and agrees that the offering and sale of the Securities has not been registered under the Securities Act or any applicable state securities laws and is being made in reliance upon federal and state exemptions for transactions not involving a public offering which depend upon, among other things, the bona fide nature of the investment intent and the accuracy of such Investor&#8217;s representations as expressed herein.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">4.7</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076158"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Intent</u><font style="font-size:11pt;">. Each Investor is purchasing the Securities solely for investment purposes, for such Investor&#8217;s own account and not for the account of others, and not with a view to the resale or distribution of any part thereof in violation of the Securities Act, and the Investor has no present intention of selling, granting any participation in, or otherwise distributing the same in violation of the Securities Act without prejudice, however, to the Investor&#8217;s right at all times to sell or otherwise dispose of all or any part of such Securities in compliance with applicable federal and state securities laws. Notwithstanding the foregoing, if such Investor is purchasing the Securities as a fiduciary or agent for one or more investor accounts, such Investor has full investment discretion with respect to each such account, and the full power and authority to make the acknowledgements, representations and agreements herein on behalf of each owner of each such account. Each Investor has no present arrangement to sell the Securities to or through any person or entity. Each Investor understands that the Securities must be held indefinitely unless such Securities are resold pursuant to a registration statement under the Securities Act or an exemption from registration is available. Nothing contained herein shall be deemed a representation or warranty by such Investor to hold the Securities for any period of time.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">4.8</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076159"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Investment Experience; Ability to Protect Its Own Interests and Bear Economic Risks</u><font style="font-size:11pt;">. Each Investor acknowledges that it can bear the economic risk and complete loss of its investment in the Securities and has knowledge and experience in finance, securities, taxation, investments and other business matters as to be capable of evaluating the merits and risks of investments of the kind described in </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">19</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-style:normal;font-weight:normal;">this Agreement and contemplated hereby, and the Investor has had an opportunity to seek, and has sought, such accounting, legal, business and tax advice as such Investor has considered necessary to make an informed investment decision. &#160;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Each Investor acknowledges that such Investor (i) is a sophisticated investor, experienced in investing in private placements of equity securities and capable of evaluating investment risks independently, both in general and with regard to all transactions and investment strategies involving a security or securities and (ii) has exercised independent judgment in evaluating its participation in the purchase of the Securities. Each Investor acknowledges that such Investor is aware that there are substantial risks incident to the purchase and ownership of the Securities, including those set forth in Parent&#8217;s filings with the SEC. Alone, or together with any professional advisor(s), such Investor has adequately analyzed and fully considered the risks of an investment in the Securities and determined that the Securities are a suitable investment for the Investor. Each Investor is, at this time and in the foreseeable future, able to afford the loss of such Investor&#8217;s entire investment in the Securities and such Investor acknowledges specifically that a possibility of total loss exists.</p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">4.9</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076160"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Independent Investment Decision</u><font style="font-size:11pt;">. Such Investor understands that nothing in the Transaction Agreements or any other materials presented by or on behalf of the Company or Parent to such Investor in connection with the purchase of the Securities constitutes legal, tax or investment advice. Such Investor has consulted such legal, tax and investment advisors as it, in their sole discretion, has deemed necessary or appropriate in connection with its purchase of the Securities.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">4.10</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref113003286"></a><a name="_Toc166076161"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Securities Not Registered; Legends</u><font style="font-size:11pt;">. Such Investor acknowledges and agrees that the Securities are being offered in a transaction not involving any public offering within the meaning of the Securities Act, and such Investor understands that the Securities have not been registered under the Securities Act, by reason of their issuance by the Company in a transaction exempt from the registration requirements of the Securities Act, and that the Securities must continue to be held and may not be offered, resold, transferred, pledged or otherwise disposed of by such Investor unless a subsequent disposition thereof is registered under the Securities Act or is exempt from such registration and in each case in accordance with any applicable securities laws of any state of the United States. Such Investor understands that the exemptions from registration afforded by Rule 144 (the provisions of which are known to it) promulgated under the Securities Act depend on the satisfaction of various conditions including, but not limited to, the time and manner of sale, the holding period and on requirements relating to the Company which are outside of such Investor&#8217;s control and which the Company may not be able to satisfy, and that, if applicable, Rule 144 may afford the basis for sales only in limited amounts. Such Investor acknowledges and agrees that it has been advised to consult legal counsel prior to making any offer, resale, transfer, pledge or disposition of any of the Securities. Such Investor acknowledges that no federal or state agency has passed upon or endorsed the merits of the offering of the Securities or made any findings or determination as to the fairness of this investment.</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Each Investor understands that any certificates or book entry notations evidencing the Securities may bear one or more legends in substantially the following form and substance:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 0pt 36pt;">&#8220;THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED UNLESS (I) SUCH SECURITIES HAVE BEEN REGISTERED FOR SALE PURSUANT TO THE SECURITIES ACT, (II) SUCH SECURITIES MAY BE SOLD PURSUANT TO RULE 144 UNDER THE SECURITIES ACT, (III) THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT THAT </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">20</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 36pt;">SUCH TRANSFER MAY LAWFULLY BE MADE WITHOUT REGISTRATION UNDER THE SECURITIES ACT, OR (IV) THE SECURITIES ARE TRANSFERRED WITHOUT CONSIDERATION TO AN AFFILIATE OF SUCH HOLDER OR A CUSTODIAL NOMINEE (WHICH FOR THE AVOIDANCE OF DOUBT SHALL REQUIRE NEITHER CONSENT NOR THE DELIVERY OF AN OPINION). NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">In addition, the Securities may contain a legend regarding affiliate status of the Investor, if applicable, provided that the Company will notify the Investor in advance of Closing if such a legend is to be placed on its Securities.</p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">4.11</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076162"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Placement Agent</u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">s</u><font style="font-size:11pt;">. Each Investor hereby acknowledges and agrees that (a) each Placement Agent is acting solely as placement agent in connection with the execution, delivery and performance of the Transaction Agreements and the issuance of the Securities to the Investor and neither any Placement Agent nor any of their respective affiliates have acted as an underwriter or in any other capacity and is not and shall not be construed as a fiduciary or financial advisor for such Investor, the Company, Parent or any other person or entity in connection with the execution, delivery and performance of the Transaction Agreements and the issuance and purchase of the Securities, (b) no Placement Agent has made and no Placement Agent makes any representation or warranty, whether express or implied, of any kind or character, and no Placement Agent has provided any advice or recommendation in connection with the execution, delivery and performance of the Transaction Agreements or with respect to the Securities, nor is such information or advice necessary or desired, (c) no Placement Agent will have any responsibility with respect to (i) any representations, warranties or agreements made by any person or entity under or in connection with the execution, delivery and performance of the Transaction Agreements, or the execution, legality, validity or enforceability (with respect to any person) thereof, or (ii) the business, affairs, financial condition, operations, properties or prospects of, or any other matter concerning the Company or Parent, and (d) no Placement Agent will have any liability or obligation (including without limitation, for or with respect to any losses, claims, damages, obligations, penalties, judgments, awards, liabilities, costs, expenses or disbursements incurred by such Investor, the Company, Parent or any other person or entity), whether in contract, tort or otherwise, to such Investor, or to any person claiming through it, in respect of the execution, delivery and performance of the Transaction Agreements, except in each case for such party&#8217;s own gross negligence, willful misconduct or bad faith. No disclosure or offering document has been prepared by any Placement Agent or any of their respective affiliates in connection with the offer and sale of the Securities. Neither any of the Placement Agents nor any of their respective affiliates have made or make any representation as to the quality or value of the Securities and the Placement Agents and their respective affiliates may have acquired non-public information with respect to the Company or Parent which the Investor agrees need not be provided to it.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">4.12</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc113820916"></a><a name="_Toc113823595"></a><a name="_Toc113830005"></a><a name="_Toc113830096"></a><a name="_Toc113830187"></a><a name="_Toc166076163"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No General Solicitation</u><font style="font-size:11pt;">. Each Investor acknowledges and agrees that the Investor is purchasing the Securities directly from the Company. Such Investor became aware of this offering of the Securities solely by means of direct contact from the Placement Agents or directly from Parent or the Company as a result of a pre-existing, substantive relationship with Parent, the Company or the Placement Agents, and/or their respective advisors (including, without limitation, attorneys, accountants, bankers, consultants and financial advisors), agents, control persons, representatives, affiliates, directors, officers, managers, members, and/or employees, and/or the representatives of such persons. The Securities were offered to such Investor solely by direct contact between such Investor, on the one hand, and Parent, the Company, the Placement Agents and/or their respective representatives, on the other hand. Such Investor did not become aware of this offering of the Securities, nor were the Securities offered to such Investor, by any other means, and none of Parent, the Company, any of the Placement Agents and/or their respective </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">21</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-style:normal;font-weight:normal;">representatives acted as investment advisor, broker or dealer to such Investor. Such Investor is not purchasing the Securities as a result of any general or public solicitation or general advertising, or publicly disseminated advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television, radio or the internet or presented at any seminar or any other general solicitation or general advertisement, including any of the methods described in Section 502(c) of Regulation D under the Securities Act.</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">4.13</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076164"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Access to Information</u><font style="font-size:11pt;">. In making its decision to purchase the Securities, each Investor has relied solely upon independent investigation made by such Investor, upon the Company Presentation and upon the representations, warranties and covenants set forth herein. Such Investor acknowledges and agrees that such Investor has received such information as such Investor deems necessary in order to make an investment decision with respect to the Securities, including, with respect to the Company. Without limiting the generality of the foregoing, each Investor acknowledges that copies of the 2024 SEC Reports are available on EDGAR at www.sec.gov. Each Investor acknowledges and agrees that such Investor and such Investor&#8217;s professional advisor(s), if any, have had the opportunity to ask such questions, receive such answers and obtain such information from Parent and the Company regarding Parent, the Company, their respective businesses and the terms and conditions of the offering of the Securities as such Investor and such Investor&#8217;s professional advisor(s), if any, have deemed necessary to make an investment decision with respect to the Securities and that such Investor has independently made its own analysis and decision to invest in the Company. Neither such inquiries nor any other due diligence investigation conducted by such Investor shall modify, limit or otherwise affect such Investor&#8217;s right to rely on the Company&#8217;s and Parent&#8217;s representations and warranties contained in this Agreement.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">4.14</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076165"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Certain Trading Activities</u><font style="font-size:11pt;">. Other than consummating the transaction contemplated hereby, the Investor has not, nor has any Person acting on behalf of or pursuant to any understanding with such Investor, directly or indirectly executed any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Investor was first contacted by the Company or any other Person regarding the transaction contemplated hereby and ending immediately prior to execution of the Original Agreement. Notwithstanding the foregoing, (i) in the case of an Investor that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Investor&#8217;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Investor&#8217;s assets, the representation set forth above shall only apply with respect to the portion of the assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement and (ii) in the case of an Investor whose investment adviser utilized an information barrier with respect to the information regarding the transactions contemplated hereunder after first being contacted by the Company, Parent or such other Person representing the Company or Parent, the representation set forth above shall only apply after the point in time when the portfolio manager who manages such Investor&#8217;s assets was informed of the information regarding the transactions contemplated hereunder and, with respect to the Investor&#8217;s investment adviser, the representation set forth above shall only apply with respect to any purchases or sales, including Short Sales, of the securities of the Company on behalf of other funds or investment vehicles for which the Investor&#8217;s investment adviser is also an investment adviser or subadviser after the point in time when the portfolio manager who manages the assets of such other funds or investment vehicles for which the Investor&#8217;s investment adviser is also an investment adviser or sub-adviser was informed of the information regarding the transactions contemplated hereunder. Other than to other Persons party to this Agreement and to its advisors and agents who had a need to know such information, such Investor has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to the identification of the availability of, or securing of, available shares to borrow in order to effect Short Sales or similar transactions in the future.</font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">22</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-decoration-line:none;text-indent:0pt;vertical-align:baseline;white-space:nowrap;">5.</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076167"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Covenants</u><font style="font-size:11pt;">.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">5.1</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076168"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Further Assurances</u><font style="font-size:11pt;">. Prior to the Closing, each party agrees to cooperate with each other and their respective officers, employees, attorneys, accountants and other agents, and, generally, do such other reasonable acts and things in good faith as may be necessary to effectuate the intents and purposes of this Agreement, subject to the terms and conditions hereof and compliance with applicable law, including taking reasonable action to facilitate the filing of any document or the taking of reasonable action to assist the other parties hereto in complying with the terms hereof. Each Investor acknowledges that the Company, Parent and the Placement Agents will rely on the acknowledgments, understandings, agreements, representations and warranties contained in this Agreement. Prior to the Closing, the Investor agrees to promptly notify the Company if any of the acknowledgments, understandings, agreements, representations and warranties set forth in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;4</u><font style="font-size:11pt;"> are no longer accurate and the Company and Parent agrees to promptly notify each Investor and the Placement Agents if any of the acknowledgments, understandings, agreements, representations and warranties set forth in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3</u><font style="font-size:11pt;"> are no longer accurate.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">5.2</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076169"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Listing</u><font style="font-size:11pt;">. Parent shall use commercially reasonable efforts to maintain the listing and trading of the common stock, $0.001 par value per share, of Parent (&#8220;</font><b style="font-size:11pt;font-weight:bold;">Parent Common Stock</b><font style="font-size:11pt;">&#8221;) on the Nasdaq Global Market and, in accordance therewith, will use reasonable best efforts to comply in all material respects with Parent&#8217;s reporting, filing and other obligations under the rules and regulations of Nasdaq, and to obtain approval of the listing of the </font><font style="font-size:11pt;">shares of Parent Common Stock issued in exchange for the Initial Shares and Pre-Funded Warrant Shares</font><font style="font-size:11pt;">.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">5.3</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref112961517"></a><a name="_Toc166076170"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Disclosure of Transactions</u><font style="font-size:11pt;">. </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(a)</font><font style="font-size:11pt;">The Company shall, by 9:00 a.m., New York City time, on the first (1st) Business Day immediately following the date hereof (</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u><font style="font-size:11pt;"> that, if this Agreement is executed between midnight and 9:00 a.m., New York City time on any Business Day, no later than 9:01 a.m. on the date hereof), issue a press release and ensure that Parent shall substantially contemporaneously file with the SEC a </font><a name="_9kR3WTr26645DQL75tq6lRw7AG"></a><font style="font-size:11pt;">Current Report</font><font style="font-size:11pt;"> on </font><a name="_9kR3WTr26646GVI10Ie"></a><font style="font-size:11pt;">Form 8-K</font><font style="font-size:11pt;"> (including all exhibits thereto, the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Disclosure Document</b><font style="font-size:11pt;">&#8221; and the actual filing of such press release and/or </font><a name="_9kR3WTr26646BNL75tq6lRw7AGE9bXGFXt"></a><font style="font-size:11pt;">Current Report on Form 8-K</font><font style="font-size:11pt;">, the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Disclosure Time</b><font style="font-size:11pt;">&#8221;) disclosing (i) all material terms of the transactions contemplated hereby and by the other Transaction Agreements and attaching this Agreement and the other Transaction Agreements as exhibits to such Disclosure Document, and (ii) all material non-public information concerning the Company, Parent the transactions contemplated hereby or the transactions contemplated by the Merger Agreement disclosed to the Investors prior to the Disclosure Time. Following the Disclosure Time, no Investor shall be in possession of any material non-public information received from the Company, Parent, their respective subsidiaries or any of their respective officers, directors, employees or agents (including the Placement Agents). The Company understands and confirms that the Investors will rely on the foregoing representation in effecting securities transactions. Notwithstanding anything in this Agreement to the contrary, neither the Company nor Parent shall disclose the name of any Investor or any of its affiliates or advisers, or include the name of any Investor or any of its affiliates or advisers in any marketing materials (whether or not made publicly available), press release, public announcement or filing with the SEC (other than any registration statement contemplated by the Registration Rights Agreement, which shall be subject to review of the Investors in accordance with the terms of the Registration Rights Agreement) or any regulatory agency, without the prior written consent of such Investor, except (i) as required by the federal securities law in connection with (A) any registration statement contemplated by the Registration Rights Agreement and (B) the filing of final Transaction Agreements with the SEC or pursuant to other routine proceedings of regulatory authorities, or (ii) to the extent such disclosure is required by law, at the request of the staff of the SEC or regulatory agency or under the regulations of the Nasdaq Global Market, provided that the Company and Parent shall use commercially reasonable efforts to provide the Investors with prior written notice of and a reasonable opportunity to review such disclosure permitted under foregoing clauses (i) and (ii). </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">23</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">5.4</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref113003754"></a><a name="_Ref113003759"></a><a name="_Toc166076171"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Integration</u><font style="font-size:11pt;">. The Company shall not, and shall use its commercially reasonable efforts to ensure that no Affiliate of the Company shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that will be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the sale of the Securities to the Investors, or that will be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any National Exchange such that it would require stockholder approval prior to the closing of such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">5.5</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc113810119"></a><a name="_Toc113811336"></a><a name="_Toc166076172"></a><a name="_Ref179881407"></a><a name="_Ref113003525"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Removal of Legends</u><font style="font-size:11pt;">.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(a)</font><font style="font-size:11pt;">In connection with any sale, assignment, transfer or other disposition of Shares by an Investor pursuant to Rule 144 or pursuant to any other exemption under the Securities Act such that the purchaser acquires freely tradable shares and upon compliance by the Investor with the requirements of this Agreement, if requested by the Investor by notice to the Company, the Company shall instruct the Transfer Agent to remove any restrictive legends related to the book entry account holding such Shares and make a new, unlegended entry for such book entry Shares sold or disposed of without restrictive legends as soon as reasonably practicable (expected to be within three (3) Business Days) following any such request therefor from such Investor, provided that the Company has timely received from the Investor a completed Investor representation letter in substantially the form attached hereto as </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit D</u><font style="font-size:11pt;"> and such other customary representations as may be reasonably required in accordance with applicable law in connection therewith. The Company shall be responsible for the fees of its Transfer Agent and its legal counsel associated with such legend removal.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(b)</font><a name="_Ref113003465"></a><font style="font-size:11pt;">In addition, without limiting Section 5.5(a), and subject to receipt from the Investor by the Company and the Transfer Agent of customary representations and other documentation reasonably acceptable to the Company and the Transfer Agent in connection therewith, upon the earliest of such time as the Initial Shares or any other Shares (i) have been registered under the Securities Act pursuant to an effective registration statement, (ii) have been sold pursuant to Rule 144 (in which case the provisions of Section 5.5(a) shall apply), or (iii) are eligible for resale under Rule 144(b)(1) without the requirement for the Company to be in compliance with the current public information requirements under Rule 144(c)(1) (or any successor provision), the Company shall, in accordance with the provisions of this </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;5.5(b)</u><font style="font-size:11pt;"> (A) upon effectiveness of the registration statement registering the resale of such Initial Shares or other Shares as set forth in clause (i), provide a &#8220;blanket&#8221; opinion to the Transfer Agent for the removal of legends in connection with any sale pursuant to the effective registration statement, and (B) with respect to clauses (i), (ii) and (iii), as soon as reasonably practicable and no later than three (3) Business Days following any request therefor from an Investor accompanied by a completed Investor representation letter in substantially the form attached hereto as </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit E</u><font style="font-size:11pt;"> deliver to the Transfer Agent irrevocable instructions that the Transfer Agent shall make a new, unlegended entry for such book entry shares. If, as a condition to the removal of any legends of any of the Securities, the Transfer Agent requires that the request for removal be accompanied by a certificate and/or an opinion of counsel reasonably satisfactory to the Transfer Agent, to the effect that the proposed transfer does not result in a violation of the Securities Act, the Company and/or its legal counsel shall provide such certificate or opinion with respect to any such transfer. &#160;Any shares subject to legend removal under this Section 5.5 may be transmitted by the Transfer Agent to the Investor by crediting the account of the Investor&#8217;s prime broker with the DTC System as directed by such Investor. &#160;The Company shall be responsible for the fees of its Transfer Agent, DTC and its legal counsel associated with such legend removal.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">5.6</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076173"></a><a name="_Ref113003146"></a><a name="_Ref113003740"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Withholding Taxes</u><font style="font-size:11pt;">. Each Investor agrees to furnish the Company with any information, representations and forms as shall reasonably be requested by the Company from time to time to assist the Company in complying with any applicable tax law (including any withholding obligations).</font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">24</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">5.7</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076174"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Fees and Taxes</u><font style="font-size:11pt;">. The Company and Parent, as applicable, shall be solely responsible for the payment of any placement agent&#8217;s fees, financial advisory fees, or broker&#8217;s commissions (other than for Persons engaged by an Investor) relating to or arising out of the transactions contemplated hereby in accordance with the engagement letter relating hereto, including, without limitation, any fees or commissions payable to the Placement Agents. </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">5.8</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076175"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Conflicting Agreements</u><font style="font-size:11pt;">. The Company will not take any action, enter into any agreement or make any commitment that would conflict or interfere in any material respect with the Company&#8217;s obligations to the Investors under the Transaction Agreements. </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">5.9</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076176"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reporting Status</u><font style="font-size:11pt;">. </font><font style="font-size:11pt;">Parent shall timely file all reports required to be filed with the SEC pursuant to the Exchange Act, and Parent shall not terminate its status as an issuer required to file reports under the Exchange Act even if the Exchange Act or the rules and regulations thereunder would otherwise permit such termination.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">5.10</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076177"></a><a name="_Ref168222545"></a><a name="_Ref179881420"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indemnification.</u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </u></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(a)</font><a name="_Ref180064204"></a><font style="font-size:11pt;">The Company agrees to indemnify and hold harmless each Investor and its Affiliates, and their respective directors, officers, trustees, members, managers, employees, investment advisers and agents (collectively, the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Indemnified Persons</b><font style="font-size:11pt;">&#8221;), from and against any and all losses, claims, damages, liabilities and expenses (including without limitation reasonable and documented attorney fees and disbursements and other documented out-of-pocket expenses reasonably incurred in connection with investigating, preparing or defending any action, claim or proceeding, pending or threatened and the costs of enforcement thereof) to which such Indemnified Person may become subject (i) as a result of any breach of representation, warranty, covenant or agreement made by or to be performed on the part of the Company under the Transaction Agreements or (ii) as a result of or arising out of any action, claim or proceeding, pending or threatened, against an Indemnified Person in any capacity by any stockholder of the Company (whether directly or in a derivative capacity) who is not an Affiliate of the Indemnified Person with respect to the transactions contemplated by the Transaction Agreements, and in each case will reimburse any such Indemnified Person for all such amounts as they are incurred by such Indemnified Person.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(b)</font><font style="font-size:11pt;">Any person entitled to indemnification hereunder shall (i) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification and (ii) permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party; provided that any person entitled to indemnification hereunder shall have the right to employ separate counsel and to participate in the defense of such claim, but the fees and expenses of such counsel shall be at the expense of such person unless (a) the indemnifying party has agreed in writing to pay such fees or expenses, (b) the indemnifying party shall have failed to assume the defense of such claim and employ counsel reasonably satisfactory to such person or (c) in the reasonable judgment of any such person, based upon written advice of its counsel, a conflict of interest exists between such person and the indemnifying party with respect to such claims (in which case, if the person notifies the indemnifying party in writing that such person elects to employ separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the right to assume the defense of such claim on behalf of such person); and provided, further, that the failure of any indemnified party to give written notice as provided herein shall not relieve the indemnifying party of its obligations hereunder, except to the extent that such failure to give notice shall materially adversely affect the indemnifying party in the defense of any such claim or litigation. It is understood that the indemnifying party shall not, in connection with any proceeding in the same jurisdiction, be liable for fees or expenses of more than one separate firm of attorneys at any time for all such indemnified parties. No indemnifying party will, except with the consent of the indemnified party, which consent shall not be unreasonably withheld, conditioned or delayed, consent to entry of any judgment or enter into any settlement </font><font style="font-size:11pt;">unless such judgment or settlement (i) imposes no liability or </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">25</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:0pt;"><font style="font-size:11pt;">obligation on, (ii) includes as an unconditional term thereof the giving of a complete, explicit and unconditional release from the party bringing such indemnified claims of all liability of the indemnified party in respect of such claim or litigation in favor of, and (iii) does not include any admission of fault, culpability, wrongdoing, or wrongdoing or malfeasance by or on behalf of, the indemnified party</font><font style="font-size:11pt;">. No indemnified party will, except with the consent of the indemnifying party, which consent shall not be unreasonably withheld, conditioned or delayed, consent to entry of any judgment or enter into any settlement.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">5.11</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref179963861"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Form S-4</u><font style="font-size:11pt;">. </font><font style="font-size:11pt;">From the date hereof until the Closing Date, the Company and Parent shall use commercially reasonable efforts to ensure the Registration Statement will register the issuance of the shares of Parent Common Stock to be issued, subject to and in accordance with the terms of the Merger Agreement, in exchange for the Initial Shares and the Pre-Funded Warrant Shares.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">5.12</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076179"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reservation of Common Stock</u><font style="font-size:11pt;">. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue the Pre-Funded Warrant Shares that are issuable upon the exercise of the Pre-Funded Warrants, if any.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">5.13</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Amendment or Waiver of Merger Agreement Terms</u><font style="font-size:11pt;">. </font><font style="font-size:11pt;">The Company and Parent shall not amend, modify or waive (or fail to contest an action regarding a breach of) any provision of the Merger Agreement in a manner that would reasonably be expected to materially and adversely affect the benefits that an Investor would reasonably expect to receive pursuant to this Agreement without the prior written consent of the Investor Majority, it being agreed that any amendment or modification to the definition of &#8220;Company Valuation&#8221; or &#8220;Company Outstanding Shares&#8221; shall be deemed to materially and adversely affect the benefits that the Investors would reasonably expect to receive under this Agreement.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">5.14</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076180"></a><a name="_Ref176887063"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Legend Removal</u><font style="font-size:11pt;">. The restrictive legends described in Section 4.10 shall promptly be removed in accordance with applicable securities laws and, if applicable, the relevant provisions of the Registration Rights Agreement following the closing of the Merger. The shares of Parent Capital Stock to be received in the Merger in exchange for the Shares and the Warrant Shares will be issued in book-entry form, free and clear of any liens or other restrictions whatsoever (subject to applicable securities laws).</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">5.15</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Stockholder Approval</u><font style="font-size:11pt;">. Parent shall use its best efforts to obtain the Required Parent Stockholder Vote to approve the issuance of the Shares for purposes of the listing rules of Nasdaq at the Parent Stockholder Meeting (as defined in the Merger Agreement), which shall be held as promptly as practicable after the filing of the Proxy Statement (as defined in the Merger Agreement) in accordance with the terms and conditions of the Merger Agreement and, in any event, no later than 60 days after the date thereof. The Company shall use its best efforts to solicit its stockholders&#8217; approval of such resolution and to cause the Board of Directors to recommend to the stockholders that they approve such resolution.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-decoration-line:none;text-indent:0pt;vertical-align:baseline;white-space:nowrap;">6.</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Conditions of Closing</u><font style="font-size:11pt;">.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">6.1</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076181"></a><a name="_Ref179879523"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Conditions to the Obligation of the Investors</u><font style="font-size:11pt;">. The several obligations of each Investor to consummate the transactions to be consummated at the Closing, and to purchase and pay for the Securities being purchased by it at the Closing pursuant to this Agreement, are subject to the satisfaction or waiver in writing of the following conditions precedent:</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(a)</font><a name="_Ref113003543"></a><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Representations and Warranties</u><font style="font-size:11pt;">. The representations and warranties of the Company and Parent contained herein shall be true and correct in all respects as of the date hereof except to the extent any such representation or warranty expressly speaks as of an earlier date, in which case such representation or warranty shall be true and correct in all respects as of such earlier date, and the </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">26</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:0pt;"><font style="font-size:11pt;">representations and warranties of the Company and Parent contained herein shall be true and correct in all material respects as of the Closing Date, as though made on and as of such date, except for those representations and warranties qualified by materiality or Material Adverse Effect, which shall be true and correct in all respects and except to the extent any such representation or warranty expressly speaks as of an earlier date, in which case such representation or warranty shall be true and correct in all material respects as of such earlier date.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(b)</font><a name="_Ref113003649"></a><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Performance</u><font style="font-size:11pt;">. The Company shall have performed in all material respects the obligations and conditions herein required to be performed or observed by the Company on or prior to the Closing Date.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(c)</font><a name="_Ref113003662"></a><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Injunction</u><font style="font-size:11pt;">. The purchase of and payment for the Securities by each Investor shall not be prohibited or enjoined by any law or governmental or court order or regulation and no such prohibition shall have been threatened in writing.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(d)</font><a name="_Ref113008634"></a><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Consents</u><font style="font-size:11pt;">. The Company shall have obtained any and all consents, permits, approvals, registrations and waivers necessary for the consummation of the purchase and sale of the Securities, including the Required Parent Stockholder Vote, all of which shall be in full force and effect.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(e)</font><a name="_Ref179876411"></a><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Transfer Agent</u><font style="font-size:11pt;">. The Company shall have furnished all required materials to the Transfer Agent to reflect the issuance of the Initial Shares at the Closing.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(f)</font><a name="_Ref113003880"></a><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Adverse Changes</u><font style="font-size:11pt;">. Since the date hereof, no event or series of events shall have occurred that has had or would reasonably be expected to have a Material Adverse Effect or a Company Material Adverse Effect (as defined in the Merger Agreement).</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(g)</font><a name="_Ref179881262"></a><a name="_Ref113003897"></a><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Opinion of Company Counsel</u><font style="font-size:11pt;">. The Company shall have delivered to the Investors and the Placement Agents the opinion of Gibson, Dunn &amp; Crutcher LLP, dated as of the Closing Date, in customary form and substance to be reasonably agreed upon with the Placement Agents and addressing such legal matters as the Placement Agents and the Company reasonably agree.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(h)</font><a name="_Ref180383017"></a><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compliance Certificate</u><font style="font-size:11pt;">. An authorized officer of the Company shall have delivered to the Investors at the Closing Date a certificate, in form and substance reasonably acceptable to the Investor Majority, certifying that the conditions specified in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sections </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6.1(a)</u><font style="font-size:11pt;"> (Representations and Warranties), </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6.1(b)</u><font style="font-size:11pt;"> (Performance), </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6.1(c)</u><font style="font-size:11pt;"> (No Injunction), </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6.1(d)</u><font style="font-size:11pt;"> (Consents), </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6.1(f)</u><font style="font-size:11pt;"> (Adverse Changes), </font><font style="font-size:11pt;">&#8206;</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">6.1(k)</u><font style="font-size:11pt;"> (No Stop Order) </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6.1(l)</u><font style="font-size:11pt;"> (Nasdaq), </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6.1(m)</u><font style="font-size:11pt;"> (Minimum Financing Amount), and </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6.1(n)</u><font style="font-size:11pt;"> (Merger) of this Agreement have been fulfilled.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(i)</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Secretary&#8217;s Certificate</u><font style="font-size:11pt;">. The Secretary of the Company shall have delivered to the Investors at the Closing Date a certificate certifying (i) the Amended and Restated Certificate of Incorporation, (ii) the Amended and Restated Bylaws, and (iii) resolutions of the Company&#8217;s Board of Directors (or an authorized committee thereof) approving this Agreement, the other Transaction Agreements, the transactions contemplated by this Agreement and the issuance of the Securities and the Pre-Funded Warrant Shares.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(j)</font><a name="_Ref113002973"></a><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Registration Rights Agreement</u><font style="font-size:11pt;">. The Company and Parent shall have executed and delivered the Registration Rights Agreement in the form attached hereto as </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit C</u><font style="font-size:11pt;"> (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Registration Rights Agreement</b><font style="font-size:11pt;">&#8221;) to the Investors.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(k)</font><a name="_Ref180690606"></a><a name="_Ref113003676"></a><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Registration Statement; No Stop Orders</u><font style="font-size:11pt;">. The Registration Statement shall have become effective under the Securities Act and no stop order suspending the effectiveness of the </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">27</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:0pt;"><font style="font-size:11pt;">Registration Statement shall have been issued and no proceeding for that purpose, and no similar proceeding with respect to the Registration Statement shall have been initiated or threatened in writing by the Commission or its staff. The Parent Common Stock shall be listed on the National Exchange and shall not have been suspended, as of the Closing Date, by the SEC or the National Exchange from trading thereon.</font><font style="font-size:11pt;"> </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(l)</font><a name="_Ref179958305"></a><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Nasdaq</u><font style="font-size:11pt;">. The Nasdaq Listing Application (as defined in the Merger Agreement) shall have been approved by Nasdaq and the shares of Parent Common Stock to be issued upon conversion of the Shares pursuant to the Merger Agreement shall have been approved for listing (subject to official notice of issuance) on Nasdaq.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(m)</font><a name="_Ref179958322"></a><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Minimum Financing Amount</u><font style="font-size:11pt;">. The Company shall receive at Closing aggregate proceeds from the purchase of Securities pursuant to this Agreement of not less than </font><font style="font-size:11pt;">(i) $100,000,000 (including in such proceeds any Convertible Securities Contributed as consideration in accordance with this Agreement) minus (ii) the amount of proceeds actually received by the Company in connection with any Interim Financing (as defined in the Merger Agreement) prior to the Closing (excluding in such proceeds any Convertible Securities Contributed as consideration in accordance with this Agreement).</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(n)</font><a name="_Ref179958331"></a><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Merger</u><font style="font-size:11pt;">. All conditions to the closing of the Merger shall have been satisfied or waived (other than the Closing hereunder and other than those conditions which, by their nature, are to be satisfied at the closing of the transactions contemplated by the Merger Agreement), and the closing of the Merger shall be set to occur substantially concurrently with the Closing hereunder. </font><font style="font-size:11pt;">The Merger Agreement shall not have been amended or modified, and the Company shall not have waived any provision thereunder, in each case in a manner that would reasonably be expected to materially and adversely affect the benefits that an Investor would reasonably expect to receive under this Agreement without having received the prior written consent of the Investor Majority.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(o)</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Parent Stockholder Approval</u><font style="font-size:11pt;">. Parent shall have obtained Required Parent Stockholder Vote, including approval of the issuance of shares of Parent Common Stock issuable in exchange for the Initial Shares and the Pre-Funded Warrant Shares.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">6.2</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076182"></a><a name="_Ref179879478"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Conditions to the Obligation of the Company</u><font style="font-size:11pt;">. The obligation of the Company to consummate the transactions to be consummated at the Closing, and to issue and sell to each Investor the Securities to be purchased by it at the Closing pursuant to this Agreement, is subject to the satisfaction or waiver in writing of the following conditions precedent:</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(a)</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Representations and Warranties</u><font style="font-size:11pt;">. The representations and warranties of each Investor in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;4</u><font style="font-size:11pt;"> hereto shall be true and correct in all respects as of the date hereof and as of the Closing Date, with the same force and effect as though made on and as of the Closing Date, except to the extent that any such representation or warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct in all respects as of such earlier date, and consummation of the Closing shall constitute a reaffirmation by the Investor of each of the representations, warranties, covenants and agreements of the Investor contained in this Agreement as of the Closing Date.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(b)</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Performance</u><font style="font-size:11pt;">. Each Investor shall have performed or complied with in all material respects all obligations and conditions herein required to be performed or observed by such Investor on or prior to the Closing Date.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(c)</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Injunction</u><font style="font-size:11pt;">. The purchase of and payment for the Securities by each Investor shall not be prohibited or enjoined by any law or governmental or court order or regulation.</font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">28</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(d)</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Registration Rights Agreement</u><font style="font-size:11pt;">. Each Investor shall have executed and delivered the Registration Rights Agreement to the Company in the form attached as </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit&#160;C</u><font style="font-size:11pt;">.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(e)</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Payment</u><font style="font-size:11pt;background:#ffffff;">. Except </font><font style="font-size:11pt;">as may be agreed to among the Company and one or more Investors in accordance with </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2.2</u><font style="font-size:11pt;background:#ffffff;">, the Company shall have received payment, by wire transfer of immediately available funds, in the full amount of the purchase price for the number of </font><font style="font-size:11pt;">Securities</font><font style="font-size:11pt;background:#ffffff;"> being purchased by each Investor at the Closing as set forth in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Exhibit A</u><font style="font-size:11pt;background:#ffffff;">.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-decoration-line:none;text-indent:0pt;vertical-align:baseline;white-space:nowrap;">7.</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref113003090"></a><a name="_Toc166076183"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination</u><font style="font-size:11pt;">. </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">7.1</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076184"></a><a name="_Ref179880831"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination</u><font style="font-size:11pt;">. The obligations of the Company, on the one hand, and each Investor, on the other hand, to effect the Closing shall terminate as follows:</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(i)</font><font style="font-size:11pt;">Upon the mutual written consent of the Company, Parent and the Investor Majority prior to the Closing;</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(ii)</font><font style="font-size:11pt;">By the Company, if any of the conditions set forth in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6.2</u><font style="font-size:11pt;"> shall have become incapable of fulfillment and shall not have been waived by the Company;</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(iii)</font><font style="font-size:11pt;">By an Investor, solely as to itself, if any of the conditions set forth in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6.1</u><font style="font-size:11pt;"> shall have become incapable of fulfillment and shall not have been waived by such Investor; or</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(iv)</font><font style="font-size:11pt;">By either the Company or an Investor, solely as to itself, if the Closing has not occurred on or before September 30, 2025</font><font style="font-size:11pt;">; </font></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u>, <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</u>, that, except in the case of clauses (ii) through (iv) above, the party seeking to terminate its obligation to effect the Closing shall not then be in breach of any of its representations, warranties, covenants or agreements contained in the Transaction Agreements if such breach has resulted in the circumstances giving rise to such party&#8217;s seeking to terminate its obligation to effect the Closing.</p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">7.2</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076185"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notice</u><font style="font-size:11pt;">. In the event of termination pursuant to </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;7.1</u><font style="font-size:11pt;">, written notice thereof shall be given to each other Investor. Nothing in this </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;7</u><font style="font-size:11pt;"> shall be deemed to release any party from any liability for any breach by such party of the other terms and provisions of the Transaction Agreements or to impair the right of any party to compel specific performance by any other party of its other obligations under the Transaction Agreements.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-decoration-line:none;text-indent:0pt;vertical-align:baseline;white-space:nowrap;">8.</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076186"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Miscellaneous Provisions</u><font style="font-size:11pt;">.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.1</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076191"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Public Statements or Releases</u><font style="font-size:11pt;">. Except as set forth in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;5.3</u><font style="font-size:11pt;">, neither the Company nor any Investor shall make any public announcement with respect to the existence or terms of this Agreement or the transactions provided for herein without the prior consent of the other party (which consent shall not be unreasonably withheld) other than filings pursuant to Section 13 and/or Section 16 of the Exchange Act, which, for avoidance of doubt, shall not require the Company&#8217;s consent; </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u><font style="font-size:11pt;"> that, the Company shall not publicly disclose the name of any Investor or any affiliate or investment adviser of any Investor without such Investor&#8217;s prior written consent (email being sufficient). &#160;</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.2</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Interpretation</u><font style="font-size:11pt;">. The words &#8220;hereof,&#8221; &#8220;herein&#8221; and &#8220;hereunder&#8221; and words of similar import when used in this Agreement will refer to this Agreement as a whole and not to any particular provision of this Agreement, and section and subsection references are to this Agreement unless otherwise specified. The headings in this Agreement are included for convenience of reference only and will not limit </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">29</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-style:normal;font-weight:normal;">or otherwise affect the meaning or interpretation of this Agreement. Whenever the words &#8220;include,&#8221; &#8220;includes&#8221; or &#8220;including&#8221; are used in this Agreement, they will be deemed to be followed by the words &#8220;without limitation.&#8221; &#160;The phrases &#8220;the date of this Agreement,&#8221; &#8220;the date hereof&#8221; and terms of similar import, unless the context otherwise requires, will be deemed to refer to the date set forth in the first paragraph of this Agreement. The meanings given to terms defined herein will be equally applicable to both the singular and plural forms of such terms. All matters to be agreed to by any party hereto must be agreed to in writing by such party unless otherwise indicated herein. References to agreements, policies, standards, guidelines or instruments, or to statutes or regulations, are to such agreements, policies, standards, guidelines or instruments, or statutes or regulations, as amended or supplemented from time to time (or to successors thereto). </font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.3</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Ref179881021"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notices</u><font style="font-size:11pt;">. Any notices or other communications required or permitted to be given hereunder shall be in writing and shall be deemed to be given (a) when delivered if personally delivered to the party for whom it is intended, (b) when delivered, if sent by electronic mail during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient&#8217;s next Business Day, provided no rejection or undeliverable notice is received, (c) three (3) days after having been sent by certified or registered mail, return-receipt requested and postage prepaid, or (d) one (1) Business Day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery, with written verification of receipt:</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(a)</font><font style="font-size:11pt;">If to Parent, addressed as follows:</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 180pt;">GlycoMimetics, Inc.<br>9708 Medical Center Drive<br>Rockville, Maryland 20850 <br>Attention: Christian Dinneen-Long <br>Email: cdinneen-long@glycomimetics.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 180pt;"><font style="font-size:11pt;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 144pt;">with a copy to (which shall not constitute notice), prior to the Closing:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 180pt;">Sidley Austin, LLP<br>2850 Quarry Lake Drive, Suite 301<br>Baltimore, MD 21209<br><font style="white-space:pre-wrap;">Attention:  Asher Rubin</font><br><font style="white-space:pre-wrap;">Email:  arubin@sidley.com </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="font-size:11pt;">with a copy to (which shall not constitute notice), following the Closing:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 180pt;">Gibson, Dunn &amp; Crutcher LLP<br>One Embarcadero Center, Suite 2600<br>San Francisco, CA 94111<br>Attention: Ryan Murr, Branden Berns, Chris Trester<br>Email: rmurr@gibsondunn.com, bberns@gibsondunn.com, ctrester@gibsondunn.com</p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(b)</font><font style="font-size:11pt;">If to the Company, addressed as follows:</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 180pt;"><font style="font-size:12pt;"><a name="_Hlk190274757"></a><a name="_Hlk190274626"></a></font>Crescent Biopharma, Inc.<br>221 Crescent Street, Building 23, Suite 105<br>Waltham, Massachusetts 02453<br><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">30</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 180pt;">Attention: General Counsel<br>Email: barbara.bispham@crescentbiopharma.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 144pt;">with a copy to (which shall not constitute notice):</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 180pt;">Gibson, Dunn &amp; Crutcher LLP<br>One Embarcadero Center, Suite 2600<br>San Francisco, CA 94111<br>Attention: Ryan Murr, Branden Berns, Chris Trester<br>Email: rmurr@gibsondunn.com, bberns@gibsondunn.com, ctrester@gibsondunn.com</p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(c)</font><font style="font-size:11pt;">If to any Investor, at its address set forth on </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</u><font style="font-size:11pt;"> or to such e-mail address or address as subsequently modified by written notice given in accordance with this </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;8.3</u><font style="font-size:11pt;">.</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;">Any Person may change the address to which notices and communications to it are to be addressed by notification as provided for herein.</p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.4</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Severability</u><font style="font-size:11pt;">. If any part or provision of this Agreement is held unenforceable or in conflict with the applicable laws or regulations of any jurisdiction, the invalid or unenforceable part or provisions shall be replaced with a provision which accomplishes, to the extent possible, the original business purpose of such part or provision in a valid and enforceable manner, and the remainder of this Agreement shall remain binding upon the parties hereto.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.5</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076192"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Governing Law; Submission to Jurisdiction; Venue; Waiver of Trial by Jury</u><font style="font-size:11pt;">.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(a)</font><font style="font-size:11pt;">This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware without regard to choice of laws or conflicts of laws provisions thereof that would require the application of the laws of any other jurisdiction.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(b)</font><font style="font-size:11pt;">The Company, Parent and each of the Investors hereby irrevocably and unconditionally:</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(i)</font><font style="font-size:11pt;">submits for itself and its property in any legal action or proceeding relating solely to this Agreement or the transactions contemplated hereby, to the general jurisdiction of the any state court or United States Federal court sitting in the City of Wilmington in the State of Delaware;</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(ii)</font><font style="font-size:11pt;">consents that any such action or proceeding may be brought in such courts, and waives any objection that it may now or hereafter have to the venue of any such action or proceeding in any such court or that such action or proceeding was brought in an inconvenient court and agrees not to plead or claim the same to the extent permitted by applicable law;</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(iii)</font><font style="font-size:11pt;">agrees that service of process in any such action or proceeding may be effected by mailing a copy thereof by registered or certified mail (or any substantially similar form of mail), postage prepaid, to the party, as the case may be, at its address set forth in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;8.3</u><font style="font-size:11pt;"> or at such other address of which the other party shall have been notified pursuant thereto;</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(iv)</font><font style="font-size:11pt;">agrees that nothing herein shall affect the right to effect service of process in any other manner permitted by law or shall limit the right to sue in any other jurisdiction for recognition and enforcement of any judgment or if jurisdiction in the courts referenced in the foregoing clause (i) are not available despite the intentions of the parties hereto;</font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">31</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(v)</font><font style="font-size:11pt;">agrees that final judgment in any such suit, action or proceeding brought in such a court may be enforced in the courts of any jurisdiction to which such party is subject by a suit upon such judgment, provided that service of process is effected upon such party in the manner specified herein or as otherwise permitted by law;</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(vi)</font><font style="font-size:11pt;">agrees that to the extent that such party has or hereafter may acquire any immunity from jurisdiction of any court or from any legal process with respect to itself or its property, such party hereby irrevocably waives such immunity in respect of its obligations under this Agreement, to the extent permitted by law; and</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(vii)</font><font style="font-size:11pt;">irrevocably and unconditionally waives trial by jury in any legal action or proceeding in relation to this Agreement.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.6</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076193"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Waiver</u><font style="font-size:11pt;">. No waiver of any term, provision or condition of this Agreement, whether by conduct or otherwise, in any one or more instances, shall be deemed to be, or be construed as, a further or continuing waiver of any such term, provision or condition or as a waiver of any other term, provision or condition of this Agreement.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.7</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076194"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Expenses</u><font style="font-size:11pt;">. Except as expressly set forth in the Transaction Agreements to the contrary, each party shall pay its own out-of-pocket fees and expenses, including the fees and expenses of attorneys, accountants and consultants employed by such party, incurred in connection with the proposed investment in the Securities and the consummation of the transactions contemplated thereby; provided, however, that the Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company), Transfer Taxes, stamp taxes and other taxes (other than income taxes) and duties levied in connection with the delivery of any Securities to the Investors. </font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.8</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076195"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Assignment</u><font style="font-size:11pt;">. None of the parties may assign its rights or obligations under this Agreement or designate another person (i) to perform all or part of its obligations under this Agreement or (ii) to have all or part of its rights and benefits under this Agreement, in each case without the prior written consent of (x) the Company, in the case of an Investor, and (y) the Investors, in the case of the Company, </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u><font style="font-size:11pt;"> that an Investor may, without the prior consent of the Company, assign its rights to purchase the Securities hereunder to any of its affiliates or to any other investment funds or accounts managed or advised by the investment manager who acts on behalf of such Investor (</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u><font style="font-size:11pt;"> each such assignee agrees to be bound by the terms of this Agreement and makes the same representations and warranties set forth in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;4</u><font style="font-size:11pt;"> hereof). In the event of any assignment in accordance with the terms of this Agreement, the assignee shall specifically assume and be bound by the provisions of this Agreement by executing a writing agreeing to be bound by and subject to the provisions of this Agreement and shall deliver an executed counterpart signature page to this Agreement and, notwithstanding such assumption or agreement to be bound hereby by an assignee, no such assignment shall relieve any party assigning any interest hereunder from its obligations or liability pursuant to this Agreement unless expressly consented to by the Company.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.9</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076196"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Confidential Information</u><font style="font-size:11pt;">.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(a)</font><font style="font-size:11pt;">Each Investor covenants that until such time as the transactions contemplated by this Agreement and any material non-public information provided to such Investor are publicly disclosed by the Company in accordance with </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;5.3</u><font style="font-size:11pt;">, such Investor will maintain the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction), other than to such Investor&#8217;s outside attorney, accountant, auditor or investment advisor only to the extent necessary to permit evaluation of the investment, and the performance of the </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">32</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:0pt;"><font style="font-size:11pt;">necessary or required tax, accounting, financial, legal, or administrative tasks and services and other than as may be required by law.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(b)</font><font style="font-size:11pt;">The Company may request from the Investors such reasonable and customary additional information as the Company may deem necessary to evaluate the eligibility of the Investor to acquire the Securities, and the Investor shall promptly provide such information as may reasonably be requested to the extent readily available; provided, that the Company agrees to keep any such information provided by the Investor confidential, except (i) as required by the federal securities laws, rules or regulations and (ii) to the extent such disclosure is required by other laws, rules or regulations, at the request of the staff of the SEC or regulatory agency or under the regulations of Nasdaq, in which case of clause (ii) or (iii), the Company will use commercially reasonable efforts to notify the Investor and provide the Investor the opportunity to review such disclosure. The Investor acknowledges that Parent and/or the Company may file a form of this Agreement and the Registration Rights Agreement with the SEC as exhibits to a periodic report or a registration statement of Parent and/or the Company.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.10</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076197"></a><a name="_Ref179881204"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reliance by and Exculpation of Placement Agent</u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">s</u><font style="font-size:11pt;">.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(a)</font><font style="font-size:11pt;">Each Investor agrees for the express benefit of the Placement Agents and their respective affiliates and representatives that (i) the Placement Agents and their respective affiliates and representatives have not made, and will not make any representations or warranties with respect to the Company, Parent or the offer and sale of the Securities, and such Investor will not rely on any statements made by any Placement Agent, orally or in writing, to the contrary, (ii) such Investor will be responsible for conducting its own due diligence investigation with respect to the Company, Parent and the offer and sale of the Securities, (iii) such Investor will be purchasing Securities based on the results of its own due diligence investigation of the Company and Parent, and the Placement Agents and each of their respective directors, officers, employees, representatives, and controlling persons have made no independent investigation with respect to the Company, Parent, the Securities, or the accuracy, completeness, or adequacy of any information supplied to the Investor by the Company or Parent, and (iv) such Investor has negotiated the offer and sale of the Securities directly with the Company and the Placement Agents will not be responsible for the ultimate success of any such investment. Each Investor further represents and warrants to the Placement Agents that it, including any fund or funds that it manages or advises that participates in the offer and sale of the Securities, is permitted under its constitutive documents (including, without limitation, all limited partnership agreements, charters, bylaws, limited liability company agreements, all applicable side letters with investors, and similar documents) to make investments of the type contemplated by this Agreement. This </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;8.10</u><font style="font-size:11pt;"> shall survive any termination of this Agreement.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(b)</font><font style="font-size:11pt;">Each of the Company and Parent agrees and acknowledges that the Placement Agents may rely on its representations, warranties, agreements and covenants contained in this Agreement and each Investor agrees that the Placement Agents may rely on such Investor&#8217;s representations and warranties contained in this Agreement as if such representations and warranties, as applicable, were made directly to the Placement Agents.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(c)</font><font style="font-size:11pt;">Neither the Placement Agents nor any of their respective affiliates or representatives (1) shall be liable for any improper payment made in accordance with the information provided by the Company or Parent; (2) makes any representation or warranty, or has any responsibilities as to the validity, accuracy, value or genuineness of any information, certificates or documentation delivered by or on behalf of the Company or Parent pursuant to the Transaction Agreements or in connection with any of the transactions contemplated therein; or (3) shall be liable (x) for any action taken, suffered or omitted by any of them in good faith and reasonably believed to be authorized or within the discretion or rights or powers conferred upon them by the Transaction Agreements or (y) for anything </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">33</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:0pt;"><font style="font-size:11pt;">which any of them may do or refrain from doing in connection with the Transaction Agreements, except in each case for such party&#8217;s own gross negligence, willful misconduct or bad faith.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:108pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">(d)</font><font style="font-size:11pt;">Each of the Company and Parent agrees that the Placement Agents and their respective affiliates and representatives shall be entitled to (1) rely on, and shall be protected in acting upon, any certificate, instrument, notice, letter or any other document or security delivered to any of them by or on behalf of the Company or Parent, and (2) be indemnified by the Company and Parent for acting as the Placement Agents hereunder pursuant to the indemnification provisions set forth in the applicable letter agreement(s) between the Company, Parent and the Placement Agents.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.11</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076198"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Third Parties</u><font style="font-size:11pt;">. Nothing in this Agreement, express or implied, is intended to confer on any Person other than the parties to this Agreement any rights, remedies, claims, benefits, obligations or liabilities under or by reason of this Agreement, and no Person that is not a party to this Agreement (including, without limitation, any partner, member, shareholder, director, officer, employee or other beneficial owner of any party to this Agreement, in its own capacity as such or in bringing a derivative action on behalf of a party to this Agreement) shall have any standing as a third party beneficiary with respect to this Agreement or the transactions contemplated hereby, except as expressly set forth in this Agreement. Notwithstanding the foregoing, each Placement Agent is an intended third-party beneficiary of the representations and warranties of the Company and Parent set forth in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3</u><font style="font-size:11pt;">, the representations and warranties of each Investor set forth in </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;4</u><font style="font-size:11pt;">, </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6.1(g)</u><font style="font-size:11pt;"> and </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;8.10</u><font style="font-size:11pt;"> of this Agreement.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.12</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076199"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Independent Nature of Investors&#8217; Obligations and Right</u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">.</u><font style="font-size:11pt;"> The obligations of each Investor under this Agreement are several and not joint with the obligations of any other Investor, and no Investor shall be responsible in any way for the performance obligations of any other Investor under this Agreement. Nothing contained herein, and no action taken by any Investor pursuant hereto, shall be deemed to constitute the Investors as, and the Company acknowledges that the Investors do not so constitute, a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investors are in any way acting in concert or as a group (including a &#8220;group&#8221; within the meaning of Section 13(d)(3) of the 1934 Act), and the Company will not assert any such claim with respect to such obligations or the transactions contemplated by this Agreement and the Company acknowledges that the Investors are not acting in concert or as a group with respect to such obligations or the transactions contemplated by this Agreement. It is expressly understood that each provision contained in this Agreement is between the Company and an Investor, solely, and not between the Company and the Investors collectively and not between and among the Investors. The Company acknowledges and each Investor confirms that it has independently participated in the negotiation of the transaction contemplated hereby with the advice of its own counsel and advisors. </font><font style="font-size:11pt;">Each Investor also acknowledges that neither Gibson, Dunn &amp; Crutcher LLP nor Sidley Austin LLP has rendered legal advice to such Investor. </font><font style="font-size:11pt;">Each Investor shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement, and it shall not be necessary for any other Investor to be joined as an additional party in any proceeding for such purpose. The Company has elected to provide all Investors with the same terms and Transaction Agreements for the convenience of the Company and not because it was required or requested to do so by any Investor.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.13</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076200"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Headings</u><font style="font-size:11pt;">. The titles, subtitles and headings in this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this Agreement.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.14</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076201"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Counterparts</u><font style="font-size:11pt;">. This Agreement may be executed in three (3) or more identical counterparts, all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile or pdf signature including any electronic signatures complying with the U.S. federal </font><a name="_9kR3WTr26646CQv0pvq6w"></a><font style="font-size:11pt;">ESIGN Act</font><font style="font-size:11pt;"> of 2000, e.g., www.docusign.com shall be considered due execution and shall be binding upon the signatory thereto with </font></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">34</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-style:normal;font-weight:normal;">the same force and effect as if the signature were an original, not a facsimile or pdf (or other electronic reproduction of a) signature.</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.15</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076202"></a><a name="_Ref179883948"></a><a name="_Ref180675769"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Entire Agreement; Amendments</u><font style="font-size:11pt;">. This Agreement and the other Transaction Agreements (including all schedules and exhibits hereto and thereto) constitute the entire agreement between the parties hereto respecting the subject matter hereof and thereof and supersede all prior agreements, negotiations, understandings, representations and statements respecting the subject matter hereof and thereof, whether written or oral. No amendment, modification, alteration, waiver or change in any of the terms of this Agreement shall be valid or binding upon the parties hereto unless made in writing and duly executed by the Company and the Investor Majority. Notwithstanding the foregoing, (i) this Agreement may not be amended with respect to any Investor without the written consent of such Investor unless such amendment applies to all Investors in the same fashion and (ii) any amendment to </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;5.5</u><font style="font-size:11pt;">, </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;5.10</u><font style="font-size:11pt;">, Section 6.1, Section 7.1 or this </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 8.15</u><font style="font-size:11pt;"> shall require the consent of each Investor. The Company, on the one hand, and each Investor, on the other hand, may by an instrument signed in writing by such parties waive the performance, compliance or satisfaction by such Investor or the Company, respectively, with any term or provision hereof or any condition hereto to be performed, complied with or satisfied by such Investor or the Company, respectively. Notwithstanding the foregoing or anything else to the contrary, no amendment, modification, alteration, change or waiver of this </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;8.15</u><font style="font-size:11pt;"> that is material and adverse to the Placement Agents shall be valid without the prior written consent of the Placement Agents, which consent may be granted or withheld in the sole discretion of the Placement Agents. For the avoidance of doubt, an amendment to this Agreement after the date hereof allowing for the sale of additional Securities (&#8220;</font><b style="font-size:11pt;font-weight:bold;">Additional Securities</b><font style="font-size:11pt;">&#8221;) to one or more Persons (whether or not an existing Investor) shall only require the approval of the Company and the Investor Majority; </font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u><font style="font-size:11pt;"> that the price paid for such Additional Securities is at least 15% greater than the Share Price and Pre-Funded Warrant Price, as applicable.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.16</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076203"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Survival</u><font style="font-size:11pt;">. The covenants, representations and warranties made by each party hereto contained in this Agreement shall survive the Closing and the delivery of the Securities in accordance with their respective terms. Each Investor shall be responsible only for its own representations, warranties, agreements and covenants hereunder.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.17</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076204"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Mutual Drafting</u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">.</u><font style="font-size:11pt;"> This Agreement is the joint product of each Investor, Parent and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.18</font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><a name="_Toc166076205"></a></u><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Arm&#8217;s Length Negotiations</u><font style="font-size:11pt;">. For the avoidance of doubt, the parties acknowledge and confirm that the terms and conditions of the Securities were determined as a result of arm&#8217;s-length negotiations.</font></div><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;font-size:11pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">8.19</font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Further Assurances</u><font style="font-size:11pt;">. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents as the other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">[Remainder of Page Intentionally Left Blank.]</i></p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">35</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">IN WITNESS WHEREOF</b>, the parties hereto have executed this Agreement as of the day and year first above written.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 24pt 216pt;"><b style="font-weight:bold;">COMPANY:</b><br><br><b style="font-weight:bold;text-transform:uppercase;">Crescent Biopharma, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:22.5pt;text-indent:-22.5pt;margin:0pt 0pt 24pt 216pt;">By: <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:3.86pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:200.74pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><font style="text-decoration-line:none;"><br></font>Name: <br><font style="white-space:pre-wrap;">Title:  </font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">IN WITNESS WHEREOF</b>, the parties hereto have executed this Agreement as of the day and year first above written.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 24pt 216pt;"><b style="font-weight:bold;">PARENT:</b><br><br><b style="font-weight:bold;text-transform:uppercase;">GlycoMimetics, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:22.5pt;text-indent:-22.5pt;margin:0pt 0pt 24pt 216pt;">By: <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:3.86pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:200.74pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><font style="text-decoration-line:none;"><br></font>Name: <br><font style="white-space:pre-wrap;">Title:  </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">IN WITNESS WHEREOF</b>, the parties hereto have executed this Agreement as of the day and year first above written.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 216pt;"><b style="font-weight:bold;">INVESTOR:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 24pt 216pt;"><b style="font-weight:bold;">[NAME]</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 216pt;">By: <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:233.36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 216pt;">Name:<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:222.68pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 24pt 216pt;">Title:<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:228.17pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 24pt 216pt;">Beneficial Ownership Limitation: [<font style="font-family:'Times New Roman';">&#9679;</font>]</p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:9.09%;padding-right:9.09%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-align:center;text-indent:0pt;"><font style="font-size:11pt;white-space:nowrap;">EXHIBIT A</font><b style="font-size:11pt;font-weight:bold;"><font style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</font><br><font style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</font><br></b><b style="font-size:11pt;font-weight:bold;">INVESTORS</b></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;"><tr><td style="vertical-align:middle;width:22.91%;background:#d9d9d9;border-bottom:1px solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 4.65pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Investor Name and Address</b></p></td><td style="vertical-align:middle;width:10.99%;background:#d9d9d9;border-bottom:1px solid #000000;border-top:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Commitment Amount</b></p></td><td style="vertical-align:middle;width:11.02%;background:#d9d9d9;border-bottom:1px solid #000000;border-top:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Initial Shares</b></p></td><td style="vertical-align:middle;width:11.02%;background:#d9d9d9;border-bottom:1px solid #000000;border-top:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Share Price</b></p></td><td style="vertical-align:middle;width:11.02%;background:#d9d9d9;border-bottom:1px solid #000000;border-top:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Shares Underlying Pre-Funded Warrants</b></p></td><td style="vertical-align:middle;width:11.02%;background:#d9d9d9;border-bottom:1px solid #000000;border-top:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Pre-Funded Warrant Price</b></p></td><td style="vertical-align:middle;width:11.02%;background:#d9d9d9;border-bottom:1px solid #000000;border-top:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Convertible Securities Amount</b></p></td><td style="vertical-align:middle;width:10.98%;background:#d9d9d9;border-bottom:1px solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;margin:0pt;padding:0pt 4.65pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Aggregate Purchase Price</b></p></td></tr><tr style="height:15.25pt;"><td style="vertical-align:top;width:22.91%;border-left:1.5pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 4.65pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;">[Name]</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;">[Address]</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;">[Address]</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;">[Email]</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:9pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:10.99%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">[<font style="font-family:'Times New Roman';">&#9679;</font>]</p></td><td style="vertical-align:middle;width:11.02%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">[&#9679;]</p></td><td style="vertical-align:middle;width:11.02%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">$[&#9679;]</p></td><td style="vertical-align:middle;width:11.02%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">[&#9679;]</p></td><td style="vertical-align:middle;width:11.02%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">$[&#9679;]</p></td><td style="vertical-align:middle;width:11.02%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">$[&#9679;]</p></td><td style="vertical-align:middle;width:10.98%;border-right:1.5pt solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 4.65pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">$[&#9679;]</p></td></tr><tr><td style="vertical-align:top;width:22.91%;border-left:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 4.65pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;">[Name]</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;">[Address]</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;">[Address]</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;">[Email]</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:9pt;font-style:italic;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:10.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">[<font style="font-family:'Times New Roman';">&#9679;</font>]</p></td><td style="vertical-align:middle;width:11.02%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">[&#9679;]</p></td><td style="vertical-align:middle;width:11.02%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">$[&#9679;]</p></td><td style="vertical-align:middle;width:11.02%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">[&#9679;]</p></td><td style="vertical-align:middle;width:11.02%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">$[&#9679;]</p></td><td style="vertical-align:middle;width:11.02%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">$[&#9679;]</p></td><td style="vertical-align:middle;width:10.98%;border-right:1.5pt solid #000000;margin:0pt;padding:0pt 4.65pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">$[&#9679;]</p></td></tr><tr><td style="vertical-align:top;width:22.91%;border-left:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 4.65pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;">[Name]</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;">[Address]</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;">[Address]</p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;">[Email]</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;width:10.99%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">[<font style="font-family:'Times New Roman';">&#9679;</font>]</p></td><td style="vertical-align:middle;width:11.02%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">[&#9679;]</p></td><td style="vertical-align:middle;width:11.02%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">$[&#9679;]</p></td><td style="vertical-align:middle;width:11.02%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">[&#9679;]</p></td><td style="vertical-align:middle;width:11.02%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">$[&#9679;]</p></td><td style="vertical-align:middle;width:11.02%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">$[&#9679;]</p></td><td style="vertical-align:middle;width:10.98%;border-right:1.5pt solid #000000;margin:0pt;padding:0pt 4.65pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">$[&#9679;]</p></td></tr><tr><td style="vertical-align:top;width:22.91%;border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 4.65pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">TOTAL:</b></p></td><td style="vertical-align:middle;width:10.99%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">[<font style="font-family:'Times New Roman';">&#9679;</font>]</p></td><td style="vertical-align:middle;width:11.02%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">[&#9679;]</p></td><td style="vertical-align:middle;width:11.02%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">$[&#9679;]</p></td><td style="vertical-align:middle;width:11.02%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">[&#9679;]</p></td><td style="vertical-align:middle;width:11.02%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">$[&#9679;]</p></td><td style="vertical-align:middle;width:11.02%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">$[&#9679;]</p></td><td style="vertical-align:middle;width:10.98%;border-bottom:1.5pt solid #000000;border-right:1.5pt solid #000000;margin:0pt;padding:0pt 4.65pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;line-height:1.19;text-align:center;margin:0pt;">$[&#9679;]</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 24pt 0pt;"><font style="font-size:11pt;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">1</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:9.09%;margin-right:9.09%;margin-top:30pt;page-break-after:always;width:81.82%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;padding-left:36pt;text-align:center;text-indent:-36pt;"><font style="font-size:11pt;white-space:nowrap;">EXHIBIT B</font><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">FORM OF PRE-FUNDED WARRANT</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"> <font style="visibility:hidden;">&#8203;</font></p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:0pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"><font style="font-size:0pt;line-height:1.19;margin-left:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;">1</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4898-3031-6054v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;padding-left:36pt;text-align:center;text-indent:-36pt;"><font style="font-size:11pt;white-space:nowrap;">EXHIBIT C</font><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;"><a name="_dxtcompanion_actionscomplete"></a></font><b style="font-weight:bold;">REGISTRATION RIGHTS AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:12pt 0pt 12pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M2"></a><a name="_DV_M1"></a></font><b style="font-weight:bold;">THIS REGISTRATION RIGHTS AGREEMENT</b> (this &#8220;<b style="font-weight:bold;">Agreement</b>&#8221;), dated as of [<font style="font-family:'Times New Roman';">&#9679;</font>], 2025, is entered into by and among Crescent Biopharma, Inc., a Delaware corporation (&#8220;<b style="font-weight:bold;">Crescent</b>&#8221;), GlycoMimetics, Inc.,<b style="font-weight:bold;"> </b>a Delaware corporation (&#8220;<b style="font-weight:bold;">Parent</b>&#8221;), and the several investors signatory hereto (individually as an &#8220;<b style="font-weight:bold;">Investor</b>&#8221; and collectively together with their respective permitted assigns, the &#8220;<b style="font-weight:bold;">Investors</b>&#8221;).&#160;Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement by and among Crescent, Parent and the Investors party thereto, dated as of October 28, 2024 (as amended, restated, supplemented or otherwise modified from time to time, the &#8220;<b style="font-weight:bold;">Purchase Agreement</b>&#8221;). </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:12pt 0pt 12pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M3"></a></font><b style="font-weight:bold;">WHEREAS:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:12pt 0pt 12pt 0pt;">Crescent is party to that certain Agreement and Plan of Merger and Reorganization by and among the Crescent, Parent, Gemini Merger Sub Corp., a Delaware corporation and wholly-owned subsidiary of Parent (&#8220;<b style="font-weight:bold;">First Merger Sub</b>&#8221;) and Gemini Merger Sub II, LLC, a Delaware limited liability company and wholly-owned subsidiary of Parent (&#8220;<b style="font-weight:bold;">Second Merger Sub</b>&#8221;), dated October 28, 2024 (as amended from time to time, including on or around the date hereof, the &#8220;<b style="font-weight:bold;">Merger Agreement</b>&#8221;), pursuant to which (i) First Merger Sub will merge with and into Crescent, with Crescent surviving and becoming a wholly-owned subsidiary of Parent, (ii) Crescent will merge with and into Second Merger Sub, with Second Merger Sub being the surviving entity and a wholly-owned subsidiary of Parent ((i) and (ii) together, the &#8220;<b style="font-weight:bold;">Merger</b>&#8221;), and (iii) Parent will change its name to Crescent Biopharma, Inc. (&#8220;<b style="font-weight:bold;">TopCo</b>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:12pt 0pt 12pt 0pt;">Upon the terms and subject to the conditions of the Purchase Agreement, Crescent has agreed to issue to certain Investors, and such Investors have agreed to purchase, severally and not jointly, an aggregate of&#160;up to $[<font style="font-family:'Times New Roman';">&#9679;</font>] of (x) shares (the &#8220;<b style="font-weight:bold;">Initial Shares</b>&#8221;) of Crescent&#8217;s common stock, par value $0.001 per share (the &#8220;<b style="font-weight:bold;">Common Stock</b>&#8221;) and/or (y) pre-funded warrants (the &#8220;<b style="font-weight:bold;">Pre-Funded</b> <b style="font-weight:bold;">Warrants</b>&#8221;) to purchase shares of Common Stock, in each case, pursuant to the Purchase Agreement. <font style="font-size:12pt;"><a name="_Hlk176435427"></a></font>The Initial Shares and the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants are collectively referred to herein as the &#8220;<b style="font-weight:bold;">Shares</b>.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:12pt 0pt 12pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M5"></a></font>To induce the Investors to enter into the Purchase Agreement, the Company has agreed to provide certain registration rights under the U.S. Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, the &#8220;<b style="font-weight:bold;">Securities Act</b>&#8221;), and applicable state securities laws<font style="font-size:12pt;"><a name="_DV_C3"></a></font>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:12pt 0pt 12pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M6"></a></font><b style="font-weight:bold;">NOW, THEREFORE,</b> in consideration of the promises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby <font style="font-size:12pt;"><a name="LastSpot"></a><a name="_DV_M7"></a></font>acknowledged, Crescent, Parent and the Investors hereby agree as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 0pt 36pt;"><font style="font-size:12pt;"><a name="_DV_M8"></a></font><b style="font-weight:bold;">DEFINITIONS.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:12pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M9"></a></font>For purposes of this Agreement, the following terms shall have the following meanings:<font style="font-size:12pt;"><a name="_DV_M10"></a></font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;">&#8220;<b style="font-weight:bold;">Company</b>&#8221; means Crescent for all periods prior to the Effective Time and TopCo for all periods following the Effective Time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;">&#8220;<b style="font-weight:bold;">Filing Deadline</b>&#8221; means, with respect to the Initial Registration Statement required hereunder, the 30th calendar day following the Closing Date and, with respect to any New Registration </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">Statements or other Registration Statement filed hereunder, the 30th calendar day following the later of (i) date on which the Company is permitted by SEC Guidance to file such New Registration Statement related to the Registrable Securities and (ii) the date on which the Company becomes aware of the necessity of filing such New Registration Statement related to the Registrable Securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;">&#8220;<b style="font-weight:bold;">Person</b>&#8221; means any individual or entity including but not limited to any corporation, limited liability company, association, partnership, organization, business, individual, governmental or political subdivision thereof or a governmental agency.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;">&#8220;<b style="font-weight:bold;">Register</b>,&#8221; &#8220;<b style="font-weight:bold;">Registered</b>,&#8221; and &#8220;<b style="font-weight:bold;">Registration</b>&#8221; refer to a registration effected by preparing and filing one or more registration statements of the Company in compliance with the Securities Act and providing for offering securities on a continuous basis, and the declaration or ordering of effectiveness of such registration statement(s) by the U.S. Securities and Exchange Commission (the &#8220;<b style="font-weight:bold;">SEC</b>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;">&#8220;<b style="font-weight:bold;">Registrable Securities</b>&#8221; means (i) the Shares, (ii) any Shares of Common Stock issued to an Investor on or around the date hereof pursuant to that certain Agreement and Plan of Merger and Reorganization, dated on or around the date hereof, by and among the Company, Crescent Biopharma, Inc., Gemini Merger Sub Corp. and Gemini Merger Sub II, LLC, and (iii) any Common Stock issued or issuable with respect to the foregoing as a result of any stock split or subdivision, stock dividend, recapitalization, exchange or similar event. Registrable Securities shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect thereto) upon the earliest to occur of (A) the date on which such Investor shall have resold such Registrable Securities covered by the Registration Statement, (B) such Registrable Securities have been previously sold by such Investor in accordance with Rule 144, (C) such securities become eligible for resale by such Investor without volume or manner-of-sale restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement under Rule 144 and (D) five (5) years after the date of this Agreement. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;">&#8220;<b style="font-weight:bold;">Registration Expenses</b>&#8221; means all registration and filing fee expenses incurred by the Company in effecting any registration pursuant to this Agreement, including (i) all registration, qualification, and filing fees, printing expenses, and any other fees and expenses associated with filings required to be made with the SEC, FINRA or any other regulatory authority, (ii) all fees and expenses in connection with compliance with or clearing the Registrable Securities for sale under any securities or &#8220;Blue Sky&#8221; laws, (iii) all printing, duplicating, word processing, messenger, telephone, facsimile and delivery expenses, and (iv) all fees and disbursements of counsel for the Company and of all independent certified public accountants of the Company (including the expenses of any special audit and cold comfort letters required by or incident to such performance); provided that in no event shall the Company be responsible for any underwriting, broker or similar fees or commissions of any Investor or, except to the extent provided for in the Purchase Agreement, any legal fees or other costs of the Investors. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;">&#8220;<b style="font-weight:bold;">Registration Statement</b>&#8221; means any registration statement of the Company filed with, or to be filed with, the SEC under the Securities Act, that Registers Registrable Securities, including the related preliminary or final prospectus, amendments and supplements to such registration statement, including pre- and post-effective amendments, and all exhibits and all material incorporated by reference in such registration statement as may be necessary to comply with applicable securities laws. &#8220;Registration Statement&#8221; shall also include a New Registration Statement, as amended when each became effective, including all documents filed as part thereof or incorporated by reference therein, and including any information contained in a prospectus subsequently filed with the SEC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;">&#8220;<b style="font-weight:bold;">SEC Guidance</b>&#8221; means (i) any publicly-available written or oral guidance of the SEC staff, or any comments, requirements or requests of the SEC staff (whether or not publicly-available); </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;">3</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">provided, that any such oral guidance, comments, requirements or requests are reduced to writing by the SEC (and shared with the Investors upon request if not publicly-available) and (ii) the Securities Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;">&#8220;<b style="font-weight:bold;">Selling Expenses</b>&#8221; means all underwriting discounts and selling commissions applicable to the sale of Registrable Securities and all similar fees and commissions relating to an Investor&#8217;s disposition of its Registrable Securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:12pt 0pt 12pt 36pt;"><font style="font-size:12pt;"><a name="_DV_M13"></a><a name="_DV_M11"></a><a name="_DV_M12"></a><a name="_DV_M14"></a><a name="_DV_M15"></a><a name="_DV_M17"></a><a name="_DV_M19"></a><a name="_DV_M18"></a><a name="_Ref179887729"></a></font><b style="font-weight:bold;">REGISTRATION.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M20"></a><a name="_Ref179887641"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Mandatory Registration</u>. The Company shall, as promptly as reasonably practicable and in any event no later than the Filing Deadline, prepare and file with the SEC an initial Registration Statement (the &#8220;<b style="font-weight:bold;">Initial Registration Statement</b>&#8221;) covering the resale of all Registrable Securities. Before filing the Registration Statement, the Company shall furnish to the Investors a copy of the Registration Statement. The Investors and their respective counsel shall have at least three (3) Business Days prior to the anticipated filing date of a Registration Statement to review and comment upon such Registration Statement and any amendment or supplement to such Registration Statement and any related prospectus (including any documents incorporated by reference therein), prior to its filing with the SEC. The Company shall (a) consider in good faith any comments as the Investor or its counsel reasonably proposed by the Investor to such document prior to being so filed with the SEC, and (b) not file any Registration Statement or related prospectus or any amendment or supplement thereto containing information regarding the Investor to which Investor reasonably believes contains untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, unless such information is required (in the opinion of the Company) to comply with any applicable law or regulation or SEC Guidance. Each Investor shall furnish all information reasonably requested by the Company with respect to such Investor as shall be reasonably required in connection with any registration referred to in this Agreement. &#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_Ref179887648"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Effectiveness</u>. The Company shall use its commercially reasonable efforts to have the Initial Registration Statement and any amendment declared effective by the SEC at the earliest possible date but no later than the earlier of the sixtieth (60th) calendar day following the initial filing date of the Initial Registration Statement if the SEC notifies the Company that it will &#8220;review&#8221; the Initial Registration Statement and (b) the fifth (5th) Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that the Initial Registration Statement will not be &#8220;reviewed&#8221; or will not be subject to further review (the &#8220;<b style="font-weight:bold;">Effectiveness Deadline</b>&#8221;). The Company shall notify the Investor by e-mail as promptly as practicable, and in any event, within twenty-four (24) hours, after the Initial Registration Statement is declared effective or is supplemented and shall provide the Investor with copies of any related prospectus to be used in connection with the sale or other disposition of the securities covered thereby. The Company shall use commercially reasonable efforts to keep the Initial Registration Statement continuously effective pursuant to Rule 415 promulgated under the Securities Act and available for the resale by the Investors of all of the Registrable Securities covered thereby at all times until the earlier to occur of the following events: (i) the date on which the Investors shall have resold all the Registrable Securities covered thereby; (ii) the date on which the Registrable Securities may be resold by the Investors without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, and without the requirement for the Company to be in compliance with the current public information requirement under Rule 144 under the Securities Act or any other rule of similar effect and (iii) five (5) years after the date of this Agreement (the &#8220;<b style="font-weight:bold;">Registration Period</b>&#8221;). The Initial Registration Statement (including any amendments or supplements thereto and prospectuses contained therein) shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading. </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;">4</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:0pt;"><font style="font-size:12pt;"><a name="_DV_M23"></a><a name="_DV_M26"></a><a name="_Ref_ContractCompanion_9kb9Ur014"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sufficient Number of Shares Registered</u>. In the event the number of shares available under the Initial Registration Statement at any time is insufficient to cover the Registrable Securities, the Company shall, to the extent necessary and permissible, amend the Initial Registration Statement or file a new registration statement (together with any prospectuses or prospectus supplements thereunder, a &#8220;<b style="font-weight:bold;">New Registration Statement</b>&#8221;), so as to cover all of such Registrable Securities as soon as reasonably practicable, but in any event not later than the Filing Deadline.&#160;The Company shall use its commercially reasonable efforts to have such amendment and/or New Registration Statement become effective as soon as reasonably practicable following the filing thereof but no later than the earlier of (a) the seventy-fifth (75th) calendar day following the initial filing date of the New Registration Statement if the SEC notifies the Company that it will &#8220;review&#8221; the New Registration Statement and (b) the fifth (5th) Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that the New Registration Statement will not be &#8220;reviewed&#8221; or will not be subject to further review. The provisions of <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sections </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2(a)</u> and <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2(b)</u> shall apply to the New Registration Statement, except as modified hereby. &#160;&#160;&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_Ref179887756"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Allowable Delays</u>. On no more than two (2) occasions in any twelve (12)-month period for not more than thirty (30) consecutive days or for a total of not more than sixty (60) days, the Company may delay the effectiveness of the Initial Registration Statement or any other Registration Statement, or suspend the use of any prospectus included in any Registration Statement, in the event that the Board of Directors reasonably determines, in good faith and upon advice of legal counsel, that such delay or suspension is necessary to (A) delay the disclosure of material non-public information concerning the Company, including in connection with the negotiation or consummation of a material transaction by the Company that is pending, that would require additional disclosure by the Company in the Registration Statement of material non-public information that the Company has a bona fide business purpose for preserving as confidential and the non-disclosure of which would be expected, in the reasonable determination of the Board of Directors, upon advice of legal counsel, to cause the Registration Statement to fail to comply with applicable disclosure requirements, or (B) amend or supplement the affected Registration Statement or the related prospectus so that such Registration Statement or prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the case of the prospectus in light of the circumstances under which they were made, not misleading (an &#8220;<b style="font-weight:bold;">Allowed Delay</b>&#8221;); <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u>, that the Company shall promptly (a) notify each Investor in writing of the commencement of an Allowed Delay, but shall not (without the prior written consent of an Investor) disclose to such Investor any material non-public information giving rise to an Allowed Delay, (b) advise the Investors in writing to cease all sales under the applicable Registration Statement until the end of the Allowed Delay and (c) use commercially reasonable efforts to terminate an Allowed Delay as promptly as practicable. Each Investor may deliver written notice (an &#8220;<b style="font-weight:bold;">Opt-Out Notice</b>&#8221;) to the Company requesting that such Investor not receive notices from the Company otherwise required by this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2</u>; <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u>, <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</u>, that such Investor may later revoke any such Opt-Out Notice in writing, which shall be effective five (5) Business Days after the receipt thereof. Following receipt of an Opt-Out Notice from an Investor (unless subsequently revoked), the Company shall not deliver any notices pursuant to this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2(d)</u> to such Investor and such Investor shall no longer be entitled to the rights associated with any such notice.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_Ref179887808"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Rule&#160;415; Cutback</u>. If at any time the SEC takes the position that the offering of some or all of the Registrable Securities in any Registration Statement is not eligible to be made on a delayed or continuous basis under the provisions of Rule&#160;415 under the Securities Act (<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u>, <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</u>, the Company shall be obligated to use commercially reasonable efforts to advocate with the SEC for the registration of all of the Registrable Securities) or requires any Investor to be named as an &#8220;underwriter,&#8221; the Company shall (i) promptly notify each holder of Registrable Securities thereof and (ii) make commercially reasonable efforts to persuade the SEC that the offering contemplated by such Registration Statement is a valid secondary offering and not an offering &#8220;by or on behalf of the issuer&#8221; as defined in Rule&#160;415 and that none of the Investors is an &#8220;underwriter.&#8221; Each Investor shall have the right to have its </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;">5</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">legal counsel, at such Investor&#8217;s expense, to review and oversee any registration or matters pursuant to this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section&#160;</u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2(e)</u>, including to comment on any written submission made to the SEC with respect thereto. In the event that, despite the Company&#8217;s commercially reasonable efforts and compliance with the terms of this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section&#160;</u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2(e)</u>, the SEC refuses to alter its position, the Company shall (i)&#160;remove from such Registration Statement such portion of the Registrable Securities and/or (ii)&#160;agree to such restrictions and limitations on the registration and resale of the Registrable Securities as the SEC may require to assure the Company&#8217;s compliance with the requirements of Rule&#160;415 (collectively, the &#8220;<b style="font-weight:bold;">SEC Restrictions</b>&#8221;); <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u>, <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</u>, that the Company shall not name any Investor as an &#8220;underwriter&#8221; in such Registration Statement without the prior written consent of such Investor (<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u> that, in the event an Investor withholds such consent, the Company shall have no obligation hereunder to include any Registrable Securities of such Investor in any Registration Statement covering the resale thereof until such time as the SEC no longer requires such Investor to be named as an &#8220;underwriter&#8221; in such Registration Statement or such Investor otherwise consents in writing to being so named). Any cut-back imposed on the Investors pursuant to this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2(e)</u> shall be allocated among the Investors on a pro rata basis and shall be applied first to any of the Registrable Securities of an Investor that the SEC has indicated cannot be included or must be limited in the number of Registrable Securities that can be included, and thereafter to all other Investors, unless the SEC Restrictions otherwise require or provides otherwise, or an Investor otherwise agrees. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_Ref179887882"></a></font>Each Registration Statement filed hereunder shall be on Form S-3 (except if the Company is not then eligible to register for resale the Registrable Securities on Form S-3, in which case such registration shall be on another form in accordance with the provisions of this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2(f)</u>). If Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the resale of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on Form S-3 as soon as such form is available, <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u> that the Company shall maintain the effectiveness of the Registration Statement then in effect until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the SEC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:12pt 0pt 12pt 36pt;"><font style="font-size:12pt;"><a name="_DV_M27"></a></font><b style="font-weight:bold;">RELATED COMPANY OBLIGATIONS.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M28"></a></font>With respect to the Registration Statement and whenever any Registrable Securities are to be Registered pursuant to <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2</u>, including on the Initial Registration Statement or on any New Registration Statement, the Company shall use its commercially reasonable efforts to effect the registration of the Registrable Securities in accordance with the intended method of disposition thereof and, pursuant thereto, the Company shall have the following obligations:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M29"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notifications</u>. The Company will promptly notify the Investors of the time when any subsequent amendment to the Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any prospectus or for additional information regarding the Investor. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M30"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Amendments</u>. The Company will prepare and file with the SEC any amendments, post-effective amendments or supplements to the Initial Registration Statement, any New Registration Statement or any related prospectus, as applicable, that, (a) as may be necessary to keep such Registration Statement effective for the Registration Period and to comply with the provisions of the Securities Act and the Exchange Act with respect to the distribution of all of the Registrable Securities covered thereby, or (b) in the reasonable opinion of the Investors and the Company, as may be necessary or advisable in connection with any acquisition or sale of Registrable Securities by the Investors. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M33"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Investor Review</u>. The Company will not file any amendment or supplement to the Registration Statement, any New Registration Statement or any prospectus, other than documents </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;">6</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">incorporated by reference, relating to any Investor, the Registrable Securities or the transactions contemplated hereby unless (A) such Investor and its counsel shall have been advised and afforded the opportunity to review and comment thereon at least three (3) Business Days prior to filing with the SEC and (B) the Company shall have given reasonable due consideration to any comments thereon received from such Investor or its counsel. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_Ref_ContractCompanion_9kb9Ur025"></a><a name="_Ref_ContractCompanion_9kb9Ur027"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Copies Available</u>. The Company will furnish to any Investor whose Registrable Securities are included in any Registration Statement and its counsel copies of the Initial Registration Statement, any prospectus thereunder (including all documents incorporated by reference therein), any prospectus supplement thereunder, any New Registration Statement and all amendments to the Initial Registration Statement or any New Registration Statement that are filed with the SEC during the Registration Period (including all documents filed with or furnished to the SEC during such period that are deemed to be incorporated by reference therein), each letter written by or on behalf of the Company to the SEC or the staff of the SEC, and each item of correspondence from the SEC or the staff of the SEC, in each case relating to such Registration Statement (other than any portion thereof which contains information for which the Company has sought confidential treatment) and <font style="background:#ffffff;">such other documents as such Investor may reasonably request in order to facilitate the disposition of the Registrable Securities owned by such Investor that are covered by such Registration Statement</font>, in each case as soon as reasonably practicable upon such Investor&#8217;s request and in such quantities as such Investor may from time to time reasonably request<font style="font-size:12pt;"><a name="_cp_text_2_4"></a></font>; <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u>, <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</u>, that the Company shall not be required to furnish any document to such Investor to the extent such document is available on EDGAR. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M34"></a><a name="_DV_M35"></a><a name="_DV_M36"></a><a name="_Ref179888390"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notification of Stop Orders; Material Changes</u>. The Company shall use commercially reasonable efforts to (i) prevent the issuance of any stop order or other suspension of effectiveness and, (ii) if such order is issued, obtain the withdrawal of any such order as soon as practicable. The Company shall advise the Investors promptly (but in no event later than 24 hours) and shall confirm such advice in writing, in each case: (i) of the Company&#8217;s receipt of notice of any request by the SEC or any other federal or state governmental authority for amendment of or a supplement to the Registration Statement or any prospectus or for any additional information; (ii) of the Company&#8217;s receipt of notice of the issuance by the SEC or any other federal or state governmental authority of any stop order suspending the effectiveness of the Initial Registration Statement or prohibiting or suspending the use of any prospectus or prospectus supplement, or any New Registration Statement, or of the Company&#8217;s receipt of any notification of the suspension of qualification of the Registrable Securities for offering or sale in any jurisdiction or the initiation or contemplated initiation of any proceeding for such purpose; and (iii) of the Company becoming aware of the happening of any event, which makes any statement of a material fact made in any Registration Statement or any prospectus untrue or which requires the making of any additions to or changes to the statements then made in any Registration Statement or any prospectus in order to state a material fact required by the Securities Act to be stated therein or necessary in order to make the statements then made therein (in the case of any prospectus, in light of the circumstances under which they were made) not misleading, or of the necessity to amend any Registration Statement or any prospectus to comply with the Securities Act or any other law. The Company shall not be required to disclose to the Investors the substance of specific reasons of any of the events set forth in clauses (i) through (iii) of the immediately preceding sentence (each, a &#8220;<b style="font-weight:bold;">Suspension Event</b>&#8221;), but rather, shall only be required to disclose that the event has occurred; provided that the Company shall not provide any material non-public information to the Investors in such notice. If at any time the SEC, or any other federal or state governmental authority shall issue any stop order suspending the effectiveness of any Registration Statement or prohibiting or suspending the use of any prospectus or prospectus supplement, the Company shall use its commercially reasonable efforts to obtain the withdrawal of such order at the earliest practicable time. The Company shall furnish to any Investor upon request, without charge, a copy of any correspondence from the SEC or the staff of the SEC, or any other federal or state governmental authority to the Company or its representatives relating to the Initial Registration Statement, any New Registration Statement or any prospectus, or prospectus supplement </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;">7</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">as the case may be. In the event of a Suspension Event set forth in clause (iii) of the second sentence of this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3(e)</u>, the Company will use its commercially reasonable efforts to publicly disclose such event as soon as reasonably practicable, or otherwise resolve the matter such that sales under Registration Statements may resume.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M37"></a><a name="_DV_M43"></a><a name="_DV_M44"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Confirmation of Effectiveness</u>. If <font style="font-size:12pt;"><a name="_DV_M45"></a></font>requested by an <font style="font-size:12pt;"><a name="_DV_C20"></a></font>Investor at any time<font style="font-size:12pt;"><a name="_DV_M46"></a></font> in respect of any Registration Statement, the Company shall<font style="font-size:12pt;"><a name="_DV_C21"></a></font> <font style="font-size:12pt;"><a name="_DV_M47"></a></font>deliver to such Investor a written confirmation (email being sufficient) from Company&#8217;s counsel of whether or not the effectiveness of such Registration Statement has lapsed at any time for any reason (including, without limitation, the issuance of a stop order) and whether or not such Registration Statement is currently effective and available to the Company for sale of Registrable Securities. &#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Listing</u>. The Company shall use commercially reasonable efforts to cause all Registrable Securities covered by a Registration Statement to be listed on the Nasdaq Global Market and/or any other National Exchange upon which the Registrable Securities are listed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_Ref179888673"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compliance</u>. The Company shall otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the SEC under the Securities Act and the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final prospectus, including any supplement or amendment thereof, with the SEC pursuant to Rule 424 under the Securities Act, promptly inform the Investor in writing if, at any time during the Registration Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof, the Investor is required to deliver a prospectus in connection with any disposition of Registrable Securities and take such other actions as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder, and make available to its security holders, as soon as reasonably practicable, but not later than the Availability Date (as defined below), an earnings statement covering a period of at least twelve (12) months, beginning after the effective date of each Registration Statement, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act, including Rule 158 promulgated thereunder (for the purpose of this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3(h)</u>, &#8220;<b style="font-weight:bold;">Availability Date</b>&#8221; means the forty-fifth (45<sup style="font-size:8.25pt;vertical-align:top;">th</sup>) day following the end of the fourth (4<sup style="font-size:8.25pt;vertical-align:top;">th</sup>) fiscal quarter that includes the effective date of such Registration Statement, except that, if such fourth (4<sup style="font-size:8.25pt;vertical-align:top;">th</sup>) fiscal quarter is the last quarter of the Company&#8217;s fiscal year, &#8220;Availability Date&#8221; means the ninetieth (90<sup style="font-size:8.25pt;vertical-align:top;">th</sup>) day after the end of such fourth (4<sup style="font-size:8.25pt;vertical-align:top;">th</sup>) fiscal quarter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_Ref179888718"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Blue-Sky</u>. The Company shall use commercially reasonable efforts to register or qualify or cooperate with any Investor and its counsel in connection with the registration or qualification of such Registrable Securities for the offer and sale under the securities or blue sky laws of such jurisdictions reasonably requested by such Investor; provided, however, that the Company shall not be required in connection therewith or as a condition thereto to (i) qualify to do business in any jurisdiction where it would not otherwise be required to qualify but for this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3(i)</u>, (ii) subject itself to general taxation in any jurisdiction where it would not otherwise be so subject but for this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;3(i)</u>, or (iii) file a general consent to service of process in any such jurisdiction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Rule 144</u>. With a view to making available to the Investors the benefits of Rule 144 (or its successor rule) and any other rule or regulation of the SEC that may at any time permit the Investors to sell shares of Common Stock to the public without registration, the Company covenants and agrees to use commercially reasonable efforts to make and keep adequate current public information available, as those terms are understood and defined in Rule 144, until the date as all of the Initial Shares may be sold without restriction by the holders thereof pursuant to Rule 144 or any other rule of similar effect (without the requirement for the Company to be in compliance with any current public information requirements). &#160;In addition for so long as any Registrable Securities are outstanding, the Company covenants and agrees to use commercially reasonable efforts to (i) file with the SEC in a timely manner all reports and other documents required of the Company under the Exchange Act; (ii) furnish electronically to each Investor </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;">8</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">upon request, as long as such Investor owns any Registrable Securities, (A) a written statement by the Company that it has complied with the reporting requirements of the Exchange Act, (B) a copy of or electronic access to the Company&#8217;s most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q, and (C) such other information as may be reasonably requested in order to avail such Investor of any rule or regulation of the SEC that permits the selling of any such Registrable Securities without registration, and (iii) provide any legal opinions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Cooperation.</u>&#160;The Company shall cooperate with the holders of the Registrable Securities to facilitate the timely preparation and delivery of certificates or uncertificated shares representing the Registrable Securities to be sold pursuant to such Registration Statement or Rule 144 free of any restrictive legends and representing such number of shares of Common Stock and registered in such names as the holders of the Registrable Securities may reasonably request in accordance with the provisions of the Purchase Agreement, and the Company may satisfy its obligations hereunder without issuing physical stock certificates through the use of The Depository Trust Company&#8217;s Direct Registration System.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Removal of Restrictive Legends</u>.&#160;Without limiting Section 5.5 of the Purchase Agreement, the Company shall use commercially reasonable efforts to cause the Company&#8217;s transfer agent to remove any restrictive legend from any Registrable Securities, as promptly as practicable following effectiveness of the applicable Registration Statement, without any request for removal being required from any holder of Registrable Securities. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:12pt 0pt 12pt 36pt;"><font style="font-size:12pt;"><a name="_DV_M48"></a><a name="_DV_M50"></a></font><b style="font-weight:bold;">OBLIGATIONS OF THE INVESTORS.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M51"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Investor Information</u>. Each Investor shall provide a completed Investor Questionnaire in the form attached hereto as <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</u> or such other form of questionnaire or information required by the Company in connection with the registration of the Registrable Securities within three (3) Business Days of request by the Company and no later than the end of the third (3rd) Business Day following the date on which such Investor receives draft materials in accordance with <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;2(a)</u>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M52"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Suspension of Sales</u>. Each Investor, severally and not jointly with any other Investor, agrees that, upon receipt of any notice from the Company of the existence of an Allowed Delay or Suspension Event, the Investor will promptly discontinue disposition of Registrable Securities pursuant to any Registration Statement covering such Registrable Securities until the Investor&#8217;s receipt of a notice from the Company confirming the resolution of such Allowed Delay or Suspension Event and that such dispositions may again be made.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Investor Cooperation</u>. Each Investor, severally and not jointly with any other Investor, agrees to cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of any amendments and supplements to any Registration Statement or New Registration Statement hereunder, unless such Investor has notified the Company in writing of its election to exclude all of its Registrable Securities from such Registration Statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:12pt 0pt 12pt 36pt;"><font style="font-size:12pt;"><a name="_DV_M53"></a></font><b style="font-weight:bold;">EXPENSES OF REGISTRATION.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M54"></a></font>All Registration Expenses incurred in connection with registrations pursuant to this Agreement shall be borne by the Company. All Selling Expenses relating to securities registered on behalf of an Investor shall be borne by such Investor.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:12pt 0pt 12pt 36pt;"><font style="font-size:12pt;"><a name="_DV_M55"></a><a name="_Ref179890062"></a></font><b style="font-weight:bold;">INDEMNIFICATION.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M56"></a></font>To the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend each Investor, each Person, if any, who controls each Investor, the shareholders, </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;">9</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">directors, officers, partners, employees, members, managers, agents, representatives and advisors of each Investor and each Person, if any, who controls any of the foregoing within the meaning of the Securities Act or the Exchange Act (each, an &#8220;<b style="font-weight:bold;">Indemnified Person</b>&#8221;), against any losses, obligation, claims, damages, liabilities, contingencies, judgments, fines, penalties, charges and costs (including, without limitation, court costs and costs of preparation), reasonable and documented attorneys&#8217; fees, amounts paid in settlement or reasonable and documented expenses (collectively, &#8220;<b style="font-weight:bold;">Indemnified Damages</b>&#8221;) reasonably incurred in investigating, preparing or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court or governmental, administrative or other regulatory agency or body or the SEC, whether pending or threatened, whether or not an indemnified party is or may be a party thereto (&#8220;<b style="font-weight:bold;">Claims</b>&#8221;), to which any of them may become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon: (i) any untrue statement or alleged untrue statement or omission or alleged omission of any material fact contained in any Registration Statement<font style="font-size:12pt;"><a name="_DV_C17"></a><a name="_DV_M57"></a></font>, or (ii) any violation or alleged violation by the Company or any of its Subsidiaries of the Securities Act, Exchange Act or any other state securities or other &#8220;blue sky&#8221; laws of any jurisdiction in which Registrable Securities are offered or any rule or regulation promulgated thereunder applicable to the Company or its agents and relating to action or inaction required of the Company in connection with such registration of the Registrable Securities (the matters in the foregoing clauses (i) and (<font style="font-size:12pt;"><a name="_DV_C30"></a><a name="_DV_M59"></a></font>ii) being, collectively, &#8220;<b style="font-weight:bold;">Violations</b>&#8221;).&#160;The Company shall reimburse each Indemnified Person promptly as such Indemnified Damages are incurred and are due and payable, for any reasonable out-of-pocket legal fees or other reasonable and documented expenses incurred by them in connection with investigating or defending any such Claim.&#160;<font style="font-size:12pt;"><a name="_DV_M60"></a></font>Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6(a)</u>: (A) shall not apply to a Claim by an Indemnified Person arising out of or based upon a Violation which occurs in reliance upon and in conformity with information furnished in writing to the Company by the Investors or such Indemnified Person specifically for use in such Registration Statement and was reviewed and approved in writing by such Investor or such Indemnified Person expressly for use in connection with the preparation of any Registration Statement; (B) with respect to any superseded prospectus, shall not inure to the benefit of any such Person from whom the Person asserting any such Claim purchased the Registrable Securities that are the subject thereof (or to the benefit of any <font style="font-size:12pt;"><a name="_DV_C27"></a></font>other Indemnified Person) if the untrue statement or omission of material fact contained in the superseded prospectus was corrected in the revised prospectus, as then amended or supplemented, and the Indemnified Person was promptly advised in writing not to use the outdated, defective or incorrect prospectus prior to the use giving rise to a Violation; (C) shall not be available to the extent such Claim is based on a failure of the Indemnified Person to deliver, or cause to be delivered, if required the prospectus to the Persons asserting an untrue statement or omission or alleged untrue statement or omission at or prior to the written confirmation of the sale of Registrable Securities; and (D) shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Company, which consent shall not be unreasonably withheld, conditioned or delayed.&#160;Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the Indemnified Person and shall survive the transfer of the Registrable Securities by the Investor pursuant to <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;8</u>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M63"></a><a name="_Ref180701087"></a></font>In connection with the Initial Registration Statement, any New Registration Statement or any prospectus, each Investor, severally and not jointly, agrees to <font style="font-size:12pt;"><a name="_DV_M64"></a></font>indemnify, hold harmless and defend, the Company, each of its directors, and officers who signed<b style="font-weight:bold;"> </b>the Initial Registration Statement or signs any New Registration Statement, and each Person, if any, who controls the Company within the meaning of the Securities Act or the Exchange Act (each, an &#8220;<b style="font-weight:bold;">Indemnified Party</b>&#8221;), against any losses, claims, damages, liabilities and expense (including reasonable attorney fees) resulting from any untrue statement or alleged untrue statement or omission or alleged omission of any material fact contained in any Registration Statement or (ii) any violation or alleged violation by Investor of its obligations under this Agreement, in each case to the extent, and only to the extent, that such violation occurs in reliance upon and in conformity with information about such Investor furnished in writing by such Investor to the Company expressly for use in connection with the preparation of the Registration Statement, any New Registration Statement. In </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;">10</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">no event shall the liability of an Investor be greater in amount than the dollar amount of the proceeds (net of all expense paid by such Investor in connection with any claim relating to this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6</u> and the amount of any damages such Investor has otherwise been required to pay by reason of such <font style="font-size:12pt;"><a name="_Hlk140523780"></a></font>untrue statement or omission) received by such Investor upon the sale of the Registrable Securities included in such Registration Statement giving rise to such indemnification obligation. Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6(b)</u>, shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the such Investor, which consent shall not be unreasonably withheld, conditioned or delayed. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such Indemnified Party and shall survive the transfer of the Registrable Securities by an Investor pursuant to <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;8</u>. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M65"></a></font>Promptly after receipt by an Indemnified Person or Indemnified Party under this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6</u> of notice of the commencement of any action or proceeding (including any governmental action or proceeding) involving a Claim, such Indemnified Person or Indemnified Party shall, if a Claim in respect thereof is to be made against any indemnifying party under this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6</u>, deliver to the indemnifying party a written notice of the commencement thereof, and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control of the defense thereof with counsel mutually satisfactory to the indemnifying party and the Indemnified Person or the Indemnified Party, as the case may be, and upon such notice, the indemnifying party shall not be liable to the Indemnified Person or the Indemnified Party for any legal or other expenses subsequently incurred by the Indemnified Person or the Indemnified Party in connection with the defense thereof; <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u>, <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</u>, that an Indemnified Person or Indemnified Party (together with all other Indemnified Persons and Indemnified Parties that may be represented without conflict by one counsel) shall have the right to retain its own counsel with the reasonable fees and expenses to be paid by the indemnifying party, if, in the reasonable opinion of counsel retained by the indemnifying party, the representation by such counsel of the Indemnified Person or Indemnified Party and the indemnifying party would be inappropriate due to actual or potential differing interests between such Indemnified Person or Indemnified Party and any other party represented by such counsel in such proceeding. The Indemnified Party or Indemnified Person shall cooperate with the indemnifying party in connection with any negotiation or defense of any such action or claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably available to the Indemnified Party or Indemnified Person which relates to such action or claim.&#160;The indemnifying party shall keep the Indemnified Party or Indemnified Person fully apprised as to the status of the defense or any settlement negotiations with respect thereto.&#160;No indemnifying party shall be liable for any settlement of any action, claim or proceeding effected without its written consent, <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u>, <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</u>, that the indemnifying party shall not unreasonably withhold, delay or condition its consent.&#160;No indemnifying party shall, without the consent of the Indemnified Party or Indemnified Person, consent to entry of any judgment or enter into any settlement or other compromise unless such judgment or settlement (i) imposes no liability or obligation on, (ii) includes as an unconditional term thereof the giving of a complete, explicit and unconditional release from the party bringing such indemnified claims of all liability of the Indemnified Party or Indemnified Person in respect to or arising out of such claim or litigation in favor of, and (iii) does not include any admission of fault, culpability, wrongdoing, or wrongdoing or malfeasance by or on behalf of, the Indemnified Party or Indemnified Person.&#160;Following indemnification as provided for hereunder, the indemnifying party shall be subrogated to all rights of the Indemnified Party or Indemnified Person with respect to all third parties, firms or corporations relating to the matter for which indemnification has been made.&#160;The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action shall not relieve such indemnifying party of any liability to the Indemnified Person or Indemnified Party under this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6</u>, except to the extent that the indemnifying party is prejudiced in its ability to defend such action.</p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;">11</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:0pt;"><font style="font-size:12pt;"><a name="_DV_M66"></a></font>The indemnification required by this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6</u> shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or Indemnified Damages are incurred.&#160;Any Person receiving a payment pursuant to this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6</u> which person is later determined to not be entitled to such payment shall return such payment (including reimbursement of expenses) to the person making it.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M67"></a><a name="_DV_M61"></a></font>The indemnity agreements contained herein shall be in addition to (i) any cause of action or similar right of the Indemnified Party or Indemnified Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to pursuant to the law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:12pt 0pt 12pt 36pt;"><font style="font-size:12pt;"><a name="_DV_M68"></a><a name="_Ref179890122"></a></font><b style="font-weight:bold;">CONTRIBUTION.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M69"></a></font>To the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum contribution with respect to any amounts for which it would otherwise be liable under <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6</u> to the fullest extent permitted by law; <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u>, <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</u>, that: (i) no seller of Registrable Securities guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any seller of Registrable Securities who was not guilty of fraudulent misrepresentation; and (ii) contribution by any seller of Registrable Securities shall be limited in amount to the net amount of proceeds (net of all expenses paid by such holder in connection with any claim relating to this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;7</u> and the amount of any damages such holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission) received by such seller from the sale of such Registrable Securities giving rise to such contribution obligation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:12pt 0pt 12pt 36pt;"><font style="font-size:12pt;"><a name="_DV_M70"></a></font><b style="font-weight:bold;">ASSIGNMENT OF REGISTRATION RIGHTS.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M71"></a><a name="_DV_M79"></a></font>The Company shall not assign this Agreement or any rights or obligations hereunder (whether by operation of law or otherwise) without the prior written consent of the Investors holding a majority of the Registrable Securities then outstanding (determined as if all of the Pre-Funded Warrants then outstanding have been exercised in full without regard to any limitations on the exercise of such Pre-Funded Warrants) (voting together as a single class); <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u>, <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</u>, that in any transaction, whether by merger, reorganization, restructuring, consolidation, financing or otherwise, whereby the Company is a party and in which the Registrable Securities are converted into the equity securities of another Person, from and after the effective time of such transaction, such Person shall, by virtue of such transaction, be deemed to have assumed the obligations of the Company hereunder, the term &#8220;Company&#8221; shall be deemed to refer to such Person and the term &#8220;Registrable Securities&#8221; shall be deemed to include the securities received by the Investor in connection with such transaction unless such securities are otherwise freely tradable by the Investor after giving effect to such transaction, and the prior written consent of the Investors holding a majority of the Registrable Securities then outstanding (determined as if all of the Pre-Funded Warrants then outstanding have been exercised in full without regard to any limitations on the exercise of such Pre-Funded Warrants) shall not be required for such transaction.&#160;No Investor may assign its rights under this Agreement, other than to an affiliate of such Investor or to any other investment funds or accounts managed or advised by the investment manager who acts on behalf of the Investor, without the prior written consent of the Company. The provisions of this Agreement shall be binding upon and inure to the benefit of the Investor and its successors and permitted assigns.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:12pt 0pt 12pt 36pt;"><font style="font-size:12pt;"><a name="_DV_M72"></a><a name="_DV_M80"></a></font><b style="font-weight:bold;">AMENDMENTS AND WAIVERS.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M73"></a><a name="_DV_M81"></a></font>The provisions of this Agreement, including the provisions of this sentence, may be amended, modified or supplemented, or waived only by a written instrument executed by (a) the Company and (b) the holders of a majority of the then outstanding Registrable Securities (determined as if all of the </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;">12</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 11pt 0pt;">Pre-Funded Warrants then outstanding have been exercised in full without regard to any limitations on the exercise of such Pre-Funded Warrants) (voting together as a single class), <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u> that (i) any party may give a waiver as to itself, (ii) any amendment, modification, supplement or waiver that disproportionately and adversely affects the rights and obligations of any Investor relative to the comparable rights and obligations of the other Investors shall require the prior written consent of such adversely affected Investor or each Investor, as applicable, and (iii) any amendments to <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;6</u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </u>or to the definitions of &#8220;Filing Deadline,&#8221; &#8220;Effectiveness Deadline,&#8221; or &#8220;Registration Period&#8221; shall require the written consent of each Investor. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of one or more Investors and that does not adversely directly or indirectly affect the rights of other Investors may be given by Investors holding a majority of the Registrable Securities (determined as if all of the Pre-Funded Warrants then outstanding have been exercised in full without regard to any limitations on the exercise of such Pre-Funded Warrants) to which such waiver or consent relates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:12pt 0pt 12pt 36pt;"><font style="font-size:12pt;"><a name="_DV_M74"></a><a name="_DV_M82"></a><a name="_Ref179890298"></a></font><b style="font-weight:bold;">MISCELLANEOUS.</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-left:0pt;margin-top:10pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(a)</font><a name="_DV_M75"></a><a name="_Ref180697058"></a><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notices</u>. Any notices or other communications required or permitted to be given hereunder shall be in writing and shall be deemed to be given (a) when delivered if personally delivered to the party for whom it is intended, (b) when delivered, if sent by electronic mail during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient&#8217;s next business day, provided no rejection or undeliverable notice is received, (c) three (3) days after having been sent by certified or registered mail, return-receipt requested and postage prepaid, or (d) one (1) business day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery, with written verification of receipt:</div><div style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.37;margin-bottom:10pt;margin-left:0pt;margin-top:10pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;margin-right:36pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">i.</font>If to Parent (prior to the Closing), addressed as follows:</div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 180pt;">GlycoMimetics, Inc.<br>9708 Medical Center Drive </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 180pt;">Rockville, Maryland 20850</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 180pt;">Attention: Christian Dinneen-Long</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 180pt;">Email: cdinneen-long@glycomimetics.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 180pt;"><font style="font-size:11pt;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 144pt;">with a copy (which shall not constitute notice), prior to the Closing:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 180pt;">Sidley Austin, LLP<br>2850 Quarry Lake Drive, Suite 301<br>Baltimore, MD 21209<br><font style="white-space:pre-wrap;">Attention:  Asher Rubin</font><br><font style="white-space:pre-wrap;">Email:  arubin@sidley.com </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 180pt;"><font style="font-size:11pt;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.37;margin-bottom:10pt;margin-left:0pt;margin-top:10pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;margin-right:36pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">ii.</font>If to the Company, addressed as follows:</div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 180pt;">Crescent Biopharma, Inc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 180pt;">221 Crescent Street, Building 23, Suite 105</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 180pt;">Waltham, Massachusetts 02453</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 180pt;">Attention: General Counsel</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 180pt;">Email: barbara.bispham@crescentbiopharma.com</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 180pt;"><font style="font-size:11pt;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 144pt;">with a copy (which shall not constitute notice):</p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;">13</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 180pt;">Gibson, Dunn &amp; Crutcher LLP<br>One Embarcadero Center, Suite 2600<br>San Francisco, CA 94111<br><font style="white-space:pre-wrap;">Attention:  Ryan Murr, Branden Berns; Chris Trester</font><br><font style="white-space:pre-wrap;">Email:  rmurr@gibsondunn.com, bberns@gibsondunn.com; ctrester@gibsondunn.com</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 180pt;"><font style="font-size:11pt;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.37;margin-bottom:10pt;margin-left:0pt;text-align:justify;text-indent:72pt;"><font style="display:inline-block;margin-right:36pt;min-width:36pt;text-indent:0pt;white-space:nowrap;">iii.</font>If to any Investor, at its e-mail address or address set forth on <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</u> to the Purchase Agreement or to such e-mail address, or address as subsequently modified by written notice given in accordance with this <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">&#8206;10</u>.</div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;">Any Person may change the address to which notices and communications to it are to be addressed by notification as provided for herein.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M106"></a><a name="_DV_M119"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Waiver</u>. No failure or delay on the part of either party hereto in the exercise of any power, right or privilege under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude any other or further exercise thereof or of any other right, power or privilege.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M107"></a><a name="_DV_M120"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Governing Law; Submission to Jurisdiction; Venue; Waiver of Trial by Jury</u>. The provisions of Section 8.5 of the Purchase Agreement are incorporated by reference herein <i style="font-style:italic;">mutatis mutandis</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M108"></a><a name="_DV_M121"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Integration</u>. This Agreement and the other Transaction Agreements (including all schedules and exhibits hereto and thereto) constitute the entire agreement between the parties hereto respecting the subject matter hereof and thereof and supersedes all prior agreements, negotiations, understandings, representations and statements respecting the subject matter hereof and thereof, whether written or oral.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M109"></a><a name="_DV_M122"></a><a name="_DV_M110"></a><a name="_DV_M123"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Headings</u>. The titles, subtitles and headings in this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M111"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Counterparts</u>. This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile or pdf signature including any electronic signatures complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com shall be considered due execution and shall be binding upon the signatory thereto with the same force and effect as if the signature were an original, not a facsimile or pdf (or other electronic reproduction of a) signature.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M112"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Further Assurances</u>. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents as the other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M113"></a><a name="_DV_M126"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Contract Interpretation</u>. This Agreement is the joint product of each Investor and the Company and each provision hereof has been subject to the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><font style="font-size:12pt;"><a name="_DV_M114"></a><a name="_DV_M127"></a></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Third-Party Beneficiaries</u>. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as expressly provided in this Agreement. Nothing </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;">14</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Severability</u>. If any part or provision of this Agreement is held unenforceable or in conflict with the applicable laws or regulations of any jurisdiction, the invalid or unenforceable part or provisions shall be replaced with a provision which accomplishes, to the extent possible, the original business purpose of such part or provision in a valid and enforceable manner, and the remainder of this Agreement shall remain binding upon the parties hereto.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Non-Recourse</u>. Notwithstanding anything that may be expressed or implied in this Agreement, the Company covenants, agrees and acknowledges that no recourse under this Agreement or any documents or instruments delivered in connection with this Agreement shall be had against any current or future director, officer, employee, stockholder, general or limited partner or member of the Investors or of any affiliates or assignees thereof, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any statute, regulation or other applicable law, it being expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise be incurred by any current or future director, officer, employee, stockholder, general or limited partner or member of the Investors or of any affiliates or assignees thereof, as such for any obligation of the Investors under this Agreement or any documents or instruments delivered in connection with this Agreement for any claim based on, in respect of or by reason of such obligations or their creation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Specific Performance</u>. In addition to any and all other remedies that may be available at law in the event of any breach of this Agreement, each Investor shall be entitled to specific performance of the agreements and obligations of the Company hereunder and to such other injunction or equitable relief as may be granted by a court of competent jurisdiction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:72pt;margin:10pt 0pt 0pt 0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Cumulative Remedies</u>. The remedies provided herein are cumulative and not exclusive of any remedies provided by law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:12pt;"><a name="_DV_M128"></a><a name="_DV_M115"></a></font><i style="font-style:italic;">[Signature Page Follows]</i></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;">15</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;"><font style="font-size:12pt;"><a name="_DV_M116"></a></font><b style="font-weight:bold;">IN WITNESS WHEREOF,</b> the parties have caused this Registration Rights Agreement to be duly executed as of date first written above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 24pt 216pt;"><b style="font-weight:bold;text-transform:uppercase;">Parent</b><b style="font-weight:bold;">:</b><br><br><b style="font-weight:bold;text-transform:uppercase;">Glycomimetics, inc.</b> </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 216pt;">By: <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:204.6pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><font style="text-decoration-line:none;"><br></font>Name:<font style="text-decoration-line:none;"><br></font>Title:</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><i style="font-style:italic;">[Signature Page to Registration Rights Agreement]</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="font-size:7pt;">4857-4104-4466v.5</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;"><b style="font-weight:bold;">IN WITNESS WHEREOF,</b> the parties have caused this Registration Rights Agreement to be duly executed as of date first written above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 24pt 216pt;"><b style="font-weight:bold;">CRESCENT:</b><br><br><b style="font-weight:bold;text-transform:uppercase;">Crescent Biopharma, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 216pt;">By: <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:204.6pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><font style="text-decoration-line:none;"><br></font>Name:<font style="text-decoration-line:none;"><br></font>Title:</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><div style="height:22.5pt;left:0%;position:absolute;top:683.95pt;width:468pt;z-index:251658240;"><div style="height:21.6pt;left:0pt;padding-bottom:0.9pt;position:relative;top:0pt;width:468pt;"><div style="height:21.6pt;left:0pt;padding-bottom:0pt;position:relative;top:0pt;width:468pt;"><div style="height:100%;left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;width:100%;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div></div></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><a name="SWStart"></a><i style="font-style:italic;">[</i><i style="font-style:italic;">Signature Page to Registration Rights Agreement]</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><font style="font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-indent:72pt;margin:0pt;"><b style="font-weight:bold;">IN WITNESS WHEREOF,</b> the parties have caused this Registration Rights Agreement to be duly executed as of date first written above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 6pt 216pt;"><b style="font-weight:bold;">INVESTOR:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 24pt 216pt;"><b style="font-weight:bold;">[NAME]</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 24pt 216pt;">By: <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:204.6pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><font style="text-decoration-line:none;"><br></font>Name:<font style="text-decoration-line:none;"><br></font>Title:</p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:0pt;margin:0pt;"><font style="font-size:0pt;line-height:1.19;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><div style="height:22.5pt;left:0%;position:absolute;top:683.95pt;width:468pt;z-index:251658240;"><div style="height:21.6pt;left:0pt;padding-bottom:0.9pt;position:relative;top:0pt;width:468pt;"><div style="height:21.6pt;left:0pt;padding-bottom:0pt;position:relative;top:0pt;width:468pt;"><div style="height:100%;left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;width:100%;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div></div></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><a name="SWStart"></a><i style="font-style:italic;">[</i><i style="font-style:italic;">Signature Page to Registration Rights Agreement]</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Investor Questionnaire</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;">The undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">QUESTIONNAIRE</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:72pt;text-indent:-72pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:bold;">1.</b></font><b style="font-weight:bold;">Name.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;padding-left:72pt;text-align:justify;text-indent:-72pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="font-size:11pt;">(a)</font><font style="display:inline-block;width:23.79pt;"></font><font style="font-size:11pt;">Full Legal Name of Investor</font></p><div style="padding-left:77.4pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:85.89%;"><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;text-align:justify;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;text-align:justify;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;text-align:justify;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;padding-left:72pt;text-align:justify;text-indent:-72pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="font-size:11pt;">(b)</font><font style="display:inline-block;width:23.17pt;"></font><font style="font-size:11pt;">Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities are held:</font></p><div style="padding-left:77.4pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:85.57%;"><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;text-align:justify;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;text-align:justify;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;text-align:justify;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;padding-left:72pt;text-align:justify;text-indent:-72pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="font-size:11pt;">(c)</font><font style="display:inline-block;width:23.79pt;"></font><font style="font-size:11pt;">Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered by this Questionnaire):</font></p><div style="padding-left:77.4pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:85.57%;"><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;text-align:justify;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;text-align:justify;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;padding-left:72pt;text-align:justify;text-indent:-72pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:72pt;text-indent:-72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">2.  Address for Notices to Investor:</b></p><div style="padding-left:5.4pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;"><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;">Telephone:<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:463.2pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p></td></tr><tr><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;">E-Mail: _____________________________________________________________________</p></td></tr></table></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><div style="height:22.5pt;left:0%;position:absolute;top:683.95pt;width:468pt;z-index:251658240;"><div style="height:21.6pt;left:0pt;padding-bottom:0.9pt;position:relative;top:0pt;width:468pt;"><div style="height:21.6pt;left:0pt;padding-bottom:0pt;position:relative;top:0pt;width:468pt;"><div style="height:100%;left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;width:100%;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div></div></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><a name="SWStart"></a><i style="font-style:italic;">[</i><i style="font-style:italic;">Signature Page to Registration Rights Agreement]</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div style="padding-left:5.4pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;"><tr><td style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;">Contact Person:<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:463.2pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:72pt;text-indent:-72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">3.  Broker-Dealer Status:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;padding-left:72pt;text-align:justify;text-indent:-72pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="font-size:11pt;">(a)</font><font style="display:inline-block;width:23.79pt;"></font><font style="font-size:11pt;">Are you a broker-dealer?</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;width:144pt;"></font><font style="font-size:11pt;">Yes &#160; &#61608; </font><font style="display:inline-block;width:15.14pt;"></font><font style="font-size:11pt;">No &#160; &#61608; </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;padding-left:72pt;text-align:justify;text-indent:-72pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="font-size:11pt;">(b)</font><font style="display:inline-block;width:23.17pt;"></font><font style="font-size:11pt;">If &#8220;yes&#8221; to Section 3(a), did you receive your Registrable Securities as compensation for investment banking services to the Company?</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;width:144pt;"></font><font style="font-size:11pt;">Yes &#160; &#61608; </font><font style="display:inline-block;width:15.14pt;"></font><font style="font-size:11pt;">No &#160; &#61608; </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;padding-left:72pt;text-align:justify;text-indent:-72pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="font-size:11pt;">Note:</font><font style="display:inline-block;width:11.56pt;"></font><font style="font-size:11pt;">If &#8220;no&#8221; to Section 3(b), the SEC&#8217;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;padding-left:72pt;text-align:justify;text-indent:-72pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="font-size:11pt;">(c)</font><font style="display:inline-block;width:23.79pt;"></font><font style="font-size:11pt;">Are you an affiliate of a broker-dealer?</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;width:144pt;"></font><font style="font-size:11pt;">Yes &#160; &#61608; </font><font style="display:inline-block;width:15.14pt;"></font><font style="font-size:11pt;">No &#160; &#61608; </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;padding-left:72pt;text-align:justify;text-indent:-72pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="font-size:11pt;">(d)</font><font style="display:inline-block;width:23.17pt;"></font><font style="font-size:11pt;">If you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 36pt;"><font style="display:inline-block;width:144pt;"></font><font style="font-size:11pt;">Yes &#160; &#61608; </font><font style="display:inline-block;width:15.14pt;"></font><font style="font-size:11pt;">No &#160; &#61608; </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;padding-left:72pt;text-align:justify;text-indent:-72pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="font-size:11pt;">Note:</font><font style="display:inline-block;width:11.56pt;"></font><font style="font-size:11pt;">If &#8220;no&#8221; to Section 3(d), the SEC&#8217;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:72pt;text-indent:-72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">4.  Beneficial Ownership of Securities of the Company Owned by the Investor.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 36pt;"><i style="font-style:italic;">Except as set forth below in this Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than the securities issuable pursuant to the Purchase Agreement.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;padding-left:72pt;text-align:justify;text-indent:-72pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="font-size:11pt;">(a)</font><font style="display:inline-block;width:23.79pt;"></font><font style="font-size:11pt;">Type and Amount of other securities beneficially owned by the Investor:</font></p><div style="padding-left:77.4pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:84.61%;"><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><div style="height:22.5pt;left:0%;position:absolute;top:683.95pt;width:468pt;z-index:251658240;"><div style="height:21.6pt;left:0pt;padding-bottom:0.9pt;position:relative;top:0pt;width:468pt;"><div style="height:21.6pt;left:0pt;padding-bottom:0pt;position:relative;top:0pt;width:468pt;"><div style="height:100%;left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;width:100%;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div></div></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><a name="SWStart"></a><i style="font-style:italic;">[</i><i style="font-style:italic;">Signature Page to Registration Rights Agreement]</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-left:72pt;text-indent:-72pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;">5.  Relationships with the Company:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 36pt;"><i style="font-style:italic;">Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;padding-left:72pt;text-indent:-72pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font><font style="font-size:11pt;">State any exceptions here:</font></p><div style="padding-left:41.4pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:92.3%;"><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:100%;border-top:1px solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The undersigned agrees to promptly notify the Company of any material inaccuracies or changes in the information provided herein that may occur subsequent to the date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall not be required to notify the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">By signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and the inclusion of such information in the Registration Statement and the related prospectus and any amendments or supplements thereto. The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the related prospectus and any amendments or supplements thereto.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">IN WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized agent.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt;">Date: <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:153.43pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><font style="display:inline-block;width:36pt;"></font>Beneficial Owner: <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:162.31pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:11pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;width:180pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="font-size:11pt;">By:</font><font style="display:inline-block;width:2.11pt;"></font><u style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:228pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;width:180pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:18pt;"></font><font style="font-size:11pt;">Name:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;width:180pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:18pt;"></font><font style="font-size:11pt;">Title:</font><font style="display:inline-block;width:204.17pt;"></font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-size:11pt;font-weight:bold;line-height:1.19;margin-bottom:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.37;text-align:justify;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">PLEASE EMAIL A .PDF COPY OF THE COMPLETED AND EXECUTED QUESTIONNAIRE TO: &#160;</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;line-height:1.19;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="display:none;font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:0pt;text-align:justify;margin:0pt 0pt 12pt 36pt;"><font style="font-size:0pt;line-height:1.19;margin-left:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><div style="height:22.5pt;left:0%;position:absolute;top:683.95pt;width:468pt;z-index:251658240;"><div style="height:21.6pt;left:0pt;padding-bottom:0.9pt;position:relative;top:0pt;width:468pt;"><div style="height:21.6pt;left:0pt;padding-bottom:0pt;position:relative;top:0pt;width:468pt;"><div style="height:100%;left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;width:100%;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div></div></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><a name="SWStart"></a><i style="font-style:italic;">[</i><i style="font-style:italic;">Signature Page to Registration Rights Agreement]</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;line-height:1.19;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;padding-left:36pt;text-align:center;text-indent:-36pt;"><font style="font-size:11pt;white-space:nowrap;">EXHIBIT D</font><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font><font style="font-size:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;line-height:1.19;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-transform:uppercase;">Investor Representation Letter</b><b style="font-weight:bold;text-transform:uppercase;"><br></b><font style="text-transform:uppercase;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">___________, 20 <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">_</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Crescent Biopharma, Inc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">Gibson, Dunn &amp; Crutcher LLP<br>One Embarcadero Center, Suite 2600<br>San Francisco, CA 94111</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">To Whom It May Concern:</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 36pt;">The undersigned (the &#8220;<b style="font-weight:bold;">Holder</b>&#8221;) hereby requests that the federal securities law restrictive legend be removed from the book entries representing _________ of shares (the &#8220;<b style="font-weight:bold;">Shares</b>&#8221;) of common stock, par value $0.0001 per share (the &#8220;<b style="font-weight:bold;">Common Stock</b>&#8221;) of Crescent Biopharma, Inc. (the &#8220;<b style="font-weight:bold;">Company</b>&#8221;). In connection with the legend removal, Holder hereby represents to, and agrees with, you as follows:</p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:11pt;">1.</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:11pt;">The</font><font style="font-size:11pt;"> Shares are owned of record and beneficially by Holder.</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:11pt;">2.</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:11pt;">Holder agrees that, if the Shares are not eligible to be sold pursuant to Rule 144 promulgated under the Securities Act of 1933, as amended (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Securities Act</b><font style="font-size:11pt;">&#8221;), any offer, sale or transfer of, or other transaction involving, the Shares will only be made (i) pursuant to the Company&#8217;s Registration Statement (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Registration Statement</b><font style="font-size:11pt;">&#8221;) filed pursuant to the Securities Act, in a transaction contemplated in the &#8220;</font><b style="font-size:11pt;font-weight:bold;">Plan of Distribution</b><font style="font-size:11pt;">&#8221; section of the prospectus included in the Registration Statement and in accordance with the terms and conditions set forth in the Registration Rights Agreement, dated [__], 2025, by and among </font><font style="font-size:11pt;">Crescent Biopharma, Inc. </font><font style="font-size:11pt;">and the investors named therein (the &#8220;</font><b style="font-size:11pt;font-weight:bold;">RRA</b><font style="font-size:11pt;">&#8221;), including, but not limited to, the restrictions upon sales that may be imposed as set forth in the RRA or (ii) to an exemption from the registration requirements of the Securities Act other than Rule 144 subject to receipt of a legal opinion from Gibson, Dunn &amp; Crutcher LLP or other counsel acceptable to the Company that such offer, sale or transfer is exempt from the registration requirements of the Securities Act;</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:11pt;">3.</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:11pt;">Holder agrees that it will (i) not offer and sell, or cause or permit to be offered or sold, any Shares in violation of federal and state securities laws, including, without limitation, prospectus delivery requirements of the Securities Act (unless exempt therefrom) and (ii) promptly stop selling or transferring Shares </font><font style="font-size:11pt;">pursuant</font><font style="font-size:11pt;"> to the Registration Statement upon receipt of written notice pursuant to the RRA from the Company that the Registration Statement may not be used to effect offers, sales or other transfers of the Shares; and</font></p></td></tr></table><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:11pt;">4.</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:11pt;">Holder (or, in the case of individuals, Holder&#8217;s employer) has in place internal policies and </font><font style="font-size:11pt;">procedures reasonably designed to monitor and ensure that no offer, sale or transfer of, or other transaction involving, the Shares is made in violation of the foregoing restrictions, and Holder will monitor all transactions involving the Shares for the purpose of ensuring that they comply with all federal and state securities laws.</font></p></td></tr></table></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><div style="height:22.5pt;left:0%;position:absolute;top:683.95pt;width:468pt;z-index:251658240;"><div style="height:21.6pt;left:0pt;padding-bottom:0.9pt;position:relative;top:0pt;width:468pt;"><div style="height:21.6pt;left:0pt;padding-bottom:0pt;position:relative;top:0pt;width:468pt;"><div style="height:100%;left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;width:100%;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div></div></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><a name="SWStart"></a><i style="font-style:italic;">[</i><i style="font-style:italic;">Signature Page to Registration Rights Agreement]</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:36pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:11pt;">5.</font></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;"><font style="font-size:11pt;">Holder is familiar with the requirements for effecting resales or transfers of, or other transactions involving, the Shares in compliance with federal and state securities laws and acknowledges and agrees that the Company and Gibson, Dunn &amp; Crutcher LLP are relying</font><font style="font-size:11pt;white-space:pre-wrap;"> on Holder&#8217;s representations and agreements in this letter.  </font></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 180pt;">Very truly yours,</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 180pt;">[HOLDER]</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;letter-spacing:-0.1pt;line-height:1.19;margin:0pt 0pt 12pt 180pt;"><font style="letter-spacing:0pt;white-space:pre-wrap;">By:  </font><u style="letter-spacing:0pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:230.61pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><font style="letter-spacing:0pt;"><br></font><font style="letter-spacing:0pt;">Name:</font><font style="letter-spacing:0pt;"><br></font><font style="letter-spacing:0pt;">Title:</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><div style="height:22.5pt;left:0%;position:absolute;top:683.95pt;width:468pt;z-index:251658240;"><div style="height:21.6pt;left:0pt;padding-bottom:0.9pt;position:relative;top:0pt;width:468pt;"><div style="height:21.6pt;left:0pt;padding-bottom:0pt;position:relative;top:0pt;width:468pt;"><div style="height:100%;left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;width:100%;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></div></div></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><a name="SWStart"></a><i style="font-style:italic;">[</i><i style="font-style:italic;">Signature Page to Registration Rights Agreement]</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>glyc-20250214.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.9.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 2/14/2025 9:06:04 PM-->
<!--Modified on: 2/14/2025 9:06:04 PM-->
<xsd:schema targetNamespace="http://www.glycomimetics.com/20250214" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:srt-roles="http://fasb.org/srt-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:attributeFormDefault="unqualified" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:glyc="http://www.glycomimetics.com/20250214" xmlns:snj="http://xbrl.sec.gov/snj/2024" xmlns:us-gaap-ebp="http://fasb.org/us-gaap-ebp/2024" xmlns:rxp="http://xbrl.sec.gov/rxp/2024q3" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:cyd-8k-sub="http://xbrl.sec.gov/cyd-8k-sub/2024" xmlns:cyd-af-sub="http://xbrl.sec.gov/cyd-af-sub/2024">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="glyc-20250214_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="glyc-20250214_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
  <xsd:element name="DocumentAndEntityInformationAbstract" id="glyc_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>glyc-20250214_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.9.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 2/14/2025 9:06:04 PM-->
<!--Modified on: 2/14/2025 9:06:04 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="glyc-20250214.xsd#glyc_DocumentAndEntityInformationAbstract" xlink:label="glyc_DocumentAndEntityInformationAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="glyc_DocumentAndEntityInformationAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="glyc_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, State or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>glyc-20250214_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.9.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 2/14/2025 9:06:04 PM-->
<!--Modified on: 2/14/2025 9:06:04 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <roleRef xlink:type="simple" xlink:href="glyc-20250214.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="glyc-20250214.xsd#glyc_DocumentAndEntityInformationAbstract" xlink:label="glyc_DocumentAndEntityInformationAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638751639641366904" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType_638751639641366904" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638751639641366904" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate_638751639641366904" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638751639641366904" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFileNumber_638751639641366904" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638751639641366904" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName_638751639641366904" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638751639641366904" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638751639641366904" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638751639641376924" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638751639641376924" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638751639641376924" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressAddressLine1_638751639641376924" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638751639641376924" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressCityOrTown_638751639641376924" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638751639641376924" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressStateOrProvince_638751639641376924" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638751639641376924" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityAddressPostalZipCode_638751639641376924" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638751639641376924" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_CityAreaCode_638751639641376924" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638751639641376924" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_LocalPhoneNumber_638751639641376924" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_638751639641376924" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_WrittenCommunications_638751639641376924" order="13" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_638751639641376924" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_SolicitingMaterial_638751639641376924" order="14" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_638751639641376924" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_PreCommencementTenderOffer_638751639641376924" order="15" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_638751639641386947" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_638751639641386947" order="16" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638751639641386947" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_Security12bTitle_638751639641386947" order="17" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638751639641386947" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_TradingSymbol_638751639641386947" order="18" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638751639641386947" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_SecurityExchangeName_638751639641386947" order="19" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638751639641386947" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638751639641386947" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638751639641386947" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey_638751639641386947" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638751639641386947" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="glyc_DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag_638751639641386947" order="22" use="optional" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45617729602976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 14, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_glyc_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 14,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GlycoMimetics, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">06-1686563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">P.O. Box 65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Monrovia<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">21770<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">243-1201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GLYC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001253689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_glyc_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">glyc_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>glyc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( &6$3EH'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " !EA$Y:X$_AW^\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M3L,P#(9?!>7>.DD9AZCK96BG(2$Q"<0M2KPMHFFCQ*C=VY.6K1."!^ 8^\_G
MSY)K$Y3I(S['/F DA^EN]&V7E EK=B(*"B"9$WJ=RISH<O/01Z\I/^,1@C8?
M^H@@.7\ CZ2M)@T3L @+D36U-<I$U-3'"]Z:!1\^8SO#K %LT6-'"40I@#73
MQ' >VQIN@ E&&'WZ+J!=B'/U3^S< 79)CLDMJ6$8RJ&:<WD' 6]/NY=YW<)U
MB71G,/]*3M$YX)I=)[]6F\?]EC62RU7!92'N]U*H:J4$?Y]<?_C=A'UOW<']
M8^.K8%/#K[MHO@!02P,$%     @ 981.6IE<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%
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M?^:+X3]>?P%02P$"% ,4    " !EA$Y:!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( &6$3EK@3^'?
M[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( &6$3EJ97)PC$ 8  )PG   3              "  <T!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 981.6J=?Q!U!!   G!
M !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( &6$3EJ?H!OPL0(  .(,   -              "  84,  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ 981.6I>*NQS     $P(   L
M         ( !80\  %]R96QS+RYR96QS4$L! A0#%     @ 981.6APX9>H_
M 0  / (   \              ( !2A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( &6$3EHD'INBK0   /@!   :              "  ;81  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( &6$3EIED'F2&0$
M ,\#   3              "  9L2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     )  D /@(  .43      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="glyc-20250214x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>glyc-20250214.xsd</File>
    <File>glyc-20250214_lab.xml</File>
    <File>glyc-20250214_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="glyc-20250214x8k.htm">glyc-20250214x8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "glyc-20250214x8k.htm": {
   "nsprefix": "glyc",
   "nsuri": "http://www.glycomimetics.com/20250214",
   "dts": {
    "schema": {
     "local": [
      "glyc-20250214.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "glyc-20250214_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "glyc-20250214_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "glyc-20250214x8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation",
     "longName": "00090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "glyc-20250214x8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "glyc-20250214x8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "glyc_DocumentAndEntityInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.glycomimetics.com/20250214",
     "localname": "DocumentAndEntityInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.glycomimetics.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001558370-25-001016-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-25-001016-xbrl.zip
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M(%%^$3T^W1M9G\"2+)[:UU8C,+_MSA/86EA[HVW3SX'K&>UQ%/*0:2*L6.:
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M,/0N_)()-9Y8T->BXDN33M%'.7TOU*WTX:K<6@K"WF%Y"8$$,+VAOU^D, 8
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M0O[SJE'3HA43[1&;D/FL+,&I!Q32IPZ?]JRY^0(TO8E=^A_:ZW^N+P!G?CN
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M5H]Y;^7O9Y6C2K-!3BKG8LB3ZWJUTCB#"P"^? MS(,5ZF33KU\VSD^MS; (
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M=.;!-T C^"-77U%RA;[48 =CGP%^ 6]HD"B+U],I4*MZ N:T;J-4X+P&K'<
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MM4-P:(]8)+K,(V<9KF')8RK.P+U^X-.NG47C9:8$U5G@7DTV#U=12$^+$99
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M^=YM,&+QP5>"",U#U E#L!091(FHHC"3"!ZZ\'/01BG4*9^1(68,3+E4C2G
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M&#+,3S$)1GF1TI^@\HY4EM&_4=4%(P<Z% PQ+6%*<6",JP;IC>+'@S&=!_S
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MQ%S46/&=&UF/$Z1;G?B$UD?K/S9%*$N=Q@X]$I!>2Z8&JTXO=*-??3_'P0.
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M9-VKU$H:Z$SFWXLDU_9U5JK_'/;V.>C .:(48X 53^W#S,1DU6FJ0>;J\*D
M%Q6XGJ%E MLK?S$2R@<>CJQ<9Y>GQQY3@YCX2+.IUK).6QRX$C%T5XU\@/2[
M$=O$-IA> ]!;IE\/Z*LQ<S7(0G2IC*NS6W/ &H*1*A<C-RI=6PJ-X&IF2J@>
M2_982;RE.#]9FHFL5BO;]KX\\@'[HW -^EIURBH:4R;V?>:;>1.+V/0Y:\Z$
MLC]95_%"C8M[V5BFJ!HAFR/9K:0QP$3A6K?V:75S6ANWA':9-_*_E3:+>;E<
M,TY\ACW29,7,04S *;K9]UCB-?5XC8KH8)@>KMPPK:4<E\1,^RMF$'E#_D(*
M;ALVH@Y&:C<V,?;]7)&0TJ^Q2(\J#B5]KL"9&R:P^LF;? ([D)BE=_J^M[VU
MO2O;7QS>040G4':M5(ZT.H'0[-0?^ZI<%,VCUIF3@J)UB^X)NE*='@61$T&[
MUU.H3[<F]EXJDA(;IO.\/%BQT"0?*ANEQ!'&7>%8DEJ:1/>!!+)TQ)BI93<=
MG!%IM-!Y8>U?FSOK0VO"-7"G0^J4D;\/8Q'CDD:/G<>9T<SF*K6<'*!/7'N3
M*+G+*BM-D()(I\PL3M0F=+4!X. $("UL'->DQ.A'.54V-.[Q2^WM8'#^@*6U
M4<((2Q9G.&2U;A1*)F#%QUK$03&F3VO:J:23<>$#F7FBJ^QOO?BGM<JX87F_
MT126MTP*'NH*DJ\,4Y/DV-W,I/1;Q5/9PI"%#JH952Y<@$WU @O%!V,\:V;,
MSDB[1RM.0GR JY"4)TTATC)"\+]@TTY-:?;69;(T=;-)1HCBY1SE%D>9F]>I
MDS5A%15$M\"8%L90AJ(SX4J38))5648F@4/]"&XQ;4CG.%"4<O"#EX!F<_'M
MX:)%/P^R'/J,A@R:"W#;2)5=UZ1FC=_+T9V>W6TA8C%D+FC1X"(7U53JVY==
M;6J7ZSB'9'IQ)>=8F!TD8?W^:  I<L@0@VH;J:R/)T1:!PBZZ&%'*]?#ME><
M50IGI0 'CLF4?DAVN#ZSW"R/&AZAD0X!B\(46<;F5*RF8'-9!Z.#)]":E0'/
MNYDVU>S+>@.ES40N[4IKI>RHIH_C!8(IO21_2%40EE16#J-:$D>+#C)-CT1J
M&W!Q4BHCSB>0DYD$$(HDQWY_14X5^TEQBDBEIO)G! 8$[)FAZ,J4Q\O$6"O6
MJ@F<FMBMY6/B0#L;@28 ;\6;39*1TW/)G,]*#AE<!V XEF4'[F<KY0*1Z$W1
MPV>U5Y9J4+=R".$\&?V-HNN&+<_TY^M(W;70[42?N;5RJ;MB>F%+ZKZ'E3E]
M2$X_42OA=@\$3I(58>Y;N2J@\Z;#4!Q1/D(5PAG*3-Q6!C#$!;E\-OM R17H
M#VI 8!XIS>;H5S Y1C3>P'R"VC@E/RC5'$%O4E.&41V3\0!]Z"MM3-3%4B;F
M95XCZA>[\.[2D)4W#=#)2MQ.QF[]$94%MRE$VF$Z5DRA1%(%E&%DIVR5M;I:
MAZED&?G**N%#X5 ?1:NUNQLW5&^,2P/"+(]:0AH^I-D-R$)@SH-[D3PP0^1W
M)?5?EDJ$1@"L/&^CO]4CHRLSYP[;+?HTDOD*-*OC;1+=<G4$VAYXO0KVT^;!
M0NP!C9I"[JA&3[R=N%;Y%#)&7!R;]6:,"W+FZ 2VPXCN&!?YX@$M;JXC\D^*
MR/?7$?EU1/['C,BOM<P6+7.5+.W;1_O]_:/M:HS%TD!7'&,YKB3GO _N7GGG
MY$[MY &P64N7HF\KG*1TA.,9+34[V8.HH_[V,9Q5(@2)KP'7F8&89Q:\//,E
MYN "S/71[^ ^$.WA/TQ[,PY,='K8G7R0<^\Q%-#+5+JK:Y?3H%HJ2!K0S%]H
MAPMN'X:+O>?H7"W3*-CJEEJ'3M"[&JUZ0OC G@J'UNPA 2M*'&-.>M;,?-'+
M4'=+0 >QI[49^(-0?&1FT+<0",C4>";O-!,8UBBW3!Q'[X'2^U/G_ZA-"OJ.
M3./&BU2AV[<A#5@8+*%L4^M!^O8E8UGC' ^SZFI[R%+KMN-K6QO-*U+1NQF3
M(*VBGLZG8?(&75PL5;?)R&3$&*\6E\T>!;:#YYZA\;OOVG!2MR/ ()@$MPE7
M/ 4)2WE*)'W$Q3AA(X\-V Z&FYUALG8M/>G07Q&7NW6P[S4!*PZWMO9WMU>=
M='@&=A&)<%CPWKDDTSP*_F^4G(.M3F6)[SVGJ*Q*(@P5DC,..Z/ .)H3HD<_
M5BQNFGE  4$+)&A^1%QE&HP5+-8;_6_J/"H/*KU%\5+Y4VX=)?.%X9^EQS)T
M .&?**>\:_A_*YFJB/F%G&6(F$7]"XD'+JZH<K+Z*3</;'S\ /H4BI.(%V^1
MY6JF'>HC-0:Y+XE7?!J']N3I3"@[%C+D1$3#QX.0092#C0^"W,I&:3@L8YIZ
M>LZM5 R?3\.PPCI),U5DY;-RALGQX.;GZ9.Q7GOE\1I$RT+NJCM43EH"^I0G
M+2U%?=Q2[B5I3KH*8L.;[9/6=W6[+F?,T]2_YAYU44/<N,D8G9X:0R.J\83\
MPXIVF5,719?_82XJ6O06TY3/=5,2SO9$9",H6:9.=NOI_U+S )3,\PZG/S99
M%1#X<8TC8.\,:(AX-WQ3XX V!:*#V*<H :-X5,R&*1D3KQP. >-SARV+  \3
M-W/[)]I'8W]0@:JX[,V+;9ZI3'O?_8[N]S"S// PA(,>.O?A_?%41TBK3TO:
MI;T8Y)H>V3#6B<-MW_/*VWA=?Q.M![:67'8M=%F"9%5+Q^@583..>RCQU=20
MKS5HG!*$=$L"R=S E,["S*IK:\TQ 6LDSYRK ["LMDX+^[!PSPKK;'"/!F<F
MC;@O*U/0-8.Q]TVI(8:)_ @6)'-Y""]:.SZ0X'J::X<^L4PMMX','$UNEZ4D
MD<10'3=XO]N70'/O!(]WSUZB9SD!PN($354K#/I^D>:[XLQT;*PF-&IAK+^%
M0%VLNI .4%=M1*"5IVZ+G.DVHT0-*IX!4QT85)"Y+D.=4]P,8> $@N-4@HF:
M%F"2R2G?W(&UI=+)4EEA98K^SF$?#))&LGN\UM\^.&B[!L\U5JN2YPZ7/-?H
M#I7G&DGZY+G&8I?\7#-AOSRWN^2Y)16WME=<L>,41&VR4,I[S40=#ZS741X*
M+KE %-Y@IDXW=X//TEMZ@ B<V$+T9&C;A-FU+G(UABU 13KD@&@C%-4HWRHS
M%)US);3<J@$$@O'TXNQRH%&H8Y:HWCD,',K'<Y93&GHVP.KF8VKD&$7N@&V2
M[:W^%A>Q9SX8WW9REN]EUW(C<+V#5)6#HL9Z!1+6>D?%5XDML;-RR<LM/YBB
MM<%)4)8_VK)@2'P+F-^X,BLJ B^%+BI'-P7"J,=1,$3 ! A-XG]!6I,;3D)*
MTALL8S#'L%L;3*0VI TXE'9@@05#8?4"8=RDYD^P@V:AE?@[-$3#AGK>375/
M[_VFNG/U:X[R.KS_I/#^]CJ\OP[OK\/[STI_7E&Q*$M/7'%!J*O@2S>T?C>#
MD-. 4%UIT%%T(66L"SU3'KS:NU!YD<9VO-C^U<YT+N'M_(X:'RW6\\2T/LKG
MRR1VZ7 -ZWQE=HC31:;BA>[2.+2\D&YBN/S,T9@X!4E0[:D2$FW*?<\DT8?*
M0X-6A4I<F43&.H'E+L9O8AW!_GXRX1?F=_5 7K#'^W/0RTBNZYDD.%;9 =QT
M08UJS*'OJ?3=*/J40MZ@K/&28@@Q^E9&HQ2^1>NM1/V<Z6)7PR2YJ47%P]C@
M.L0?* N+DB(M#D?L5@G$U*HN(SU1W<+\/1S$L6+Z1,7Y>=#OWPM<NS!@,TS#
MY6Q-/2R"$;%_H*;'G"9 H1GJ#KZ^RTO-TG(34\VW<7]&HI';;KO[ [\THYBN
M2 [$0'-$9HW^XQIHQLT "6:8"$K3P8NR$UHA558A1>(I2&"A<G"DW&HXFFG.
ME +H!DTD/H0  $TOA=F+97HN+6[*2H5=BJ[6G(BC!>,[3H.[6)L7XC\3]FS'
M::8342;U%5J"CG.2%#F=F9SO8W)[K'(YO/HP?[%@.PKW'CEJ(W@+EYFGNO+V
M$L7U\7GS<M-L)6OMS(L4QP',QV48ZB9/9MFGRH:%96M%\9!(FP57V2$+(#U3
M02QP=;2=/4U==GATL#'J;6SW0+JFVG<O.>XFDQ0GK^FI?F]CT,/(R-K3UTU3
M664)#(S1[S5[^D2+63$+X6E\&Z:)ANF\#^Z^CDJSH=E;V]PR\F#5/<-ZCK_<
M3]/@H'&!^O/2+05;[[J8H?L,-JZH$NA'SX7P097?S_+TCR =)T7&\;<OX8@$
M9DY!21*-0481K7D2144>R&%&J>IX-.#?3\CL;YJ-[E'U#<.9RU%:@P/#4@T,
M-K34Q670M4HNMC5#]1ZRPXL!"$XBIN%E7;X2\& PWDF3*Y@Y6#+NO2$]]IB:
M2N@4Z]ZB.(FKKZGWV[>U2!FK\L,-.%/C-<OC7K^9?K+:$*]?)1)7_RKKBRKM
MERU_,VWUP:!"/K[_'L0%7A(J%=_!&I9TW#Q@,#"S(M88P0U+*;'CPCW?U(<B
M;&G01KYLVCV';S$@&8I9Z\K1]\*BF42A42S55HI'A5,Z.$ M36D4IJ-BIN6&
MJ68->IS.BFUPC3;@!-R>FRO=^BTK95* 7:&:]DG#XOT:(>WE(\4P$QPCAM(2
MZ,#2@YC(30@QC*8%<M>+%!58$GF;(IAI7$G&[E6?Z_#,G[[B[>.IY-"^$_XO
MZ6' 5A)]?;500*=]X7?9&#3MUL#S:&%?4DT8^)A]8S#Y@CJNKT5[#%@ ZH%P
MBH6X1">EY53-!FQ\R5HA[J80K[SZQ_:*@;A76"*I4UBWI:1HH[U(#BMFH$QO
M%.-/J1B3KL4TIVUIVX\L!&"[A[F!>I8$%,FRU :_J<)5%&FDG0VF\[CX*T->
M*D2CXX3VM'XI\E8Q^Y? R8J2S<?9L0W/42B:CH*H,?)7$'GGF/ML7!1LYC-;
M8O5%=3E='?@F:M!-;T#I"O9 4^YW$4;LI+E6D59M2?IV>!'.C/48 >U\L@V$
MRI1\E%:U3VI8_$%<[_*+>#PH 46'A4O?T+<:5'<H'CO$M@4X3H3""9:SI(I8
M8[^6RMVD\LJ+)>QLK58JG\59D3ZD$*=>?Z,@3:7^3)@Y%?!(?@J,A_Q\^A6H
MQ+ (%)<LFVFPT8C:%:^D87:3&:E<$@=/2)>$-Z>D'&=A7I#>0[_%FBD:Z[%I
M+S@^L480/ E!L+-&$*P1!#\F@N!'I>RO)!9IYV%;YH*59Z2)PXSZ>-^S%H79
M1L4NYHBSE!5C)4MT<DFNT@)]#J?(2!2U-L"XZ9G%LN9:LUWQ]3FS<VYZGW)3
M,[8\(I!Z%'I(7>+L^HE!D9,-7W:;SR[,3FAQ,]2MXKPI>;_=]V#G\ :,%4?#
M/\E J$62]%.M=R>914Y2;V6H%X;(,U63(N-603;BJ!EZ)CAN@BEY*#$J;9K3
MJ1D8!?Y-.9772K8\HN<IK?WJZ]<\YUV4RCK1^;?3YRZD"O5#,ES7-L+2Z:SS
MI:ZG\\>=SNT5$3%B9'KGZ&AK;[^>+6^9@RLF:3R&>]!4\4Z(PY]*R)K:EB5_
MSF.S,YY$!V%298G;5G<4L6MB29J?\.',3GC(\F*,:DJ1Z1SQ^3Q)<\\JW*G#
M@/<D;)LY.[JYV/GU*MW>V=D].-K:/RI^B^YD[AX0>Y:./8 "QH#VA(:W&K98
MGALOXV"2).R,>%\'(RS^_A(L" J'2@5K&,:NBN2FS]]Q?OF8B$1@NY,3-M8L
MG:KV!:WJ7T-:C08:)#!)F6^Q!A@<4PH7\+- VNA4'9I918!.5F#U,'#Q=O05
M(L<EYOC-U)B6$"$61IAN@UHDJ5)!R@X]>>$KUL-(,>91G-O<.-88.J]$%P55
M@LPU\ _VE,J7*,'U$@[L&:0J&["K22<MB8'D17Y-[6Y'P<:)&S<LZ83+]=*Z
M*IQZ1B6Q<<O<V86Q/%U9 ,%C#M-])7=YQ$4@X!6_%\CGFLCRTSTJ%S$IM_8Z
M;5VFKQ@ET7&$V-FK,V7M DBFJ%"91VOP!$$FGMMRF&2WOCD9$(Z!0HMFM&U$
MW3W$3AJ;[/YZDA936V /A/')<H75Y-?^_N[!X?D_^H=_;)V<[ORQEZ6__<_A
MR9?CF__9.7C=A>;D+(8IR0L!D5ZHVQ!TB]<)[*9.Q6DDZPZ&&:6"0[B W^8-
MPV1^'8!Y/%(%>=%P#Z+DJ%%KX, ^'@54';:'267-D56QW;5]CJOMMN?%CP!$
M-IJ=3"E'-6"R>8(Z#_R*JXDCY+4E( O01/O+LNO,JPJB)M:%Y]$2G<VY$!<9
ME/I81=REQJ'6SMK''CL/V;$4M+[MNF?994&<97(0E#1B=5C4/36 7,0<92S:
MQ<]9%AAOB)P!#4MJ'9?IIJ2OB,?24L1KB=2&TFKE]2NJ/);O&&5)V;]?#4SZ
MF"U2[4@E-<#:02VT%!HDX\ 9C?*%85<J-*%/@$VL?V0 Y_7"&T^A6ZH/:L?#
M@ #H66FLO!&(_)LD 948CVC6S8Z3;*9 G),JM+'=I^/_>-,@SW>V^IZ"MZG?
M-WM&F3LOAC"$>J OA:B%6MC=KK:P;;5@5^<JI18,Y*R(IF5M$%J"HMHNS>+V
M12VQ$Z4$[3O"(9ND02'J]Q#GC5.]S2GAF]0(.B:"4JE;IJCL#=X?;R_^^?XF
MCM4T#6?][8^?.E&Q#4"/?_&/<'2#41?**BARU:UV7L.X]G>VMX(7!\.-8:^G
M]<AW9^>#@9UOKU4]F:JSDO?,NU*CZQC$P93CFJ>@-"0SF%5:%?I@E>=:IK9_
M<+1=3JZH%T\G":ATFF[%QT]ANW'?+T HP4D6<>$:NYU7YFP^+3"T$,28Q8'8
MTR= LS\_0 =;NG*.SX_G6?[;:#:]WHG30?JOXO6[Q<';X[,NR\=,RA5I._I@
M#[%^1:<U5#[@;9Q^[GD?DTUO;V?_)QBW79R]6Y$5RSYA_^3BR^L/X1][L]O=
MK?TNW3[]_.">EI$+B6CD"]O(IKPP&[7.AG(Q1T&D%4BRH</8UM3Q.<X(P/MO
M,8>,2P2A:*!0D:;7X (%9@5]X+:PNC(KLNY0'O-0'FSC4&[)4%*9,\1W$P#W
M]T*HC#D!@472: 3ZIH@=MY1C#7O?+/8L$XR2(TK^9=3VA@FJN]P9$:1LX='#
MIBG3-*OB=*68IX'^TQ&NPI512;HHA7D#HKP!5$2PSR^]I0>!4W^970I,/,UC
MA^D!VC2-03<AJY6*+:H42>'*,-UC\K^,N:-1OMTI=$OK2$P4J@'37C$&CJN4
M_B$(,M88*C5CK+(R5C(""U9COAM2[37@Y$F D]TUX&0-.%D#3KXEX$3+MR2M
M\<6[9YJ3"E12@"XJO)5$+\G'ODT8GVKF(0W_,%:D4X((GZX9D7%G3E"3NO;G
MR_Z2>>E!7!,EN2#[OK)B*,5\*Z8UAJ?@P!XGHT(JK:+]@&4CN6R$7V& 3M%9
M,,ZD]%GF<\M<:U(K:?.HK 9+"K^P/6:.?[II#GR3-\HHS6_9/0HGF3")J&\<
M0!&Z!2I_RS0;K3X*I-J0EG3A;!I^_=:&0MIE%WL/UV5P-<H&$4("G:ZN"%$^
MI:U4<F["PDA VT[(1VO_C*$1[(U49-.4 >+RYW)N^"5@1D=!:K-XZB0A\N:6
M<]MECV]Z \,+@:[U!L>UW_KIUK#D56)L)3Q_V&DN@H:K2$JC90[][Y)R:E01
MT^+F^\(<H;YXLL<\N6,U#,BO3'H:\16/PCEO9^$@=3@,;/<%T3T$,\_8+<;A
M;;Q1G;IJ%0?%9> .OI0>K,D=6U 9N6,F6,N? (MU=ZVQ0&/!0J[T]E/K-'CX
MUQK;U<4QO<):"\SP>;"$X?.HE:44GFM$G<ASK2RE\-S^DN=:64KAN58V57BN
M]1O@N58V57BN]1O@N58V5>2#:'^NG4T5GFO\!@D0[*TV"# 8D<V-Q\6QACW@
MX7C"(7C,,'9^/S=>G(>&![3&@B<:5VS@K XX8F-=83F).%H[,47B64? [FU@
MQIN:D,H#HNB"Z#[[.\&+_M[&A%W;_;VQ_"4"U,8)]$P^B(%U<$[O;3BVV%Z)
M%4?0JJ4;BQT=928K%9RL]U$[Q^<I%D<R^FAY:V9JWI,S"R,:]/4F^-  >'@[
M&)S;D5$3'Y2T,>U5RPH\"LEM>]^'<5"ADFQ?3I"H63)@L=W&6,$MD=&=),U-
M@"6IFD0Z_["J8CLEN2EA#J2KF$!,&"$X<<DGQLXYCQ!,!/O%3$)E50W\6&)D
MZ#3LK0.L@1R!8+3G IK!DQ I(!@>E.K4/*E47FVK4O@+_9A!'$S= NX$:\!K
M)UIE$9?:;<]:<T(X(&8#)I<+<98!75,28:Q?B>."]39X3'V.<Z7V.%?T"C,W
MP@-E*0/"$V 48,'@NX5WS?-- [WI79KB\(*I;WITEF0\WC@\2-6%BA;('F@+
M6<,T-8-1TK"8O)U<?@<VOZ0N2-"?=S=I/-5*8_4B]9V%CT[C)V\E]AC=T^CG
M9,DC9>1%VH3-P]3]=::V>BVW%]53SI5KY*>NW>\_K2>."#>/2R1F7)X1(_N,
M*&62CF4ND]W*D=VJ178+W*.;W-;<"7:9()@BT("M;\27HN/9_-)KAZ%5,FUE
M?L5^%3&9D^V8E>:XC@+4 &MA9B29:.FP?LGLF('2RAN9 M;8O!K;K&1$,<%L
M8YE+-T8=,A389$;KD;P\/=9Q6QD7R;\I!T?PA+,B*F$N)A>E5D>BW+V6;,L\
MJVZ(I,TG=Z7<&@DO>2G@S'"7"VD-;.EF/ZRP H+HK2MF^C]/,49SF9-"]H>1
M\K! 9_"ORQR&^J$*JL[0HO(>7)+]#E''(?^D'0R:R4G_Y>OL+.R"+:(RZ9SB
MFHMQ.*?=)0JBA)AD5YE.$RUJ@)'Q7-^;!5P,"N0I_4LV]36(Q#40K.-^63GC
M\<Z*&8_/R#=$DEJO=SB*'KI%F$6(#Y-P)BH0Z1J@3VBUF=(G ZJT8 "MEUP\
MC"J1X9[B&AO8D%8FPK*#H_*40>6AF903_R2_6_.7X2W]HUT'EK+>+-TVRXI(
M-ZW-LF)BS;<J)E?N)5G:&C?\,:&J3=,RE#,0'C_"Q70H_+W,^4]7F&6(_*G(
MA&%<Z7_4=="<2N*A148(<74=1!,ZPE0\#:82P_"F\B69]244H9/?B9\F#S.V
M<1HWFH64.3&'3[F=23LG1PYN0S1EJS3*"1@B*>O%053"FJTV;*B("[UL/*';
M3V+XS+'/+]2).@'65)3/1X<^=P85_**D(Z3\D%A-DYQL.I=DFP]X4_[0MF76
M0(TG 37VUD"--5!C#=3XED -D>]5 2Z%-#%U)J_"(;0=-&2_<2AGH#@FJLVA
M"%XBT$DHNU#[:F^\=HSI/9]7+OF7?YW0?^"+A>I"B(PU\ZYT7C@T\5!HHE33
MZFNUP\VUQN#BQR ;![\_^@-02QAD63'3,0?VLX\,8W^JYE8NDZ2>!FD*8VUE
M#)V9LSA3-.)822XVJ._=QDA\%8<PF$P(GXU!=OP[:PK.,ULI6;^H+<02JB_5
MD?:S6ICO%DWZ ?ZLNV4.7KS!G./6@W*6-SWCBPNN@=*7L\E+?CZA3J0@#_H0
MJ^1ZUO!M!,3_W[QX]9)17]1L7N([89V$F48!Z7N<  <54)G-V0&'3N_AFB>E
MD[FR<DK4G153HKY.DQLE,:0W.&!II^"L17]$*1]1P  VPLAC)&ZID* KG;(!
M6$9T2QQXA+V3*L;!P5[/R=U&J!T*%AEI6<*6AC16!+RGD6HJ\[-\:W+I<MM&
M6;L5.NW3E9-D[JZ8)/.B<K:88_HAM#Q+;ZL:RX$='QL&6<BP@UEP0Q51+8;D
MJF+A* ZTWE=(7Z1/WE5-')F%^Z]VNLP3ZYD.EG=D]&G1/>R!/[/\)E11''21
M8BZ!]CPMI.Z)I0B6.9B=UD0E9M=-#E=(XOVF->);FJ?O@$VM+Q9L<"SDR\20
M0IIV)<^H7&^H^H0EC-#LXX_)_YV$&>5A:4:^_SM%@$2F=_5:_"X3OW4ZN6\M
M?G=7*WX_)A8<N3R^OZKT+:N(6 AJD+B5Q3]4^1TJ* [(%SVS,4)=8JFRC?M"
MBP=?8V]8\>*;JI[6#HJ+\J[*&ZQ!D'9)&PP:H 7-3ZU5GVY[K\[]]ZWWWJIA
MII@Y_QJY6E)&#-(/'V"]+[SW ;6"&HFAG5A!%U]YEW#>T;[Y:A*AH0:%W\"1
MT:E&45LN1&,"A,ZEIC\8I9-F.N6! ?LZA<+3V?F,^;/+/9(1U5AJB;.3:LD0
M)*#$F58&>J6\S$MO8X!8+YCXH:R$"IU# ^F/H"N<@K<^^=]\*^O$RONBW&AR
M_2SE$J);VYIR^"P2S'R13!G\OD^GQR>(B3;83"SU.!MR/K5>XM"9-Y)Q+5P;
MGPB<BVG_,$YGC+^3H^BUIBFQA"R1"A.2Y$2!60Z->OT#W^L?'1W87V:BX/IM
MQTF:%G,D;L!V1N*4HF#XP8$=#/?EV7]LFD[CG4SEX!CY9ICJ ZZS28Q_E GO
MDCD,Z<9KF>P9[?*HW.4U$H_&:6_/G0_MT?--:KO)<=$Y[I9GULY)]*9%.*[@
MNQL[>B_1"-6B\?J'WF>8 :KWF2DY>?M'>_N,:SS:._ UIT8:PE<.-"KS=1#?
MH/L0=NV"?Z6-Y:R-YA&<PW_#OA.XH84!)R\'-^'D"*%7?$XCE$Z#6 !3OJDD
M<R]IQ.G5<7H3)3>_Q9\&6P<[1_/_V3D=#?]Q]&7PCRX4$F\,ZG+ *L15D-W@
MFAU1]EWU'.C(^&8H!&DE.Z5>*6]NQOO&T#/RS0S1"B3]J?J@;>/<&H*AQN%S
MZ]TBGTD!:AK1W5B[3"MRZHL:%2RP,;JEI37\4),^3O!$V2FS$^L4H'4_371Z
M%Y,UC,63;BH3AEE6.*P\=//&<4\7$^I K-JECF$W[E5?R]TZ2@#3"]-<(^[Q
MGQJ;3#]I<IM,G]&-4O"4GQR,04\KW>TE@B'SRWM=&0RB%P4T]GZ T%GGF>8>
MU(C;*E.,542X'\KB;*1WGV"> F.69#*O<.@+$,)T3BC[ !D@.E]GX:SYF;NI
MW#LKY&>FRL&[6XU9=**.KQ@]>[P8XJ[D(-G7X'G3U2!L3'E>\E-)@@EMDM^+
M<,XII*A6%CD74*"$,(HYY'=)>I-A:?%T?!>DA-Z9Y/RO.P6OS.MYX91/%.3!
MD.IV+:=>?@!OU-F5=\D=>P!_%*G35OD@(9!F!DG.CU ICM(2KEXKE;XE/E'+
M;6DI-=?"RI=9+):&0MDW5+K-Y>E,1Y>J"H/Q__:+ZUD7M> J37X+.D:&X C,
M<.*YR"8HW&381'?:>F'5#WX!+1MK0(] '>O*J6 4?*6+ !IR!<R"4.F(4VHL
M9_K\>I&%Q,)$R]RP/0?6T7-KY<78P'#=O$Z6R77.'-P]"5&RA<:$D11_F)K;
M %1M!BQAUDAXB]Y@TK=-@)RG*<.T;%8L[ 8M+4/Q;GD*I=JQW3*RO#]@AQ!]
M^AHZ]R3HW/X:.K>&SJVA<]\2.D>!4W,P-)_+B'URBVF=Z\*Q5 IC0R.'ARI*
M[BPZU19)KVU,/-',D8^^C3$LSB!N.0%*O67S'NVG[:-%RCN=;Y'P]XZ;0V@K
MEBNF!J+E1L=0D;7K.;54Y>YES$*-1L-Z62K+!/HN1S(SZZ(&DQ>(A&?HO7D/
M*C;H< )%"(S2\1AT,U0^5*3FUQBEB0OT+?B>>C&C?'A]!US-D?-E?HUZ*^=$
MZ]GA9TH_51Y\\?@,U0%-T^P8ZS&DIC=BSIO+<U"HR=+5/S 1)9+.C*W7#-'!
M9*GDPLCK*.F4NRJ=8'<2%AMP'0&ZWHG<)SXF[1+0W+6<&5MIFGT+'+5%.T"O
M1U%[".I&?#G6DWK!E.FSAOU69_B>P\?K+4+A!*:QT#\9G^?1_I]%IOL0&^.>
M74:DOT_<7;U7)87 PR9";W'<BKX>^NK%AMG9L.BBL!) SYJO<U%/,9X#2OB]
MI&LZR?]6<<PA3CP\Z4;7Q/!4Y,%421C5 H@5 L@E5K@1[_N6/.52(/I>37,E
MCY@KIJT1$T/,J00H7VI_I9,6PL+=<M6LX9OMCIH5<?3K0EJ[^WLU6A]S[>!P
M"77/[HI3.JO\_;1R[37YI\#*VEC^Q7G X4.&U7,0$>GR?(>KL19.=!GB75IC
MA[V8U(5&VY=\RE5 OLO?HR6V<*/@Z9[H$I<Y!_-\BXK 9RC%A'WUR*&"UKZ;
MKL?<#90\9Y\'3W YG7.3W<L$0(>>_#8*N70VWT'D.M+2]L37HV2:TIY8,#Y[
M.K52%JMAE[?YN!__/6]/SB\>\"6-A.K;6_W]G_8/CGK^UV/<_AJ$V^YC?PK7
M]M<MA>2*HJZ30NH"LZZW2XRJCN'?[_)D1U_LS1'FSKYGV*@,;J3A#6Z4ED2&
MQ014AGF%:DJZ]I"ZPV2"-'-VV>NB5;B5\U_NU]HN9$VUJMMX&U]G#B\-K].#
M9K++I/BKBD3:2!<NX(S_-=<($*07LDAB2U9X_(KZN& W" ,C5%F22L>%I2G&
M89&6VL3'MV":: 8P-_H,JO-'M#5U\;_R;,J$A(RM6>.0X%I7M9Z5>K5%#Q7&
M^M-\;Q9FD0K&&O(@)+F^C&\[Q[*CYJ_CDIW4W14R?XK:NF)R!1ODQ"*RS#2D
M37"J]\E7TU\_)B)HX977X5QC+^R,1)1"89:7T%QBCTY$=;0QNA1]J^%T-?;.
M$!*3>CFZP6IWY* 1.6#HHD.5UB!^#1!?S5E9I2:S"JYZDJE*?-AFU\,K,;0Q
ML<FSF:Z,@J6:<;O:,/-?8WI4D<9A=NUD^9X>MU&:U6E>!A330C.ZY'OQLJ32
M\_MJ>Y:>0AJHB.H)KD5--U%3)PG[AH#?$FE_T9"S_*O)''G.)<G[6X??;L(W
M@EXG83@P$ $BO!?-G^18"1[@C88JI&K,_6E)/-?*GJ.5F$IT^JX/*IVJU.($
M$&\]/6F$EBH=Y5C$AZ(%*D*W>#TYM+1_\',0WIM2\I0NCDQ<_0QT3(KIM3>%
M9N(F :3[>KC9;^OM>CEV6X[#/V<Y=ER-YT'*5&(-"W'WZRY$>=577X-'W=?@
M&C[Q0/C$P1H^L89/_)CPB?5YTWS>C+J=-U<$MBB#HV*,D21'.1]K;HF*2C,A
M8U&*G+#EJ$OQX _#!1<@5^(1Q$<O;,X7XX^IDF$WR?>>;]F)#^R:-@A!P&"F
MB.491MIMK[^_1P<2_;&[O6=9=!7K#5KE)W:#%_WM]OLV*)T]>(*7T7+#?W@Q
M\-Y0U[L[&GUC8_J6TD! T273()$<\JPU=@#-;C:';32*U')B_R'RDN!K0K+1
M-<J@6A$*WY1WZA,5IQA% 6H6[$=$$&FI[)8OSZR(F:_5G-+3+]EJ ?LYZ1OI
MW:+@1#CZ>J!<<B2>9DZ5@<_*K@.F_D*'(]&!38*("PN47L-:,@>7DQ"WX21
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M_!.K*4R)(L@\+HM)$6$)(2&5)Z=P,$97>'Z->3$$-H#II437M/2V:^:P,MX
M4F$>I"4K1G4-=CN 6Z0!O7=)*C)TU3K\=>VL:HV2AR@!)+PH@G"CFHZB,FQ
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M"LBXEXP&>;9R%$<__^/][L[[N,_CWR$'[_&+_]/OP2IOBM,7?[M,QIC_77(
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M;2UO9)X&PKBU._(R+.I8M]K"+!"?/DG6*%LA+TL0 :VI5&4JU$8PH1%LR;+
MZF$-#M6 RTN/6FR".F34#L*?*C))!E0\2@IJG;4'&&:[:%-9>79]P;M$VVX7
MDZ,607,YN?KV\[9>5*MAX,P([DAKCH!9(4"1<8J$]DN#ALD722952RUJPPAO
MX?PGU;.[RZ#W-B7IEK5;VZ3TZOP$*LDC^U]2/?CO]4:?=.Q2V+ .>Z]F[K5;
M>MK?P(V#FRF1KC7/UVH[ZR'TTH:H0XH24&I7.:^(<41(O5@3N?8#(1.\K>_
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M&"FRM;+Z>!'[3]I6*C7<<1+5*#NZSGJ\;!9=(01[9NDMX?4M&MQ0^5$X92H
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M7;$?ULC:%"W)TZ<>.6LA::B1CY"H8-T._$W;OYO-)DT?D(U$^K2;+3#PD3R
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MN< 1T<QLV=D*@R:O3T@ZABZT!!,84L/4R@LLYA>SDIB.6"$QW0I/2!HOF5?
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MA;9N@)W1807)U1/*_&5,&BZ?]=_G,KJ.4WQ1%66%]";P?+"')Y=PF(R"^B*
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M/3;D\V?V-,U+&@T>R+ <S8>CK4#SJ1_<(QG92#MOML&,GYM_H@""6V6!!]#
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MD.L%<--(HEBNUFTL:2MB-"A*V]EHM:[W,W-.LZ"(82X?.SCPB"91)K@S"_]
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M1A.;MS&>O/:2_Z N]WF610DQ 9ET,LC[<@DW$QXMZH_U.$'QLV]49A:<4,L
M4ZRK>E]07;$>=5ZT!;"F=4._5VIKY0&-OZ$I:B?S@A_7RN?-H[DQ;1TYHA+K
M<-\"C-S]8NK?M):*YWRX =SYQKEP>I7!M  'VU8EMC*1/^OLQMY61-F-IVQ&
MW$;![#V^@CGWJOC/L2RA1;^$X-I=8;HH-1*^#'[/$X(/VTBSW^ HM(%>0FN(
MJ]]@%="%D[:^40J1OZ&E;6E @A/<'[#9WV([=%0%]=J8&O#-)V['DHZ<FJ<W
M*)(Z=(#V/%84S%IDURIWU^496LB.W*1T3HD@V56#M3RUY,OTX+6S$]B^ULS
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M9HQX['&\O/[_V[L6YK:-)/U7IG)W6U(5S"6II^5<+K)$V[JR9:^DQ+N52J5
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M&AF3Y:-1)($R:-@&XZ0EROO'P&<F,9[?A2!C)%\19NSS$7S6+\I62-,22VR
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M  !G;'EC+3(P,C4P,C$T>#AK+FAT;5!+ 0(4 Q0    ( &6$3EIUGODXOB$
M  P5 0 8              "  >$P  !G;'EC+3(P,C4P,C$T>&5X,3!D,2YH
M=&U02P$"% ,4    " !EA$Y:O<1^JO82 0#AQ@< &               @ '5
M4@  9VQY8RTR,#(U,#(Q-'AE>#$P9#(N:'1M4$L%!@     &  8 DP$   %F
$ 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>glyc-20250214x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="glyc-20250214.xsd" xlink:type="simple"/>
    <context id="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001253689</identifier>
        </entity>
        <period>
            <startDate>2025-02-14</startDate>
            <endDate>2025-02-14</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Tc_VFZFOnyiGUW7BkFyDsRoyQ_2_1">0001253689</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Tc_G70hKF1Zr0mf8M4xS-2ptA_3_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Narr_hkHrv1rqhkqZiIHUhxoJmw">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Narr_Achih0528kWTRxt5H6pNGQ">2025-02-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Narr_tH5F6Xi56USkDEwsYqDqYA">GlycoMimetics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Tc_TE3aAhMD9Uy8KXayjPqxLQ_1_0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Tc_VlaW4NVFgUKYklpi8ujmqg_1_2">001-36177</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Tc_HtaYfpdrxkurU8KX1CstVA_1_4">06-1686563</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Narr_6WsCYmA5LkyAAKZe3MhWAQ">P.O. Box 65</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Narr_1Qn0II5Ct0OAHSBpuk8HVA">Monrovia</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Narr_ipRb7N7CdUGULi7CzxncVQ">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Narr_WWMxc3G7f0i-T70P6iFFAA">21770</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Narr_L8n1veQWX0Cbn4_HlqfBuA">240</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Narr_HAYE4dzPykyGMXQdhhQqQg">243-1201</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Narr_T-O69Ap4hEqqVb61LJTExw">true</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Narr_1yY4ExtT5E6WWY_Cw4HVHw">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Narr_c77Rbco8QUypY9vQj0BBZQ">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Narr_77h5LUwZBUuMmKRlH0OtBA">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Tc_8KQidQyaJEOwbeIKp1xoyw_2_0">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Tc_PVJzyohEWUqcxzc4qnD-6g_2_1">GLYC</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Tc_D8_yu_gLG0-hXm6vPt0dOg_2_2">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_2_14_2025_To_2_14_2025_4jbcjpCqnkmCCf4jpVZX5g"
      id="Narr_wBsVxEXIGEWPN4Qm2WN_8Q">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
